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A host can adopt two strategies when facing infection: resistance, where host immune 
responses prevent or reduce pathogen replication; or tolerance, which refers to all 
mechanisms that reduce the impact of the infection on host health or performance. 
Both strategies may be under host genetic control, and could thus be targeted for 
genetic improvement. Although there is ample evidence of genetic variation in 
resistance to infection, there is limited evidence to suggest that individuals also differ 
genetically in tolerance. Furthermore, although resistance and tolerance are typically 
considered as alternative host defense mechanisms, relatively little is known about the 
genetic relationship between them and how they change together over time and jointly 
determine infection outcome. In this thesis, two datasets from experimental challenge 
infection experiments were considered for investigating tolerance genetics: Porcine 
Reproductive & Respiratory Syndrome (PRRS), an endemic viral disease which 
causes loss of growth and mortality in growing pigs; and Listeria monoctyogenes 
(Lm), a bacterium which causes food-borne infections in mammals. The two datasets 
differed substantially in size and genetic structure; the PRRS dataset consists of 
thousands of records from outbred commercial pig populations, whereas the Listeria 
dataset comprises much fewer records from genetically diverse highly inbred strains 
of a mice as a model species. The aims of this thesis were to: 1) Identify if genetic 
variation in host tolerance to infection exists, with case studies in PRRS and listeria, 
using conventional reaction-norm methodology; 2) Identify if host tolerance, along 
with resistance, changes longitudinally as infection progresses; 3) Identify whether the 
WUR genotype is associated with tolerance slope; 4) Analyse the dynamic relationship 
between host performance and pathogen load over the time-course of infection by 
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examining the relationship at different stages of infection using GWAS; 5) Develop 
novel trajectory methodology to offer insight into health-infection dynamics, and 
identify whether there is genetic variation in trajectories; 6) Develop novel trajectory-
derived phenotypes that analyse changes in host performance with respect to changes 
in pathogen load, as an alternative to tolerance, and identify whether genetic variation 
exists. This study found that conventional reaction-norm methodology is limited to 
capture genetic variation in tolerance in outbred populations without measures of 
performance in the absence of infection. However, by utilising repeated longitudinal 
data on the same dataset, stages of infection (early, mid and late) were defined for each 
individual, based on host pathogen load. Using these stages of infection, genetic 
variation in tolerance was identified over all stages of infection and at mid to late stage 
of infection. Genetic correlation between resistance and tolerance was strong and 
positive over all stages of infection, and evidence suggested that resistance and 
tolerance may be under pleiotropic control. Furthermore, this research found that 
genetic correlations between resistance and growth changed considerably over time, 
and that individuals who expressed high genetic resistance early in infection tended to 
grow slower during that time-period, but were more likely to clear the virus by late 
stage, and thus recover in growth. However, at mid-late stage of infection, those with 
high virus load also had high growth, indicating potential epidemiological problems 
with genetic selection of host resilience to infection. Furthermore, genome wide 
association studies for pathogen load and growth associated with different stages of 
infection did not identify novel genetic loci associated with these traits than those 
previously reported for the whole infection period. By adopting conventional 
methodology, this study found genetic variation in tolerance of genetically diverse 
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mouse strains to Lm and pigs to PRRS, despite statistical problems. The relationship 
between resistance and tolerance indicated that both traits should be considered in 
genetic selection programs. By adopting novel trajectory analysis, this study 
demonstrated that level of expression of resistance and tolerance changed throughout 
the experimental infection period and, furthermore, that expression of resistance, 
followed by tolerance, determined survival of infection. Survivors and non-survivors 
followed different infection trajectories, which were partially determined by genetics. 
By deriving novel phenotypes from trajectories that explained changes in growth in 
relation to change in pathogen load at specific time points, and applying these to the 
PRRS data, this study did not identify genetic variation in these phenotypes. The 
genetic signal in these phenotypes may have been masked by the fact that individuals 
were likely at different stages of infection. In summary, this study has shown that 
genetic improvement of tolerance, in addition to resistance may be desirable, but could 
be difficult to achieve in practice due to shortcomings in obtaining accurate and 
unbiased tolerance estimates based on conventional reaction-norms. Infection 
trajectories have proven to be a promising tool for achieving an optimally timed 
balance between resistance and tolerance, but further work is needed to incorporate 




Infectious diseases are a major concern for livestock production. Sometimes it is not 
possible to control spread of a pathogen by conventional methods e.g. vaccination. 
Genetic selection to improve host response to infection has gained increased attention. 
When facing infection, a host can adopt two strategies: resistance, where the host 
immune response prevents or reduces pathogen replication; or tolerance, where the 
host reduces the impact of the pathogen on health. To date, it is not clear whether either 
of these defense strategies, or both together, are important for limiting the impact of 
infection, and determining survival. Here, we considered two case studies of infections 
that affect livestock: 
1) Listeria monocytogenes (Lm), which is a zoonotic, bacterial pathogen that can 
cause severe food-borne infections in humans and animals using genetically 
different inbred strains of mice as a model species. 
2) Porcine Reproductive & Respiratory Syndrome (PRRS), which is a viral 
disease that can lead to severe weight loss and mortality in growing pigs. 
Individuals are known to differ in resistance in both Lm and PRRS, and that the 
outcome of infection is partly determined by the host’s genetics. However, it is not 
known whether hosts also vary genetically in tolerance. Our research identified that 
pigs may exhibit tolerance to PRRS, but that the methodology normally used to define 
and estimate tolerance were impractical to estimate tolerance of pigs to PRRS in this 
study, and that large amounts of data are required to estimate tolerance. When using 
repeated data for each individual, we found that pigs do vary genetically in tolerance 
to PRRS, and that resistance and tolerance to PRRS were positively related, meaning 
that the two traits may be controlled by similar genes. Furthermore, we found mice 
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exhibit different degrees of both resistance and tolerance to Lm based on their genetics. 
We also examined changes in host health and resistance at different stages of infection. 
We found that the relationship between health and resistance changed throughout 
infection, and that pigs that exhibit resistance at early stage of infection could recover 
health better later in infection.  Furthermore, we established a novel method which 
allowed us to investigate how resistance and tolerance change together over the time-
course of infection. For Lm, only mice exhibiting high resistance early in infection 
survived. We also found that a host can show one of four unique types of response to 
Lm infection based on both on bacterial load and health outcome over time. These 
types are partly determined by genetic factors. However, when applying this method 
to examining how pigs differed in their response to PRRS, we could not determine any 
genetic basis. Our study provides new insights into the complex relationship between 
resistance and tolerance and helps to understand what matters to recover from and 
survive infection challenges, and the need to use new methods to capture this 
relationship. 
 




1.1 Infectious disease threat to livestock production 
Infectious diseases pose a severe threat to livestock production worldwide. 
Management challenges and high population density on farms provide an environment 
in which pathogens can transmit easily between hosts, evolve, and lead to, often 
severe, epidemics. Pathogens affecting livestock production have been diverse, from 
viruses and prions to bacteria and parasites which have led to severe economic losses 
to the livestock industry (with costs up to 20% and 50% of turnover in developed and 
developing countries respectively), and severe animal welfare implications [1]. 
In some cases, conventional infection control measures, such as vaccination 
programmes and culling, have been successful. However, there are some pathogens 
which cannot be controlled or eliminated, due to e.g. high pathogen mutation rate or 
lack of vaccine efficacy. The question, then, is how to control the spread of infectious 
disease on, or across, farms, and, how to mitigate the impact of the infection on animal 
health and production. One possible solution that has gained attention in recent years 
is genetic selection for improved host response to infection. Recent advances in genetic 
and genomic technologies have provided opportunities to implement genetic selection 
programs to improve host response to infectious disease which, when combined with 
conventional infection control measures, could provide a strategy to control infectious 




1.2 Resilience, Resistance & Tolerance 
A host can respond to infection in different ways. Generally, resilience refers to the 
ability of a host to cope with stressors, such as infectious challenge [4]. Resilience thus 
describes how host fitness, health or performance, such as body weight or growth, is 
affected by being exposed to infection. An individual that performs better than another 
when exposed to infectious pathogens is therefore more resilient (i.e. performance is 
less impacted by infection). Improving host resilience is an obvious goal for genetic 
selection [2]. However, resilience is a composite trait, comprising two underlying 
strategies that a host can adopt when infected with a pathogen. The first strategy is 
resistance, which is well-defined in the literature, and considered as the ability of the 
host to prevent or inhibit pathogen replication [5]. Resistance can be viewed as a 
function of the host immune system, and its involvement in the detection, 
neutralisation, destruction or removal of pathogens [6]. As such, resistance is often 
defined as the inverse of within-host pathogen load, i.e. the lower the pathogen load, 
the more resistant the host (figure 1A) [5].   
Another strategy a host can adopt when infected with a pathogen is tolerance. Similar 
to resilience, tolerance refers to the ability of the host to maintain fitness, health or 
performance in the face of pathogen challenge. However, unlike resilience, tolerance 
to pathogens is only defined for infected animals and describes this ability in relation 
to changes in within-host pathogen load [5,7,8]. Similar to resilience, tolerance may 
be defined as a reaction norm of performance with respect to pathogen load, but where 
the x-axis for a resilience reaction norm refers to exposure i.e. external pathogen load, 
the x-axis for a tolerance reaction norm refers to within-host pathogen load [8,9] (see 
figure 1B & C for illustration, and 1.3 Conventional methodology for estimation of 
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genetic variation in tolerance section). As such, tolerance does not impact on the 
pathogen life-cycle, per se. Rather, tolerance mechanisms work on host repair and 
damage control. Although the immunological mechanisms underlying tolerance are 
largely unknown, it has been suggested that tolerance can be related to tissue damage 
caused by the pathogen (direct tolerance) or by the host immune response (indirect 
tolerance) which can be achieved through tissue protection and repair [6,10]. 
Furthermore, possible mechanisms for a host to express tolerance have been suggested, 
such as: the ability of the host to minimise damage caused by host inflammatory 
response, to take into consideration the costs of mounting an immune response to a 
pathogen, in terms of nutrient resources, and to minimise the cost of damage caused 
by the pathogen [11]. For example, a host can respond to infection by undergoing 
anorexia, where infected individuals can increase tolerance to infection by reducing 
their intake, thus diverting essential nutrients required for digestion to manage 
infection, assuming the costs of digestion are high [12,13]. 
The first study to demonstrate genetic variation in tolerance in animals was provided 
by Raberg et al [5], where mice were shown to differ in both tolerance and resistance 
to Plasmodium chabaudi. However, tolerance terminology has been ambiguous in the 
literature. For example, ruminants with improved ability to counteract the lifecycle of 
pathogenic trypanosomes have been referred to as trypano-tolerant ruminants [14]. In 
this case, tolerance actually referred to resistance mechanisms or encompassed both 
resistance and tolerance mechanisms. Indeed, many scientists and animal breeders 
consider resilience and tolerance as interchangeable terms regarding the same trait, as 
both are concerned with the impact of pathogens on host performance [4]. Assuming 
individuals are equally exposed to pathogens, measures of performance under 
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infection are often used as measures of resilience [15]. The crucial difference between 
resilience and tolerance, that tolerance quantitatively accounts for pathogen burden, 
has been largely ignored by the literature. This may explain why few studies to date 
have explicitly investigated the relationship between resilience and tolerance. 
Despite tolerance mechanisms being studied extensively in plants [16–18], and being 
acknowledged as playing a vital role in ecology and immunology [6,7,11,19], to date, 
genetic analyses of host response to infection have focused primarily on the 
mechanisms underlying host resistance [3,20–24], the rationale being that 
improvement of host resistance mechanisms should, in turn, improve host resilience 
to infectious disease. This is because hosts that harbor fewer pathogens are expected 
to be healthier and thus perform better. Estimates and genetic parameters of resistance 
have been explored, with genetic variation in resistance identified to different 
infectious diseases and across different livestock species [25,22,26,27]. However, 
despite interest in improving host resilience through resistance mechanisms, few 
studies focused on improving host resilience through tolerance mechanisms [28]. It is 
important to distinguish between resistance and tolerance as selection for one may 
affect the other, and may have different epidemiological and evolutionary outcomes. 
There have been conceptual theories and supporting evidence to suggest an 
antagonistic relationship between resistance and tolerance [29]; that cost and trade-off 
associated with both tolerance and resistance would create a negative genetic 
correlation between the traits [18,30].  
In addition to the trade-off theory promoting negative genetic correlation between 
tolerance and resistance, there has been both discussion and evidence to suggest that 
tolerance and resistance co-occur together, contributing additively to host fitness [31]. 
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It has been argued that expression of tolerance is conditional upon host resistance [26] 
and that, in the presence of disease, tolerance and resistance are expressed 
pleiotropically, with tolerance only expressed when the host experiences damage [9]. 
Furthermore, from an immunological perspective, resistance may require 
immunological mechanisms to reduce pathogen load, which may be damaging to the 
host. In this case, resistance would be related to indirect tolerance (to damage caused 
by immune response), which would be advantageous to the host over direct tolerance 
(to damage caused directly by the pathogen), thus there would be an expected positive 
genetic correlation between resistance and indirect tolerance. The genetic correlation 
between direct tolerance and resistance would thus depend on the genetic relationship 
between indirect and direct tolerance [10]. The authors of the former study suggested 
that resistance and tolerance could not evolve independently, using the rationale that 
resistance is only beneficial when disease reduces performance, which would not 
occur if the host expressed tolerance, and that tolerance is only expressed when 
infection causes damage, which would not occur if the host was resistant. 
Additionally, there has been support for the argument that resistance and tolerance 
have alternative evolutionary outcomes and different degree of genetic variation; 
notably that tolerance will tend to fixation, whereas genetic variation in resistance is 
more likely to be maintained [32]. It has also been argued that hosts with resistant 
genotypes to one pathogen may still be susceptible to another, where a tolerant 
genotype may allow tolerance to multiple pathogens given that tolerance mechanisms 
would limit the damage caused by pathogens [33]. With that in mind, selecting for host 
tolerance may be a viable infection control strategy where elimination of a pathogen 
is unlikely, such as where the pathogen is highly prevalent in a population [26]. Unlike 
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resistance, tolerance should not, in theory, impose selection pressure on the pathogen, 
as it does not limit pathogen replication, at least directly [32]. However, tolerance may 
be driven to fixation in a population, given that it would be a selective advantage to 
carry the gene [32]. Some studies have identified host genetic variation in resistance, 
but not tolerance, concluding that lack of genetic variation in tolerance meant that the 
host had evolved “maximum tolerance” [34]. 
 
1.3 Conventional methodology for estimation of genetic variation in tolerance 
As stated above, tolerance is typically defined as a reaction norm of performance with 
respect to pathogen load. Assuming a linear relationship, tolerance can be estimated 
by regression of host performance against pathogen load (figure 1B/C), where the 
corresponding regression slope provides a measure of tolerance. Thus, slopes of equal 
value would indicate equal tolerance between genotypes (figure 1B); a slope value of 
zero would confer complete tolerance, that is, no performance is lost with increasing 
pathogen load (figure 1C); and a negative value would then indicate a reduction in 
performance due to infection. The steeper the slope, then, the less tolerant an 
individual (figure 1C). A positive value would confer overcompensation, where an 
increase in host performance would occur, despite being infected with a pathogen. 
Evidence for genetic variation in tolerance has been provided by showing a significant 
statistical interaction between family (or genotype, or breed) and infection severity in 




Figure 1. Graphical illustration of A) Resistance, and B/C) Tolerance. Figure 1A) 
shows 2 genotypes (a and b) infected with a pathogen. Genotype b has a lower 
pathogen load, and as therefore the more resistant genotype. Figure 1B shows two 
genotypes (a & b) of equal tolerance, where performance is lost with respect to 
pathogen load at an equal rate. However, genotype a has higher vigour (performance 
in absence of infection) than genotype b. Figure 1C shows two genotypes (a & b) that 
differ in tolerance to infection. Genotype b has a steeper slope then genotype a, and is 
thus less tolerant than genotype b, suffering greater loss in performance with respect 
to pathogen load. Despite having lower vigour, genotype a exhibits complete tolerance 
(slope value of zero), thus suffers no loss in performance related to pathogen load. 
 
For outbred populations with a complex pedigree structure, tolerance slopes of related 
individuals can be estimated by random regression models, which, when combined 
with pedigree or genomic information, provide estimates for genetic variance of 
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tolerance, and for genetic variance in host performance as a function of pathogen load 
[35]. Such a random regression model can provide additive genetic variance estimates 
for vigour (intercept – performance in the absence of infection), tolerance (the 
regression slope), and the covariance between them. However, due to the large amount 
of data required to obtain unbiased variance estimates for reaction norm slopes 
[4,35,36], very few studies to date have applied this methodology to gain insight into 
the genetic basis of disease tolerance in outbred populations [37]. To our knowledge, 
there is currently no conclusive evidence for genetic variation in tolerance of domestic 
livestock to infections. 
 
1.4 Novel methodology for estimation of genetic variation in tolerance 
Using the reaction norm approach, tolerance can be estimated at the group level [8], 
but cannot be estimated at the individual level, as estimation of regression slopes 
requires multiple pairwise measures of the response variables [38]. There are 
disadvantages of estimating tolerance with the reaction norm methodology. Firstly, the 
current methodology can only provide unbiased tolerance slope estimates if hosts are 
assumed to become infected at the same time, or if infection time is known, which will 
not be the case in farms. Secondly, in animal breeding, there is restricted selection 
accuracy and response to selection if phenotypes are on the group level [4]. 
Resistance and tolerance are comprised of many different immunological and 
pathological processes and are thus likely highly dynamic. As such, expression of host 
resistance and tolerance, and their relationship are likely to change over the time-
course of infection. It has been reported that genetic variation of tolerance and 
resistance are time-dependent [39], with genetic variation in both tolerance and 
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resistance identified at acute stage of infection, and genetic variation in only tolerance 
during recovery [31]. As a potential method of capturing this dynamic relationship and 
simultaneously improving host resistance and tolerance, 2D infection trajectories that 
describe how changes in performance change with respect to changes pathogen load 
throughout the time course of infection, may be able to provide valuable insight. It has 
been suggested that such infection trajectories could be used to describe changes in 
health dynamics in disease space [38] and that host resilience can be predicted based 
on partial trajectory analysis [40]. Doeschl-Wilson et al., introduced the theory of 
trajectories to the context of animal breeding, suggesting different trajectory classes 
may exist, depending on the dynamics of host health-pathogen interactions [41]. 
 
1.5 Genome Wide Association Studies 
Another approach to analysing the relationship between health and pathogen load is to 
adopt genome wide association studies (GWAS). To identify genomic regions that are 
associated with phenotypic traits, GWAS have been be adopted in animal breeding 
[42]. GWAS enables the statistical association of genetic markers with phenotypic 
traits of interest by linking the marker genotypes of each individual to the phenotype 
[43–45]. For the pig dataset in this study, Single Nucleotide Polymorphisms (SNPs) 
were previously used as genetic markers to detect QTL. Currently, high-density SNP 
chip panels provide genotypes for hundreds of thousands of genetic loci [46], across 
the whole genome of an individual, in this case, the Sus scrofa genome. By identifying 
genomic regions associated with a phenotypic trait, chromosomal position can be 
further investigated to identify potential target genes for selection, and the associated 
biochemical pathways the gene encodes. Numerous studies have used GWAS to 
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demonstrate genetic basis for traits associated with Porcine Reproductive and 
Respiratory Syndrome (see 1.6.1 Case study 1: Porcine Reproductive and 
Respiratory Syndrome (PRRS) section of thesis). 
Genomic association studies, such as GWAS, rely on linkage disequilibrium (LD), 
between the genetic markers and QTL that is, marker and SNP genotypes are not 
independent of each other. Furthermore, if SNPs are in high LD with each other, it is 
more appropriate to identify genomic regions comprising several SNPs associated with 
a phenotypic trait, rather than carrying out the GWAS at the level of individual SNPs. 
There are different methods that can be adopted to identify genomic regions associated 
with a trait. GWAS using Bayesian variable selection can be used, which is a method 
adapted from genomic prediction methodology [47–50]. 
 
1.6 Case studies considered in this thesis  
To identify genetic variation in tolerance through conventional and novel 
methodology, two case studies will be considered in this thesis: Porcine Reproductive 
and Respiratory Syndrome (PRRS) and Listeria. The PRRS data were from an outbred 
population of pigs, and was used for conventional estimation of tolerance, whereas the 
Listeria data came from genetically diverse inbred mice, as a model species, which 
were used to develop and test the novel trajectory methodology. 
 
1.6.1 Case study 1: Porcine Reproductive and Respiratory Syndrome (PRRS) 
Porcine Reproductive and Respiratory Syndrome (PRRS) is a viral disease, endemic 
in pigs worldwide. PRRS causes respiratory problems and considerable reduction in 
the growth rate of piglets, with estimates ranging between 10% to 20% [51], with 
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resulting production losses amounting to an annual cost of $493.57 million to the U.S. 
swine industry [52]. PRRS is caused by a single-stranded positive sense RNA virus, 
which has a high mutation rate causing antigenic and genic shift in both structural and 
non-structural proteins of the virus, allowing the virus to avoid innate immune 
response [53]. As such, vaccination has been largely unsuccessful [54], and so host 
genetic improvement in response to PRRS has gained increased attention [3,55,56]. 
Large-scale PRRSV challenge studies carried out by the PRRS Host Genetics 
Consortium (PHGC) have demonstrated considerable genetic variation in resistance 
of pigs to PRRSV infection, as well as in growth of infected piglets [57,58,55]. Genetic 
correlations between resistance and growth (resilience) have been shown to be positive 
and strong [55], indicating that selection for improved resistance is expected to 
simultaneously improve resilience to infection and vice versa. However, it is currently 
unknown whether there is genetic variation in tolerance to PRRS. The PRRS Host 
Genetics Consortium (PHGC) data, which provide simultaneous measures of growth 
and viral load for over 1,500 pedigreed pigs infected with the same PRRS virus load 
offer a unique opportunity to estimate genetic parameters for tolerance. 
 
1.6.2 Case study 2: Listeria 
Listeria monocytogenes is a zoonotic facultative anaerobe. The natural route of 
transmission is by epithelial cells in the intestine, from where dissemination is possible 
and can lead to systemic infection. Animals do not generally show clinical signs when 
infected with listeria, with 6% carrying listeriae as part of their faecal flora [59]. 
However, in a small proportion of cases, severe listeriosis can occur, where it may be 
possible for listeria to cross the blood-brain barrier causing meningitis, or crossing the 
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placenta, causing abortion in pregnant animals. Theoretically, this points to variation 
in tolerance, rather than in resistance to this disease. A recent listeria infection 
challenge experiment collected data from multiple repeated measures for individual 
host mice from genetically diverse inbred strains. This dataset provided individual 
longitudinal measures for both performance and infection intensity prior and during 
infection thus constitute the ideal dataset to test whether the previously proposed 
infection trajectories provide valid new insight into the genetic and dynamic regulation 
of host resistance and tolerance. 
 
1.7 Aims of this study 
This study aimed to: 
1) Identify if genetic variation in host tolerance to infection exists, with case 
studies in PRRS and listeria, using conventional reaction-norm methodology. 
2) Identify if host tolerance, along with resistance, changes longitudinally as 
infection progresses. 
3) Identify whether and to what extent a previously identified genomic region 
associated with resistance is also associated with tolerance. 
4) Analyse the dynamic relationship between host performance and pathogen 
load over the time-course of infection by examining the relationship at different 
stages of infection using GWAS. 
5) Develop novel trajectory methodology to offer insight into health-infection 
dynamics, and identify whether there is genetic variation in trajectories. 
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6) Develop novel trajectory-derived phenotypes that analyse changes in host 
performance with respect to changes in pathogen load, as an alternative to 
tolerance, and identify whether genetic variation exists. 
 
1.8 Structure of this thesis 
This thesis consists of 5 research chapters: In chapter 2, random regression 
methodology is applied to the PHGC data to estimate genetic variation in tolerance of 
pigs to PRRS at both the acute phase of infection (defined as 0 to 21 days post-infection 
(dpi)) and over a prolonged observation period (defined as 0 to 42 dpi). In chapter 3, 
the PHGC data are partitioned into stages of infection (early, mid and late stages), 
based on individual viremia profile characteristics to allow for more biologically 
relevant models. Random regression models are then applied to each stage of infection 
to identify if genetic variation in tolerance exists at different stages of infection. 
Furthermore, by harnessing information on growth and serum virus load for each stage 
of infection for each individual, a random regression model is applied across all stages 
of infection to identify if repeated measures could help identification of genetic 
variation in tolerance. Chapter 3 also assesses the association between the previously 
identified resistance genotype and tolerance. In chapter 4, the stages of infection 
defined in chapter 3 are used to analyse the relationship between growth and resistance 
by examining genetic correlations and heritabilites of the traits throughout different 
stages of infection. Additionally, a GWAS is adopted to identify genomic regions 
associated with growth and resistance to PRRSV infection over time. After thorough 
inspection of the shortcomings of random regression models for estimating genetic 
parameters for tolerance in chapters 2-3, a novel approach based on previously 
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described individual infection trajectories is proposed in chapter 5. The methodology 
is first applied to infection data from a mouse model, as these are less noisy and thus 
easier to analyse. In line with the previous chapters, a conventional reaction norm 
approach is first used to identify genetic variation in tolerance of inbred strains of mice 
to listeria. Subsequently, bacterial infection trajectories of mice are constructed and 
analysed, in particular with regards to the question whether trajectories are genetically 
determined and could be used to discriminate the infection paths between animals that 
eventually succumb or recover from infection. In chapter 6, trajectories are then 
implemented for the pigs of the PHGC PRRSV infection trials. Finally, in chapter 7, 
the general discussion section combines the results from each chapter and discusses 




Chapter 2  
Use of multi-trait and random regression models to identify 
genetic variation in tolerance to Porcine Reproductive and 
Respiratory Syndrome virus 
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A host can adopt two response strategies to infection: resistance (reduce pathogen 
load) and tolerance (minimize impact of infection on performance). Both strategies 
may be under genetic control and could thus be targeted for genetic improvement. 
Although there is evidence that supports a genetic basis for resistance to porcine 
reproductive and respiratory syndrome (PRRS), it is not known whether pigs also 
differ genetically in tolerance. We determined to what extent pigs that have been 
shown to vary genetically in resistance to PRRS also exhibit genetic variation in 
tolerance. Multi-trait linear mixed models and random regression sire models were 
fitted to PRRS Host Genetics Consortium data from 1320 weaned pigs (offspring of 
54 sires) that were experimentally infected with a virulent strain of PRRS virus to 
obtain genetic parameter estimates for resistance and tolerance. Resistance was 
defined as the inverse of within-host viral load (VL) from 0 to 21 (VL21) or 0 to 42 
(VL42) days post-infection and tolerance as the slope of the reaction-norm of average 
daily gain (ADG21, ADG42) on VL21 or VL42. 
Multi-trait analysis of ADG associated with either low or high VL was not indicative 
of genetic variation in tolerance. Similarly, random regression models for ADG21 and 
ADG42 with a tolerance slope fitted for each sire did not result in a better fit to the data 
than a model without genetic variation in tolerance. However, the distribution of data 
around average VL suggested possible confounding between level and slope estimates 
of the regression lines. Augmenting the data with simulated growth rates of non-
infected half-sibs (ADG0) helped resolve this statistical confounding and indicated that 
genetic variation in tolerance to PRRS may exist if genetic correlations between ADG0 
and ADG21 or ADG42 are low to moderate. 
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Evidence for genetic variation in tolerance of pigs to PRRS was weak when based on 
data from infected piglets only. However, simulations indicated that genetic variance 
in tolerance may exist and could be detected if comparable data on uninfected relatives 
were available. In conclusion, of the two defense strategies, genetics of tolerance is 
more difficult to elucidate than genetics of resistance. 
 
2.2 Introduction 
Infectious challenges in domestic livestock not only raise health and welfare concerns, 
but also have detrimental effects on livestock production. The impact of infections on 
an animal’s productive performance is controlled by two alternative (albeit not 
mutually exclusive) host traits that may be amenable to genetic improvement: 
resistance and tolerance. Resistance is defined as the ability of a host to prevent 
pathogen entry or inhibit replication of the pathogen, whereas tolerance refers to the 
ability of a host to limit the impact of infection on health or performance without 
interfering with the pathogen life-cycle per se [7]. Thus, animals with greater 
resistance are expected to harbor fewer pathogens that can inflict loss in performance. 
In contrast, animals with greater tolerance may harbor high within-host pathogen load 
but are able to prevent or repair the damage of infection on health and performance 
[5,60]. To date, most efforts to control infectious disease have targeted primarily 
improvement of host resistance. More recently, the focus has expanded towards 
boosting host tolerance as an alternative means to counteract the detrimental impact of 
infection on health and performance [6,28]. However, little is known about the extent 
to which tolerance is genetically controlled and thus suitable for genetic improvement. 
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Porcine Reproductive and Respiratory Syndrome (PRRS) is an endemic virus, which 
causes one of the most devastating swine diseases worldwide. PRRS causes 
considerable reduction in the growth rate of piglets, with estimates ranging from 10 to 
20%, depending on pig breed and virus strain [51], with resulting production losses 
amounting to an annual cost of $493.57 million to the U.S. swine industry alone [52]. 
As vaccination has been largely unsuccessful [54], genetic solutions to PRRS have 
gained increased attention [3,55,56]. Recent large-scale PRRSV challenge studies 
carried out by the PRRS Host Genetics Consortium (PHGC) have demonstrated 
considerable genetic variation in resistance of pigs to PRRSV (virus) infection, as well 
as in weight gain of infected piglets [57,58,55]. Furthermore, genetic correlations 
between resistance and weight gain have been shown to be positive and strong (ranging 
from 0.57 to 0.75 for two different PRRSV strains) [55], indicating that selection for 
improved resistance is expected to simultaneously improve growth under infection and 
vice versa. However, it is not currently known whether pigs also differ genetically in 
their tolerance to PRRSV infection, or whether pigs with greater genetic resistance to 
PRRSV are also genetically more tolerant to PRRS. 
Resistance can be measured as the inverse of within-host pathogen load, whereas 
tolerance is related to the degree to which performance is reduced by infectious 
pathogens. Tolerance is mathematically defined as a reaction-norm of performance 
with respect to pathogen load [5,9]. Assuming a linear relationship, reaction-norms 
can be modelled by linear regression of performance against pathogen load, where the 
regression slope provides a measure of tolerance (Figure 1). Thus, a slope of zero 
indicates complete tolerance, while a more negative slope indicates lower tolerance. 
Statistically significant differences in reaction-norm slopes associated with, e.g., 
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different breeds or families are indicative of genetic variation in tolerance. For outbred 
populations, tolerance slopes for groups of related individuals can be estimated by 
random regression models, which provide estimates for genetic variance of tolerance 
and for genetic variance in host performance as a function of pathogen load when 
combined with pedigree or genomic information [35]. However, due to the large 
amount of data required to obtain unbiased variance estimates for reaction norm slopes 
[4,35,36], very few studies have applied this methodology to gain insight into the 
genetic basis of tolerance in outbred populations [37]. The PRRS Host Genetics 
Consortium (PHGC) data, which provide simultaneous measures of growth and viral 
load for over 1,500 pedigreed pigs infected with the same PRRS virus load offer a 
unique opportunity to estimate genetic parameters for tolerance. 
The main aim of this study was to determine whether pigs previously found to differ 
genetically in resistance to a virulent strain of PRRSV also differ genetically in 
tolerance. Furthermore, by augmenting the data with simulated data, novel insights 
into data requirements for accurately estimating genetic variance in tolerance using 
random regression models were obtained. 
 
2.3 Methods 
2.3.1 Infection experiment and data 
Data were provided by the PRRS Host Genetics Consortium (PHGC) from 9 different 
PRRSV challenge trials with an identical infection protocol [55,3], comprising 
altogether 1569 pigs supplied by various commercial breeding companies, as outlined 
in Table 1. 
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Table 1 Animal, pedigree and breed composition of the PHGC trials 




dams Breed cross 
1 174 6 70 LW × LR 
2 164 10 72 LW × LR 
3 115 7 47 LW × LR 
4 191 6 33 Duroc × LW/LR 
5 182 10 38 Duroc × LR/LW 
6 109 26 53 LR × LR 
7 186 6 27 Pietrain × LW/LR 
8 158 15 43 Duroc × LW/LR 
15 166 11 49 Pietrain × LW 
LW: large white breed; LR: landrace breed 
 
All experimental protocols for these trials were approved by the Kansas State 
University Institutional Animal Care and Use Committee. In each trial, approximately 
200 commercial crossbred piglets were transferred from high health farms at weaning 
age (mean age=26 days, range=17 to 32 days) to a research facility at Kansas State 
University. The source farms were determined to be free of PRRSV, Mycoplasma 
hyopneumoniae, and swine influenza virus. Pigs were randomly placed in pens of 10-
15 individuals. Following a 7-day acclimation period, pigs between 17 and 32 days of 
age were experimentally infected both intramuscularly and intranasally with 105 
(TCID50) of NVSL-97-7985, a highly virulent PRRSV isolate [61]. Body weight 
(BW) and blood samples were collected at 0, 7, 14, 21, 28, 35 and 42 days-post-
infection (dpi). Pigs were then euthanized at 42 dpi and ear notches were collected for 
genotyping. Trials 7 and 8 were terminated at 35 dpi due to facility availability. 
Estimates for Average Daily Gain (ADG) from 0 dpi until day of measurement were 
obtained by dividing the difference in body weight between the day of observation and 
0 dpi by the corresponding time period. Note that measurements of ADG for these pigs 
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prior to infection were not available, nor were ADG measurements for non-infected 
relatives. 
Serum viremia, measured using a semi-quantitative TaqMan PCR assay for PRRSV 
RNA, provided repeated (bi-weekly up to 14 dpi, then weekly) measures for log10-
transformed qPCR viremia, as described in Boddicker et al. [22,57,58]. Mathematical 
functions were previously fitted to these log10 transformed viremia measures to smooth 
the data and to obtain continuous viremia estimates over the 42-day observation period 
[62]. As outlined in Islam et al, the uni-modal Woods function and the extended bi-
modal Woods function provided a good fit to the individual’s data with either uni-
modal (!(#) = &'#()*+,)-) (~67%) or bi-modal (! # = &'#()*+,)- +
max	(0, &5 # − #7 (8*+,8 # − #7 )) (~33%) viremia profiles, respectively, with 
strong correlations between model predictions of VL and actual viremia measures 
(genetic and phenotypic correlation estimates were 0.98±0.03 and 0.90±0.01, 
respectively) [55]. 
Across all trials, 198 pigs died before 42 dpi. PRRS was identified as the primary cause 
of mortality, except for trial 6, for which mortality was higher (46% by 42 dpi) and 
was potentially caused by secondary bacterial infections [58]. These pigs were 
included in the analyses until their time of death.  
Only offspring from sires with more than 10 progeny with phenotypes were considered 
in this study to reduce the risk of bias in tolerance estimates [35]. As such, the number 
of animals included was 1320 from 0 to 21 dpi and 1001 from 0 to 42 dpi, originating 
from 54 sires. 
Pedigree information and genomic information using genotypes from Illumina’s 
Porcine SNP60 Beadchip v.1 [46], was available for all pigs. The pedigree-based 
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numerator relationship matrix (A) and genomic relationship G-matrix (Gm), were 
constructed in ASReml 3.0 [63] using the VanRaden method for all animals used in 
the analysis, where A contains the additive genetic relationship between animals, and 
Gm contains the genotypes for each animal. For the G-matrix, SNPs that were fixed in 
a trial were removed. Trials 1, 2, and 3 had the most extensive pedigree information, 
with pedigree up to two generations back, while the rest of the trials only had sire and 
dam recorded. As such, there were no relationships between animals in different trials, 
except for trials 1, 2, and 3, which consisted of animals from consecutive parities of 
the same breeding company (Table 1). Pedigree was corrected using parental 
genotypes for all trials, as described by Boddicker et al. [58] and Hess et al. [55]. The 
G-matrix was constructed using the VanRaden method [64], and included relationships 
between animals across trials regardless of breed, as outlined by Hess et al. [55]. The 
A-matrix was used for all the following statistical models, unless otherwise noted. 
 
2.3.2 Resistance, tolerance, and performance without infection 
Resistance is often quantified by a measure of within-host pathogen load, whereby 
lower pathogen load reflects higher host resistance [4–6]. In this study resistance to 
PRRS was defined as the inverse of serum viral load, whereby VL42 represents the 
cumulative log-transformed viral load from 0 to 42 dpi from the Woods curve. As 
viremia had reduced to undetectable levels within 21 to 28 dpi for a large proportion 
of pigs, cumulative viral load (and thus resistance) was not only calculated for the 
entire observation period from 0 to 42 dpi, but also for the period from 0 to 21 dpi. 
This represents the acute phase of infection, yielding two indicator traits for resistance 
(VL21 and VL42). 
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In this study, tolerance was assessed by regressing performance measures (i.e. ADG21 
or ADG42 on y-axis) on pathogen load (i.e. VL21 or VL42, respectively on x-axis). The 
regression of ADG42 on VL21 was also evaluated to account for the possibility of a 
time lag in growth response with respect to changes in pathogen load. 
Growth performance of an infected individual is likely to depend on both their 
response to infection and performance in the absence of infection. Performance in 
absence of infection (i.e. when pathogen load is equal to zero), commonly denoted in 
the tolerance literature as vigor [65], constitutes the intercept of the linear reaction-
norms (Figure 1). Previous simulation studies indicated performance measures in the 
absence of infection are important for obtaining unbiased tolerance slope estimates 
[35]. However, information on performance of the PRRSV challenged pigs in absence 
of infection was not available in this study. 
Two approaches were adopted to overcome this lack of performance measures without 
infection. 1) in line with the standard approach of quantitative genetic studies of 
reaction-norms, the origin of the explanatory variable VL was shifted to the mean VL; 
this ‘shifted intercept’ for ADG is referred to as the ‘level’, in contrast to vigor 
[36,66,67] (Figure 1). Note that this approach does not provide accurate information 
about the genetic relationship between tolerance and vigor, as the genetic correlation 
between level and slope is not equal to the genetic correlation between performance at 
VL = 0 and slope [68,69]. Furthermore, individual body weight at the start of the 
infection (BW0) was included as a fixed covariate in the corresponding statistical 
models to partially account for differences in vigor. 2) to gain better insight into data 
requirements for accurately estimating genetic parameters for tolerance, and about 
how these estimates depend on the genetic relationship between growth in absence or 
	 29	
presence of infection, growth records of infected pigs were augmented with simulated 
growth records of non-infected half-siblings, as outlined in step 4 below. 
 
Figure 1. Graphical illustration of reaction norms for analysis of tolerance.  
 
Mean VL is indicated by the stippled line in each graph. Each line corresponds to one 
of four hypothetical sires. Figure 1A shows the null model, where all sires have equal 
tolerance and equal overall growth level. As such, there is only one (average) 
tolerance slope. Figure 1B shows reaction-norms of sires with equal tolerance. Sires 
differ in intercept (growth where VL=0) and level (growth at mean VL), but have equal 
tolerance slopes. No re-ranking of sires occurs between growth associated with low 
and high VL, and genetic correlation between intercept and level is 1.00. Figure 1C 
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illustrates reaction norms of sires with variation in intercept and tolerance slopes, but 
no variation in level. Re-ranking of sires occurs depending on whether offspring 
harbor low or high VL, respectively, as indicated by crossing over of lines before and 
after mean VL. Figure 1D describes reaction norms of sires where variation occurs at 
intercept, level and tolerance slope. Sire re-ranking occurs between low and high VL, 
and genetic correlation between intercept and level is below one. 
 
2.3.3 Statistical analyses 
All statistical analyses were carried out using ASReml 3.0 [63]. Random regression 
reaction-norm models are prone to biased estimates if data requirements to disentangle 
intercept from slope are not met [35,36,70] thus a stepwise approach was adopted. 
(Step 1) multi-trait animal models were used to estimate the genetic relationship 
between resistance and growth under infection; (Step 2) multi-trait models were used 
to provide evidence for genetic variation in tolerance of pigs to PRRS based on the 
genetic correlation between growth associated with low and high VL, respectively; 
(Step 3) a univariate random regression model was applied to obtain estimates for 
genetic variance in tolerance; and (Step 4) data were augmented using simulated 
performance in the absence of infection (ADG021 or ADG042), with increasing 
simulated genetic correlation from weak to strong between ADG021 and ADG21 or 
ADG042 and ADG42, respectively. The random regression models from step 3 were 





2.3.4 Step 1: Animal models to estimate the genetic relationship between resistance 
and performance prior to and post infection 
Our first step in analyzing variation in growth under infection was to estimate 
heritabilities and correlations between VL and growth in absence of and post infection 





































where 9:, 9; and 9< are phenotypes for body weight at the start of infection (BW0) 
(9:), ADG21 or ADG42 (9;), and VL21 or VL42 (9<), respectively; ?:, ?;and ?< are the 
vectors of the fixed effects for the interaction of experimental trial and parity of the 
dam when offspring were born (trial-by-parity),  sex of the offspring, and age at start 
of experimental infection, which was fitted as fixed covariates. To account for 
differences between viremia profiles and the two mathematical functions used to fit 
these, a binary variable associated with the viremia profile class (uni- or bi-modal) was 





= I⊗K, where I is the genetic variance-covariance matrix and 
A the pedigree relationship matrix; C:, C; and C< are vectors of pen effects nested 




= L⊗ M, where L is the identity matrix and 
M is the corresponding variance-covariance matrix of pen effects for the different 




= L ⊗ N, 
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with corresponding variance-covariance matrix N; F:, F; and F< are the vectors of 




= L ⊗ O, where O is the variance-covariance 
matrix for the residual effects for each trait; and =', =5 and =P, @', @5 and @P, B', B5 
and BP, and D', D5 and DP are the incidence matrices for the fixed, animal, pen and 
litter effects, respectively. In addition to the trivariate animal model, corresponding 
bivariate and univariate models were also used to check the robustness of variance 
components. As heritability estimates differed between models, heritability estimates 
were presented from the corresponding univariate models. 
 
2.3.5 Step 2: Multi-trait models to examine evidence for genetic variation in 
tolerance: growth associated with low versus high VL 
The trivariate model [1] from step 1 does not show how growth changes with respect 
to viral load, and, therefore, does not account for genetic variance in tolerance. A 
multi-trait sire model for ADG of progeny with categorized VL was used to assess 
sire-by-VL interactions to get a first indication whether sires varied genetically in 
tolerance to infection. If these genetic correlations are less than unity, this is indicative 
of sire rank changes when offspring are faced with low and high VL respectively, 
providing evidence for genetic variation in tolerance slope. Hence, individuals were 
sorted according to their VL from 0-21 dpi or 0-42 dpi, and partitioned into VL groups, 
where the low and high VL groups (n=330 each) consisted of individuals with VL 
values in the lower and upper quartiles, respectively, and the mid-range group 
consisted of the middle half of the data (n=660). A multi-trait sire model was then 
fitted to measures of ADG associated with low, mid and high VL from 0-21/0-42 dpi 
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(ADGlow, ADGmid and ADGhigh), respectively. The fixed and random effects of this 
model were identical to those used in model [1], with exception of a, which now refers 
to sire effects on performance and explains ¼ of the additive genetic variance, and of 
e, where residual covariance was fixed at 0. Furthermore, the pedigree relationship A-
matrix was replaced with the genomic relationship matrix (G-matrix) to improve 
convergence. 
 
2.3.6 Step 3: univariate random regression models for estimating genetic variance 
in tolerance  
The multi-trait models in the previous steps provide evidence for genetic variation in 
tolerance but do not yield direct estimates of genetic variance in tolerance. A random 
regression reaction norm model was applied, whereby the origin of the reaction-norms 
was centered at the mean viral load values, thus providing only variance component 
estimates for level (ADG at mean VL) rather than vigor (ADG at zero VL). The 
following linear random regression sire model (RRM) for ADG on centered values of 
VL, which will be referred to as the level-slope model (as shown in Figure 1D), was 
used: 
9 = =? +	=QN?R + @AS + @QNAR + BC +DE + F, [2] 
where 9 is the vector of ADG21 or ADG42, respectively; ? is the vector of fixed effects 
outlined in model [1], with age and BW0 included as additional fixed covariates to 
account for variation in age and body weight at the start of infection; and ?T is the 
population average tolerance slope; AU and AT are the sire effects on level and on 
tolerance slope, respectively, assumed to follow a multi-variate normal distribution 










; , where XAS
;  and 
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XAR
;  are the variance of AS, and AR, respectively, XASAR is the covariance between sire 
effects for level and slope; other random effects p, l, and e were fitted as described in 
model [1]; =QN and @QN are the incidence matrices for population average tolerance 
slope and those associated with each sire, respectively, consisting of individual VL 
measures, and = is the incidence matrix for the fixed effects (including VL as fixed 
covariate) and @ is the incidence matrix for the random sire effect on level (@). 
To test the significance of sire effects on level and slope and to determine which of the 
models illustrated in Figure 1 best described the data, the model fit of the level-slope 
model [2] was compared with that of hierarchical models: (a) without any additive 
genetic effects (Figure 1A), (b) with only sire effects for level (Figure 1B), and (c) 
containing only sire effects on slope (Figure 1C). Significance of each random effect 
was assessed using the likelihood ratio test (LRT) [71], with the LRT test statistics 
below assumed to follow a Y5 distribution, with 1 degree of freedom for inclusion of 
an additional sire effect (e.g. null to level model, including sire effect) and a mixture 
of 1 and 2 degrees of freedom for additional sire slope effects and covariance (for 
example, from level to level-slope model), [72,73]. 
 
2.3.7 Step 4: Random regression model using simulated performance in absence of 
infection for estimating genetic variance in tolerance  
The random regression models fitted in step 3 generated potential confounding 
between level and tolerance slope variance estimates i.e. genetic variance in slope was 
absorbed by genetic variance in level due to the limited distribution of VL around 
average VL required to estimate the genetic variance in level. To assess whether 
confounding could be resolved by inclusion of performance measures of non-infected 
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relatives in the statistical models, growth in the absence of infection (ADG021 or 
ADG042) was simulated for one hypothetical paternal half-sib for each individual with 
ADG21 and ADG42 records, respectively, thus doubling the size of the dataset. Data 
were simulated assuming a heritability of 0.4 for both ADG021 and ADG042 [74]. With 
the expectation that a higher rg between the traits would imply less genetic variance in 
tolerance, low (0.05), moderate (0.30), strong (0.60) or high (0.90) genetic correlations 
(rg) between ADG021 and ADG21, or ADG042 and ADG42, respectively, were simulated 
(see Appendix 2.1 for a detailed description of the simulations). Note that no 
assumptions were made with regards to genetic variance in tolerance. 10,000 replicates 
of simulated half-sib records for ADG021 and ADG042 were generated. 
The random regression models [2] were then applied to the extended datasets for each 
replicate, where the response vector y now comprised either simulated ADG021 and 
measured ADG21, or ADG042 and ADG42. VL was no longer centered at mean VL, but 
comprised VL equal to zero for the non-infected pigs and VL21 or VL42 for the infected 
pigs. The remaining fixed and random effects were identical to those in model [2], 
except no fixed effects or random pen or litter effects were fitted for the simulated 
half-sibs. Thus, by including simulated data of non-infected pigs model [2] was 
replaced by an intercept-slope model, with genetic variance estimated for growth in 
the absence of infection, and for tolerance slope. 
As in step 3, hierarchical models were fitted (a) without any additive genetic effects 
for intercept or slope (Figure 1A, null model), and (b) with additive genetic effects for 
intercept only (Figure 1B, intercept-only model) and (c) with additive genetic effects 
for intercept and slope (Figure 1D, intercept-slope model). The model fit was assessed 
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using the loglikelihood ratio test outlined in step 3 above. Results were evaluated based 
on the mean and standard deviation of the estimates over replicates. 
 
2.4 Results 
2.4.1 Step 1: Relationship between resistance and performance prior to and post 
infection  
ADG21 and ADG42 ranged from a weight loss of 40 g/day to a weight gain of 720 and 
680 g/day, respectively, with corresponding mean daily weight gains of 280 and 380 
g/day (Table 2). 
 
Table 2. Summary statistics of resistance and growth traits. Body weight at 0 dpi 
(BW0), average daily gain and viral load from 0-21 and 0-42 dpi (ADG21, ADG42, 
VL21 and VL42), respectively. AUC is the area under the curve for the log-transformed 
estimates for viral load in blood as measured by rtPCR. 




BW0 [kg] 7.30 1.39 3.45 12.88 1320 
ADG21 [kg/day] 0.28 0.12 -0.04 0.72 1319 
ADG42 [kg/day] 0.38 0.11 -0.04 0.68 1001 
VL21 [AUC]* 115.69 9.37 77.04 153.62 1320 
VL42 [AUC]* 159.90 23.42 88.00 236.35 1001 
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Figure 2 depicts the distributions of growth and VL for the two observation periods 
between 0-21 dpi and 0-42 dpi. The wide distribution of individuals with above 
average growth rate despite high VL (ADG+VL+), and with low growth rate despite 
low VL (ADG-VL-) may be indicative of phenotypic variation in tolerance. 
 
Figure 2. Scatter plots of data for ADG and VL from A) 0-21 and B) 0-42 dpi.  
ADG and VL from 0-21 and 0-42 dpi (n=1320 and 1001, respectively) were distributed 
into one of four quadrants according to their growth and VL after infection with PRRS 
virus (n=330 and 250 in each quadrant for 0-21 and 0-42 dpi, respectively). The 
quadrants (ADG+VL- blue, ADG+VL+ green, ADG-VL- orange, ADG-VL+ red) refer 
to high growth rate and high resistance (low VL), high growth rate and low resistance 
(high VL), low growth rate and high resistance and low growth rate and high low, 
respectively. Quadrants were centered at mean VL and at mean ADG.  
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Growth rate under infection and resistance were found moderately heritable and had 
large standard errors (Table 3). Heritability estimates were similar for the two time 
periods considered. 
 
Table 3. Estimates of heritability and correlations between resistance and growth 
traits. Heritability estimates (diagonal) and phenotypic (upper triangle) and genetic 
correlations (lower triangle) with standard errors (SE) from the trivariate animal model 
for Body Weight at 0 dpi (BW0), Average Daily Gain and Viral Load from 0-21 and 
0-42 dpi (ADG21, ADG42, VL21 and VL42), respectively. Correlations between ADG21 
and VL42 were not calculated, as VL is expected to impact ADG and not the other way 
around. 
 Trait 
Trait BW0 ADG21 ADG42 VL21 VL42 
BW0 0.11 (0.10) 0.35 (0.03) 0.40 (0.03) -0.21 (0.07) -0.20 (0.03) 
ADG21 0.48 (0.30) 0.29 (0.11) 0.80 (0.01) -0.29 (0.03) . 
ADG42 0.24 (0.45) 1.00 (0.04) 0.34 (0.14) -0.33 (0.03) -0.36 (0.03) 
VL21 -0.33 (0.45) -0.53 (0.27) -0.64 (0.26) 0.19 (0.11) 0.80 (0.01) 
VL42 -0.54 (0.37) . -0.82 (0.16) 0.79 (0.14) 0.18 (0.10) 
 
Although standard errors were high, genetic correlations between VL and growth 
under infection were statistically significantly different from one (p<0.001, based on 
the LRT comparing models with and without genetic correlations fixed to unity), 
indicating that not all genetic variation of growth under infection was explained by 
genetic differences in resistance (inverse of VL) (Table 3). Furthermore, genetic 
correlations between growth under infection and BW0 were also significantly different 
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from one, implying that growth prior to and post infection were not under identical 
genetic regulation. Genetic correlations between growth under infection and VL were 
moderate to strong and negative whereas genetic correlations between growth under 
infection and BW0 were moderately positive. Phenotypic correlations were of the same 
sign but generally weaker than the genetic correlations (Table 3). Phenotypically and 
genetically, these results indicate that pigs with greater resistance tend to grow faster. 
 
2.4.2 Step 2: multi-trait models to examine evidence for genetic variation in 
tolerance. Trivariate models for growth at low, mid and high VL failed to converge 
for both time periods of infection. Using bivariate models for the upper and lower 
quartiles for VL, high genetic correlations of 0.94 (0.18) and 0.91 (0.13) between 
growth associated with low to high VL were identified for ADG21 and ADG42, 
respectively. Genetic correlations significantly less than one would imply that growth 
rates associated with different degrees of infection severity, as indicated by low versus 
high VL, are genetically distinct traits and would thus be indicative of genetic variation 
in tolerance (Figure 1). Genetic correlations close to one indicate limited re-ranking 
among sires between high and low levels of VL and, thus limited genetic variance in 
tolerance. Furthermore, there was no significant difference between genetic variances 
of ADG associated with low and high VL, for either the 0-21 and 0-42 day period 
(where genetic variances for ADG associated with low and high VL were 2.10E-
03(1.22E-03) and 4.56E-03(1.81E03) for 0-21 dpi, and 3.46E-03(1.24E-03) and 6.89E-
03(2.18E-03) for 0-42 dpi, respectively). Referring to the expectations outlined in Figure 
1, the results of this multi-trait model imply that random regression models of Step 3 
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with the same tolerance slope for each sire would provide a better fit to the data than 
models with different slopes for each sire (Figure 1C & D). 
 
2.4.3 Step 3: Estimation of genetic variance in tolerance using univariate random 
regression models 
Univariate random regression models without genetic effects, but including VL as 
fixed linear (and higher order polynomial) covariate were used to test the average 
association between growth and VL (Null model in Table 4). These identified a 
statistically significant linear association between growth and VL (p<0.0001), with a 
population average tolerance slope estimate of -2.78E-03 (3.32E-04) and -1.28E-03 
(1.51E-04) kg/day per unit of VL increase for ADG21 regressed on VL21 and ADG42 on 
VL42, respectively. This corresponds to an average growth rate difference of 213 g/day 
and 190 g/day between pigs with lowest and highest observed VL for the 21- and 42-
day observation period, respectively, or differences in body weight of 4.5 and 8.0 kg 
over the 21- and 42-day observation periods, respectively. Similarly, body weight prior 
to infection had a significant association with ADG post infection (BW0 p<.0001), 
with a positive regression coefficient of 0.025 (0.002) at 21 dpi and of 0.029 (0.003) 
at 42 dpi. 
The log-likelihood of the model improved significantly when genetic effects (random 
sire effects) were included in the model (level model) (p<.0001) (Table 4). This 
indicates significant genetic variance in growth performance of pigs infected with 
PRRSV. However, including sire effects of slope only (Figure 1c) did not improve 
model fit over the null model (p>0.60) and resulted in negligibly small slope variance 
estimates.  
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Table 4. Variance components for ADG (kg/d) from 0-21 dpi (4A) and 0-42 dpi 
(4B). Variance components estimated from random regression models: null model, 
containing no genetic effect; level-only model, containing only the overall sire effect 
on growth under infection; slope-only model, containing only sire effect on the slope 
of the regression line of growth over VL; and level-slope model, containing sire effects 
on level and slope, respectively. All other fixed effects/covariates and random effects 
were identical between models. Results for ADG42 on VL21 were similar to those for 
ADG42 on VL42 and are therefore not shown. 
4A 







 Estimate (SE) Estimate (SE) Estimate (SE) Estimate (SE) 
Level . 2.01E-03 (7.68E-04) . 2.01E-03 (7.68E-04) 
Covariance . . . 2.21E-13 (1.04E-14) 












6.18E-03 (2.91E-04) 6.18E-03 (2.91E-04) 6.18E-03 (2.91E-04) 
LogLikelihoo
d 












 Estimate (SE) Estimate (SE) Estimate (SE) Estimate (SE) 
Level . 2.32E-03 (1.02E-03) . 2.33E-03 (1.03E-03) 
Covariance . . . -3.95E-15 (2.04E-16) 
Slope . . 8.60E-08 (1.47E-07) 3.41E-07 (5.94E-07) 
Pen(Trial) 2.43E-04 (1.30E-
04) 
2.82E-04 (1.36E-04) 2.39E-04 (1.29E-04) 2.78E-04 (1.35E-04) 
Litter 1.76E-03 (3.27E-
04) 
1.23E-03 (2.98E-04) 1.75E-03 (3.27E-04) 1.22E-03 (2.98E-04) 
Residual 5.39E-03 (3.03E-
04) 
5.33E-03 (2.99E-04) 5.36E-03 (3.05E-04) 5.30E-03 (3.02E-04) 
LogLikelihoo
d 
1889.55 1911.18 1899.72 1911.35 
 
Models with sire effects on both level and slope, as well as a genetic covariance 
between them, yielded a significantly better model fit than the null model (p<0.0001). 
However, the level-slope model did not provide a significantly better fit than the level-
only model for either 0 to 21 and 42 dpi (p=1.00 and 0.66, respectively) (Table 4). 
All four models provided similar estimates of variance components for non-genetic 
random effects (Table 4). Estimates of the sire variance for level were very similar 
between the level-only model and the level-slope model and very low, whereas 
estimates for sire variance in tolerance slope differed slightly between the slope-only 
and the level-slope model (Table 4). The fact that addition of the slope did not affect 
the variance estimate for level suggests potential confounding of level and slope (see 
2.5.2 Statistical Considerations) The estimate of the covariance between level and 
slope was close to zero, and constrained at the boundary for both time periods, 
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indicating numerical difficulties in accurately estimating these variance components. 
However, shifting the covariate VL to ensure a zero covariance between the new level 
and slope has no effect on the model likelihoods, suggesting that the results are robust. 
In conclusion, the random regression models did not allow estimation of genetic 
variance in tolerance of pigs to PRRSV infection. Based on statistical model fit alone, 
the level-only model accounting for genetic variance in growth rate at mean VL only 
constitutes a more appropriate model to describe genetic variation in growth response 
of infected pigs than the level-slope model accounting for genetic variance in both, 
growth rate at mean VL and tolerance. However, as outlined in more detail in the 2.5.2 
statistical considerations section below, it cannot be excluded that any genetic 
variance in tolerance that may exist is absorbed in the genetic variance for level 
because of the confounding between level and slope. 
 
2.4.4 Step 4: Random regression models including simulated performance in 
absence of infection for estimating genetic variance in tolerance  
Models with genetic effects on both intercept and slope, as well as a genetic covariance 
between them, consistently yielded a significantly better model fit than the null model 
(p<0.0001 for both 0-21 and 0-42 dpi), regardless of simulated genetic correlation 
between ADG021 and ADG21 or ADG042 and ADG42. However, the intercept-slope 
model consistently provided a significantly superior fit over the intercept-only model 
only when the simulated genetic correlation between growth in absence of infection 
and growth under infection was low to moderate (Table 5). Generally, the ability to 
identify genetic variance in tolerance decreased with an increase in the simulated 
genetic correlation, as indicated by reduced improvement in log-likelihoods and a 
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lower proportion of replicates with significant genetic variation in tolerance slope 
(p<0.05) (Table 5). Somewhat surprisingly, for the 0-21dpi observation period, the 
majority of replicates indicated significant genetic variation in tolerance, even for 
strong genetic correlations between ADG021 and ADG21 (Table 5). In contrast, only 
low to moderate genetic correlations between ADG042 and ADG42 resulted in 
significant genetic variance in tolerance for the majority of replicates for the 42 day 
observation period (Table 5). 
  
Table 5. Effect of the genetic correlation (rg) between simulated ADG in the 
absence of infection with observed ADG under infection on evidence for genetic 
variance in tolerance. Effect of the genetic correlation (rg) of simulated ADG021 with 
ADG21 and ADG042 with ADG42 on the average change in log-likelihood of the 
intercept-slope model over the intercept-only model (∆LogLikelihood), the average p-
value of log likelihood improvement, provided by a log-likelihood ratio test, and the 
proportion of the 10,000 replicates with significant genetic variance in tolerance (i.e. 




rg ∆LogLikelihood p-value 
Proportion with significant genetic 
variance for tolerance (p<0.05) 
0 to 21 
0.05 10.96 (4.19) 0.000 1.00 
0.30 6.18 (3.39) 0.005 0.98 
0.60 2.32 (1.49) 0.041 0.76 
0.90 1.00 (2.12) 0.067 0.55 
0 to 42 
0.05 8.67 (4.40) 0.003 0.99 
0.30 4.34 (3.16) 0.023 0.87 
0.60 1.31 (1.56) 0.107 0.41 
0.90 -0.80 (2.43) 0.187 0.06 
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Table 6 shows that random regression sire models when including records from both 
non-infected and infected siblings can generate robust genetic variance estimates for 
both intercept and slope. As expected, genetic variance estimates for tolerance slope 
tended to decrease with increasing genetic correlations between ADG021 and ADG21 
or ADG042 and ADG42, whereas the genetic variance estimates in the intercept tended 
to increase (see Appendix 2.1). Genetic correlations between ADG in absence of 
infection and ADG under infection also affected the estimated genetic correlations 
between intercept and tolerance slope. Low (simulated) genetic correlations between 
ADG021 and ADG21 or ADG042 and ADG42, respectively, led to negative genetic 
correlations between performance in the absence of infection and tolerance, whereas 
strong positive genetic correlations between the growth traits suggested that pigs with 





Table 6. Variance components of intercept, slope and covariances from random 
regression models. Variance components estimated from random regression models 
based on simulated ADG021 and measured ADG21 (kg/d) or ADG042 and ADG42. Fitted 
models were the intercept-only model, containing only the overall sire effect on 
intercept; and the intercept-slope model, containing sire effect on intercept and slope 
for ADG21 or ADG42, respectively. All other fixed effects/covariates and random 
effects were identical between models. Standard errors (in brackets) were calculated 
as the standard deviation over 10,000 replicates. rg is the simulated genetic correlation 
between ADG021 or ADG042 and ADG21 or ADG42. 




rg Intercept Intercept Covariance Slope 
0 to 21 




























0 to 42 


































2.5.1 Summary of findings 
Performance of an infected individual is likely to depend on its ability to restrict 
pathogen load (resistance) and its ability to limit the impact of infection (tolerance). 
The extensive PHGC dataset has identified substantial genetic variation in resistance 
of growing pigs to PRRS and led to the discovery of a major quantitative trait locus 
associated with both resistance and growth of pigs under infection [22,55,57,58]. 
Surprisingly, the dataset provided little evidence that pigs also vary genetically in 
tolerance to this virus. However, the simulations revealed that genetic variation in 
tolerance to PRRS may exist, depending on performance in the absence of infection 
(vigor). Furthermore, this analysis raised numerous statistical difficulties associated 
with genetic improvement of host tolerance, which could be overcome by including 
measures of performance of infected and non-infected relatives in the analysis. 
Focusing on data from infected pigs alone, genetic correlations between body weight 
prior to infection, resistance (inverse of VL) and growth under infection were found 
to be moderately strong and positive, in line with previous studies [22,55]. This 
indicates that heavier individuals prior to infection counteract an increase in pathogen 
load, and thus tend to have lower VL, and therefore lower infection-induced reductions 
in growth rate. Genetic correlations between VL and growth were strongly negative, 
implying that animals that were genetically more resistant also tended to grow faster 
under infection. However, correlations were significantly different from one, 
indicating that genetic variation in growth of PRRSV infected pigs is not fully 
explained by heterogeneity in growth prior to infection and resistance. Therefore, 
genetic variation in tolerance may also play a part in host response to PRRSV 
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infection. However, the multi-trait model provided little evidence of genetic variation 
in tolerance. This was further supported by the random regression models. These 
showed that, although growth rate declined, on average, linearly with increasing VL, 
there was no statistically significant difference in tolerance between the sires of the 
infected piglets. 
However, closer inspection of the underlying data structure raised suspicion that 
genetic variance in the reaction norm level absorbed genetic variance in tolerance due 
to confounding between level and slope in these data (see 2.5.2 statistical 
considerations). To disentangle the genetic variance in reaction-norm intercepts (i.e. 
growth rate in the absence of infection) and slopes (i.e. tolerance), the experimental 
data were augmented with simulated growth rates of non-infected relatives. The 
resulting data structure thus mimicked that of ‘sib challenge tests’ that are common 
practice in aquaculture and other livestock species [75–77]. The simulations 
demonstrated that inclusion of these additional data in the random regression models 
resolved the confounding between level and slope and resulted in more reliable genetic 
parameter estimates for tolerance. Crucially, the simulations revealed that it would be 
wrong to conclude that pigs in this study lacked substantial genetic variation in 
tolerance to PRRS, as was suggested by the models based on the collected data alone. 
As demonstrated by the simulations, genetic variance estimates for tolerance strongly 
depend on the genetic correlations between growth in the absence and growth under 
infection. Low to moderately strong genetic correlations between these two traits 
implied significant genetic variance in tolerance of the pigs in this study. Interestingly, 
estimated genetic correlations between body weight of pigs prior to infection and 
growth under infection were found moderately strong. Thus, if body weight prior to 
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infection was a reliable predictor for growth rate in the absence of infection, evidence 
for genetic variance in tolerance would emerge directly from the data. 
 
2.5.2 Statistical considerations 
Here, the conventional reaction-norm approach was adopted to model genetic variation 
in tolerance to infections [5,8]. Using both simulated and real data, we demonstrated 
that random regression models embedded in the mixed model machinery are a 
powerful tool to estimate genetic variance in tolerance for outbred populations if the 
data structure is appropriate [4,35,37]. Random regression models are also known to 
be highly sensitive to the underlying data structure and prone to generate inaccurate 
variance estimates for slope, in particular if sample size is limited or information on 
relatedness is poor, as was the case for the data in this study [35,36,70]. To prevent 
bias in the slope variance estimates [35,70], only sires that had more than 10 offspring 
were included in this study. However, the associated reduction of the data to records 
from only 54 mostly unrelated sires may have caused a trade-off between reducing 
bias and reducing statistical power, as indicated by lower heritabilities for ADG and 
VL than found in previous analyses on the same data [22,55]. Furthermore, to alleviate 
the potential impact of limited information of relatedness (as only sires and dams were 
known for the majority of pigs), the analyses were repeated including the genomic 
relationship matrix rather than the pedigree relationship matrix, which is not able to 
capture the difference between siblings due to Mendelian sampling. However, this had 
a negligible impact on the variance estimates and on the log-likelihoods of the 
reaction-norm models (results not shown). 
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As is common practice for quantitative genetics models using REML, the likelihood 
ratio test (LRT) was used to test the significance of random effects such as the sire 
tolerance slope estimates [78]. For variance components constrained to the positive 
parameter space, the conventional LRT that assumes the test-statistics to follow a chi-
square distribution with degrees of freedom equal to the number of additional 
parameters to be estimated in the more complex model has been described to be overly 
conservative [63]. For this reason the widely used adjustment of Stram & Lee [72] 
based on mixture distributions was applied. However, in this proposed adjustment 
individual subjects (in this case sires) were assumed independent. Due to lack of 
detailed pedigree information in the present study, the majority of sires were indeed 
assumed unrelated, with the exception of sires from trials 1-3. Repeating the analysis 
with the assumption that all sires were unrelated provided almost identical model 
results to those reported here. We therefore believe that the LRT is a valid method for 
testing the null hypotheses of zero genetic variance in tolerance and genetic 
correlations equal to zero or one in this study. Nevertheless, sires and sire by VL 
interactions were also fitted as fixed effects in the statistical models of step 3. In 
accordance with the results of modelling sires as random effect, there were no 
significant differences between the tolerance slopes associated with different sires 
according to the Wald test (p=0.981 and 0.081 for the 0 to 21 and 0 to 42 dpi time 
periods, respectively). 
Perhaps most importantly, reaction-norms require considerable variation in the 
independent variable to generate unbiased tolerance slope estimates [7]. However, this 
study, in line with other infection challenge experiments, used an identical infection 
route, pathogen strain and dose for all individuals. Consequently, it provided a 
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relatively narrow value range for pathogen load (VL42 values ranged between 88 and 
236 AUC in our study), with no values close to zero. To better accommodate the 
distribution of the data in the models, the VL was centered at the mean VL value, in 
line with common practice in the animal breeding literature [36,67,70]. However, the 
relatively narrow range of the VL of offspring, combined with the relatively low 
numbers of offspring for some sires, may have hampered the ability of these models 
to disentangle sire effects on level and slope. This confounding is likely further 
aggravated by genetic variation in resistance to PRRS, which implies that VL is not 
homogeneously distributed amongst sires, with more resistant sires predominantly 
having progeny with low VL, and less resistant sires predominantly progeny with high 
VL. 
Considering all these effects combined, the weak evidence for significant genetic 
variation in tolerance to PRRS from the random regression models in this study may 
simply reflect a lack of statistical power to disentangle sire effects on regression slope 
and level. The complementary simulation studies presented here, which assumed that 
additional performance measures of related uninfected individuals were available, 
demonstrated one way of increasing statistical power. Similarly, it might be possible 
to increase statistical power by harnessing information from repeated measures of 
growth and pathogen load for each individual over the course of infection in the 
statistical models. By increasing the range of distribution of VL for each individual, a 
more robust slope may be fitted through the centre of the data, alluding to an “overall” 
picture of tolerance across multiple time-points in infection. 
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2.5.3 Implications for genetic improvement of tolerance of pigs to PRRS and other 
diseases 
Genetic improvement of tolerance may have several advantages over improving 
resistance. Firstly, host resistance limits pathogen replication within the host and, as a 
consequence, selection for host resistance may impose selection advantages on 
pathogen strains that can overcome host resistance mechanisms and eventually result 
in a loss of selection advantage of the host [32,79]. Given the high mutation rate of 
RNA viruses such as PRRSV [80], this is a potential pitfall for a long-term breeding 
strategy focused on resistance. It has been proposed that, theoretically, tolerance might 
not impose such selection pressure on the pathogen [32]. 
Secondly, it has been suggested that improving host tolerance may offer cross-
protection against other strains of the virus, or other prevalent infectious agents, as 
tolerance mechanisms primarily target host-intrinsic damage prevention or repair 
mechanisms, compared to resistance mechanisms, which interfere directly with the 
pathogen life-cycle [5,6,11]. This is particularly relevant for PRRS, which is often 
associated with co-infection with other respiratory viruses, such as PCV2 or the 
influenza virus, which can mimic the respiratory clinical signs associated with PRRS 
[81]. Furthermore, in a globalized animal breeding market, where PRRS is endemic 
and highly prevalent in farms, (estimated 60-80% in the U.S, and up to 79% in 
mainland Europe), and where environmental conditions are difficult to improve, 
eradication of the virus has proven to be challenging [82–84]. Selective breeding for 
tolerance is considered desirable when pathogen prevalence is high, when pathogen 
elimination has proven difficult and when pathogens can evolve rapidly to evade 
control measures that aim to interfere with the pathogen life-cycle [24]. All these cases 
	 53	
apply to PRRS. Therefore, improvement of tolerance of pigs to this ubiquitous virus 
may constitute a viable alternative to eradication programs, as it would allow pigs to 
maintain homeostasis despite infection [81]. However, tolerance would result in 
continued presence of the virus which could rebound and result in further pathogenesis 
in the host and threats to the herd. Thus, distinction between resistance and tolerance 
in genetic improvement programs is imperative if they have different effects on 
pathogen prevalence and evolution, as implied by theory [26,32]. 
Obtaining reliable tolerance estimates from natural disease outbreaks is extremely 
difficult due to the myriad of confounding factors (e.g. difference in exposure and 
onset of infection, differences in the individual immune status, co-infections), which 
can severely bias tolerance estimates and mask the underlying genetic signal [4,37]. 
For this reason, empirical evidence for genetic variation in host tolerance to infections 
stems primarily from challenge experiments in inbred lines of model species [5,30,85]. 
The PHGC challenge data constitute a unique data source for investigating the genetic 
basis and relative importance of host resistance and tolerance in outbred pigs’ 
responses to virus infections, as it provides the required measures of both pathogen 
load and performance for large sample sizes, without the confounding factors inherent 
to field data. The analyses of these data however demonstrated that the limited data 
range produced in challenge experiments, together with other factors that affect the 
distribution of the data, such as genetic variance in host resistance, can easily blur the 
tolerance signal in multi-trait and reaction-norm models, and highlight the importance 
of performance records of non-infected relatives for obtaining accurate tolerance 
estimates. 
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Collecting equivalent performance records of non-infected relatives of the challenged 
individuals would be extremely valuable for establishing the relationship between 
tolerance and performance in the absence of infection, and for identifying shared or 
distinct genomic regions associated with these traits. A strong genetic correlation 
between these traits would imply that one could select for high performance at the 
nucleus to improve tolerance and performance in the more infectious commercial 
farms. In the current pig breeding structure, a direct data pipeline of performance 
measures between pigs in commercial farms experiencing disease outbreaks and those 
of related selection candidates in the almost pathogen free nucleus may be useful. 
Obtaining unbiased and comparable measures of within-host pathogen load from 
natural disease outbreaks constitutes the main challenge for producing reliable 
tolerance estimates from natural disease outbreaks [4]. A practically more feasible 
approach is to estimate genetic correlations between performance in clean and 
infectious environments and to include performance during disease outbreaks in the 
selection criterion [15,86], although this approach does not allow distinction between 
resistance and tolerance. 
Based on resource-allocation theory and earlier findings, resistance and tolerance are 
conventionally considered as alternative host defense mechanisms to infections, 
leading to the notion of a trade-off between improving resistance and tolerance. A 
companion genome-wide association study on the same PHGC data indeed found 
different regions that were associated with tolerance and with resistance [87]. 
Emerging evidence from different studies suggests that both resistance and tolerance 
mechanisms may be required for effective host protection to infection and that the 
optimal host response to infection likely depends on a carefully timed interaction 
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between pathogen elimination (i.e. resistance) mechanisms and host mechanisms that 
promote tissue damage control and increase disease tolerance [85,88]. The 
aforementioned companion study identified several overlapping genomic regions 
associated with resistance and tolerance of pigs to PRRS and found that the 
WUR10000125 SNP, previously associated to confer greater resistance to PRRS 
(lower VL21), also confers greater tolerance. Valuable insights about these interactions 
could be harnessed from the available longitudinal measures of pathogen burden and 
growth, e.g. by following the infection trajectories of individuals and target entire 
trajectories rather than resistance or tolerance for genetic improvement  [41,85]. 
In order to target both resistance and tolerance in a sustainable breeding program, the 
epidemiological and evolutionary consequences of genetic selection in either or both 
traits combined must be studied in more detail. In particular, it needs to be determined 
whether evolutionary theory predicting a lower risk of pathogen evolution from 
selection for improved host tolerance rather than resistance hold in the case of PRRS; 
and to what extent genetically more resistant or tolerant pigs are also less infectious 
[60,89,90]. It is probable that control of PRRS and other infectious diseases by genetic 
selection is a “balancing act” [3], involving mechanisms associated with resistance and 
tolerance to provide the fittest pigs. 
 
2.5.4 Conclusions 
Using evidence from the available data alone suggests that growing piglets differ 
genetically in resistance but did not explicitly show evidence for genetic differences 
in tolerance to PRRSV infection. However, statistical constraints may have masked 
genetic variation in tolerance. Currently unknown genetic correlations between 
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performance under and in absence of PRRSV infection could reveal significant genetic 
variance in tolerance. Future studies are warranted to validate the results in this study 
for infections with the same and different strains of the PRRS virus, including vaccine 
strains. This study shows that genetics of tolerance is more difficult to analyze than 




2.1 Simulating ADG in absence of infection 
To assess the impact of additional measures of performance in the absence of infection 
(i.e. true intercept) on genetic parameter estimates for tolerance, average daily gain in 
absence of infection (ADG0) was simulated for paternal half-sibs of the infected 
individuals in the dataset. ADG021 and ADG042 were simulated for both observation 
periods from 0-21dpi and from 0-42dpi, respectively, assuming a heritability of 0.4 
[74] and a genetic variance half of that of the genetic variance for average daily gain 
under infection ADGI (where ADGI stands for ADG21 and ADG42, respectively). A 
smaller variance was assumed for ADG0 since part of the variation in ADGI is due to 
different levels of VL. Since it was expected that genetic variance estimates for 
tolerance depend on the genetic relationship between ADG0 and ADGI (see Figure 1 
in main manuscript), different values of genetic correlations (rg) between ADG0 and 
ADGI were simulated representing weak, moderately low, moderately strong and 
strong genetic relationships between the traits with corresponding values of 0.05, 0.30, 
0.60 and 0.90, respectively.  
The simulated values for ADG021 and ADG042 were produced as follows: 
  
2.1.1 Step 1: Calculate sire breeding values for growth under infection (ADGI)  
Firstly, sire breeding values were calculated for ADG under infection (ADGI) from 0-
21 or 0-42 dpi (ADG21 and ADG42, respectively) using sire estimated breeding values 
(EBVS) from the level model, described in main text, using the following equation: 
[\]
^_`a = b[\c
^_`a + db, [1] 
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Where the prediction error (db) was sampled using: 
PEV	 = ĝ
hija
5 − k&l	 b[\ mnop , 
where ĝ
hija
5  is the additive genetic variance of ADG under infection, and sire EBVs 
were acquired from the level model. 
 
2.1.2 Step 2: Calculate sire breeding values for growth in the absence of infection 
(ADG0) 
Breeding values were calculated for ADG in the absence of infection (ADG0) for 0-21 
or 0-42 dpi (ADG021 or ADG042, respectively) using the following equation: 
[\]
^_`q = rsthijq,sthija[\]
^_`a + ubv', [2] 







where lw is the simulated genetic correlation between ADG0 and ADGI (simulated as 




 are the square roots of the 
additive genetic variance in ADG0 and ADGI, respectively, and the residual (ubv') 
was sampled from: 






2.1.3 Step 3: Calculate phenotypic values for growth without infection for progeny 
(half sibs) (PProg) 
Finally, phenotypic values of growth without infection were simulated for one paternal 






^_`q + ubv5, [3] 






where phenotypic variance of ADG0 (g|hijq






Following this approach, phenotypes for ADG021 and ADG042 were generated for one 
half-sib per infected individual in the dataset, thus doubling the size of the dataset. For 
each simulated population, 10,000 replicates were generated. Table 1 below shows the 
means (and standard errors) for the simulated true ADG0 breeding values, the genetic 
variances and correlations between true breeding values of ADG0 and ADGI. 
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Table 1. Mean sire breeding value and genetic variance of simulated performance 
in absence of infection (ADG0), where rg is simulated genetic correlation between 
ADG0 and ADG under infection (ADGI) for the 21- or 42-day observation periods. 
Correlations between breeding values of ADG0 and ADGI are also shown. Standard 











21 day observation period 
0.05 2.34E-04 (1.20E-04) 9.36E-04 (1.55E-05) 0.05 (0.14) 
0.30 1.04E-03 (1.15E-04) 1.26E-03 (1.62E-05) 0.30 (0.12) 
0.60 2.07E-03 (9.41E-05) 3.39E-03 (1.61E-05) 0.60 (0.08) 
0.90 3.01E-03 (5.23E-05) 3.44E-03 (1.75E-05) 0.90 (0.02) 
42 day observation period 
0.05 1.81E-04 (1.47E-04) 1.32E-03 (2.33E-05) 0.05 (0.14) 
0.30 1.46E-03 (1.40E-04) 1.35E-03 (2.32E-05) 0.30 (0.12) 
0.60 2.83E-03 (1.16E-04) 1.51E-03 (2.65E-05) 0.60 (0.08) 




Chapter 3  
Harnessing longitudinal information to identify genetic 
variation in tolerance of pigs to Porcine Reproductive and 
Respiratory Syndrome virus infection 
 
3.1 Introduction 
In chapter 2, evidence for genetic variation in tolerance of pigs to PRRS was 
inconclusive due to limited statistical power to distinguish between parameters related 
to overall growth response under infection and those related to tolerance. It was 
concluded that more measurements, in particularly a wider spread of measurements, 
would be required to resolve this confounding and to accurately estimate genetic 
variance in tolerance. Estimation of genetic variance in tolerance in chapter 2 was 
based on the cumulative host response over specific periods of infection, such as from 
0 to 21 days post-infection (dpi) representing the acute phase of infection, or from 0 
to 42 dpi representing the prolonged period until the end of the experiment. This 
resulted in single measurements for cumulative virus load and growth for each animal 
included in the random regression sire models. 
The hypothesis of this chapter is that genetic variance in tolerance may be identified 
by considering individual stages of infections and by utilizing information from the 
repeated individual measures of viremia and growth in the statistical models. This is 
built on previous research, which indicated that the genetic expression of host response 
traits is dynamic, changing throughout time-course of infection [37,85]. Similarly, 
tolerance has been identified as likely being time-dependent [31,37,39,85].  
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Recent studies of the PHGC data have fitted mathematical Woods functions through 
the repeated viremia measurements of individuals to create a viremia curve profile for 
each individual that describes within-host viremia changes over the duration of 
infection (figure 1) [62]. These Woods function viremia profiles allow partitioning of 
host response into different stages of infection, such as the phase of viremia increase 
towards peak viremia or phases related to viremia clearance, respectively [55,62].  
The aims of this chapter were to estimate genetic variation in tolerance at different 
stages of infection, defined by viremia curve characteristics. Secondly, by using 
repeated measures for each individual at each stage of infection, this research aimed 
to increase the statistical power to detect genetic variation in tolerance to PRRS over 
the 42-day observation period. Thirdly, this study aimed to identify the genetic 
relationship between tolerance and resistance, and whether this changed over different 
stages of infection. Finally, this study aimed to investigate the association between a 
previously identified quantitative trait locus (QTL), shown to have significant effects 
on cumulative VL and growth, with tolerance, and whether the strength of this 




The data analysed in this chapter came from the same pigs of the nine PRRS Host 
Genetics Consortium (PHGC) PRRSV challenge trials as used in chapter 2, with the 
exception that pigs that had experienced a rebound in viremia were omitted from the 
analyses presented in this chapter. Rebounders were omitted to remove noise 
associated with the later stage of infection; this way all pigs considered here 
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experienced a gradual viremia decline after peak viremia had been reached. From the 
resulting 1011 pigs (offspring of 49 sires), repeated growth and viremia measures were 
used in the tolerance analysis of this chapter. Please see chapter 2 for more information 
on the infection protocols and trials. 
 
3.2.2 The WUR10000125 single nucleotide polymorphism (SNP) and associated 
resistance and growth genotypes 
All PHGC pigs were genotyped with 60K Beadchips [46]. Previous genome wide 
association studies performed on the same dataset as used here had identified a 
quantitative trait locus (QTL) on chromosome 4, where the single nucleotide 
polymorphism (SNP) WUR10000125 (WUR) was strongly associated with 
differences in growth under infection and in resistance. More specifically, the 
favourable B allele corresponded to both higher resistance to PRRSV and faster 
growth over the 21-day infection period (indicated by lower within-host viral load 
(VL21)). Individuals with AB genotype had 4.5% lower VL and were 2kg heavier than 
individuals with the AA genotype, with the genomic window containing the WUR 
genotype explaining 13.2% and 9.14% of the genetic variance for VL and growth, 
respectively [55,57,58].  Thus, using the Illumina A/B genotype reference system, 
each pig of this study was assigned to one of the three WUR genotypes; the number of 
pigs with AA, AB and BB were n=689, 286 and 36, respectively. 
 
3.2.3 Defining stages of infection 
The experimental observation period (0-35 dpi for trials 7 and 8, and 0-42 dpi for all 
other trials) was partitioned into three stages, i.e. early, mid and late stage of infection. 
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These stages were defined according to viremia profile characteristics, so that the early 
stage corresponds to the phase of rapid viremia increase towards peak viremia, the mid 
stage corresponds to the initial phase of rapid post-peak viremia decline, and the late 
stage corresponds to the phase where viremia continues to decline but at a decreasing 
rate. The mathematical definition of these stages was achieved by fitting individual 
viremia profiles, defined by the Woods function described below, to the repeated 
viremia measures of each individual pig, as illustrated in Figure 1 [55,62]. The Woods 
function, which had been previously shown to be a good fit to the viremia data of each 
individual pig that did not experience viremia rebound [62], is given by: 
\(#) = &'#()*+,)-, [1] 
where \(#) is log10 scaled serum viremia at t dpi; &' affects the magnitude of points 
on the curve; r' is indicator of the rate of increase to peak viremia, ' is an indicator 
of the rate of decline after peak viremia. Using the analytical expression [1], two 
critical time points can be derived by differentiation: TÅÇÉÑÖ =
Ü)á
à)á
 for each individual 
i, the time when viremia reaches its maximum value and	âäãåÖ =
Ü)áç Ü)á
à)á
	, the time 
post peak viremia when the rate of viremia decline reaches its maximum (i.e. the 
inflection point of the Woods function). 
These critical time points (Tpeak and Tmax, respectively) were used to define lower and 
upper boundaries of each stage of infection in this study. Stages of infection were thus 
defined from time of initial infection (0 days post-infection (dpi)) to Tpeak (early); from 
Tpeak to Tmax  (mid), and from Tmax to end of observed infection period, which was at 
35 dpi for trials 7 and 8, and 42 dpi for all other trials (late). 
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Figure 1. Illustration of an individual viremia profile used to define stages of infection, 
where the green dots represents log-transformed viremia measures, and the green line 
represents the fitted Woods function over the time-course of infection (up to 42 dpi) 
(with 90% and 95% credibility intervals in grey) for one individual. Early stage of 
infection is defined from initial infection (0 dpi) to time where peak viremia (Vpeak) is 
reached (Tpeak, in this example, approximately 9 dpi); mid stage of infection is defined 
from Tpeak to Tmax (tmax in this example, approximately 16 dpi); and late stage of 
infection, defined from Tmax to end of experiment (42 dpi, or 35 dpi for trials 7 & 8). 
Figure modified from Islam et al 2013 [62]. 
 
As the function was fit to each individual separately, separate values for the parameters 
Tpeak and Tmax were obtained for each individual (Table 1). Table 1 shows the variation 
in the corresponding time periods for each stage of infection. Average duration of each 
stage of infection was 6.90, 9.19 and 14.26 dpi for early, mid and late stages of 
infection, respectively, corresponding to average Tpeak and Tmax of 6.89 and 16.16, 
respectively. 
	 66	
Table 1. Descriptive statistics of duration of each stage of infection, where early 
stage is defined as initial infection (0 dpi) to Tpeak; mid stage is defined as Tpeak to Tmax, 
and late stage of infection is defined from Tmax to end of the observation period (35 
dpi for trials 7 an 8 and 42 dpi for all other trials). Descriptive statistics of Tpeak and 
Tmax are also shown. All measures below are in dpi. 
Stage of infection Mean Standard deviation Minimum Maximum 
Early 6.90 1.32 3.01 10.60 
Mid 9.19 2.11 4.04 14.87 
Late 14.26 0.60 13.53 14.92 
Tpeak 6.89 1.32 3.01 10.60 
Tmax 16.16 2.38 10.01 26.97 
 
Using these definitions of infection stage, resistance was then quantified, as 
previously, as the inverse of the cumulative log-transformed viral load in blood (VL) 
over a given stage of infection [5,4,55,6]. This was calculated as the area under the 
curve of the log-transformed viremia estimates throughout the observation period, 
obtained by numerical integration the Woods function, described in model [1] above 
over the corresponding time periods, yielding estimates for VLearly, VLmid and VLlate. 
To calculate the corresponding ADG for each stage of infection, a linear spline curve 
was fitted through weekly body weights (BW) for each individual using the 
smooth.spline function in R (Dipley, BD and Maechler, M). BW was interpolated at 
time of peak viremia (Tpeak) and time of maximal viremia decay (Tmax) using the 
predict function in R. From this, ADGearly, ADGmid and ADGlate were calculated by 
dividing the difference in body weight at the start and end of the stage in consideration 
by the corresponding duration.  
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3.2.4 Estimating genetic variance in tolerance slope at each stage of infection 
To estimate genetic variance in tolerance, a random regression reaction norm model 
was applied to the data, whereby the origin of the reaction-norms was centred at the 
mean viral load for each stage of infection, thus providing only variance component 
estimates for level (ADG at mean VL) rather than vigour (ADG at zero VL) for each 
infection stage. As in chapter 2, the linear random regression sire model (RRM) for 
ADG on centred values of VL, which will be referred to as the level-slope model, was 
used to identify genetic variance in tolerance at each stage of infection, where ADG at 
early, mid and late stages of infection were regressed on VL at the corresponding 
stages of infection. Additionally, to account for a potential time lag between changes 
in viremia and changes in growth, ADG at mid and late stages of infection were also 
regressed on VL at earlier stages of infection.  
As in chapter 2, to test the significance of sire effects on level and slope and to 
determine which of the models best described the data, the model fit of the level-slope 
model was compared with that of hierarchical models without any additive genetic 
effects, and with only sire effects for level. Significance of each random effect was 
assessed using the likelihood ratio test (LRT) [71], with the LRT test statistics below 
assumed to follow a Y5 distribution, with 1 degree of freedom for inclusion of an 
additional sire effect (e.g. null to level model, including sire effect) and a mixture of 1 
and 2 degrees of freedom for additional sire slope effects and covariance (for example, 




3.2.5 Estimating genetic variance in tolerance slope over all stages of infection using 
a repeated measurement model 
To increase statistical power to identify genetic variance in tolerance across all stages 
of infection, repeated measures of ADG and VL at each stage of infection were used 
(i.e. to triple the size of the dataset) in the univariate following random regression sire 
model (referred to as the level-slope repeated measure model): 
9 = =? +	=QN?R + @AS + @QNAR +éè + BC +DE + F			[;] 
where 9 is the vector of repeated ADG measures of early, mid and late stages of 
infection; ? is the vector of fixed effects outlined in model [2], with BW at each stage 
of infection and age included as additional fixed covariates to account for body weight 
at the different stages of infection and variation in age at start of infection, respectively; 
and ?T is the population average tolerance slope; AU and AT are the sire effects on level 
and on tolerance slope, respectively, assumed to follow a multi-variate normal 












;  and XAR
;  are the variance of AS, and AR, respectively, XASAR is the covariance 
between sire effects for level and slope; c is the variance of permanent environmental 
effect; the random pen and litter effects p and l were fitted as described in chapter 2; e 
is the vector of error terms, with var(F) = L⊗ O, where O is the variance-covariance 
matrix. To prevent upward bias genetic variance in slope caused by heterogeneous 
variance error [35,91], 2 heterogeneous residual structures based on data ordered from 
low to high VL (n=1517 and 1516, respectively). 
 =QN and @QN are the incidence matrices for population average tolerance slope and 
those associated with each sire, respectively, consisting of individual VL measures, 
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and = is the incidence matrix for the fixed effects (including VL as fixed covariate) 
and @ is the incidence matrix for the random sire effect on level (@); and W, U and M 
are the incidence matrices for permanent environmental, pen and litter effects, 
respectively. Model fit was compared to null and level repeated measure models using 
LRTs. 
 
3.2.6 Estimating the relationship between resistance and tolerance 
To determine the relationship between resistance and tolerance at each stage of 
infection, phenotypic and genetic correlations of, and between, traits were estimated 



























where 9: and 9; are ADG and VL for different stages of infection (early, mid or late), 
respectively; 	?: and ?; are a vectors of fixed effects/covariates for ADG or VL, 
containing the interaction of experimental trial and parity of the dam, when offspring 
were born (trial-by-parity), sex of the offspring, and BW0 (for ADG only) and age, 
which were fitted as fixed covariates, VL at stage of infection was also fitted as a fixed 
covariate for ADG to fit an average slope; A: and A; are the sire effects for ADG and 
VL, respectively, where A:	includes the sire effect on slope and level, and were 













5 ,   and σÉõú
5  are the sire 
variances of level, slope and VL, respectively, respectively, σÉôÉö is the covariance 
between the sire effects on level and slope, σÉôÉõú is the covariance between sire effects 
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on level and VL, σÉöÉõúis the covariance between sire effects on slope and VL; and A 
is the numerator relationship matrix among sires;	C:	and	C;	are vectors of pen effects 
nested within a trial for each trait, with	Var
C:
C;
= I ⊗ K,	where	I	is the identity matrix 
and	K	is the corresponding variance-covariance matrix of pen effects for the different 
traits;	E:	and	E;	are the vectors of litter effects for each trait, with	Var
E:
E;
= I ⊗ L,	
with the corresponding variance-covariance matrix	L;	F:	and	F;	are the vectors of error 
terms for each trait, with	Var
F:
F;
= I ⊗ R,	where	R	is the variance-covariance matrix 
for the residual effects for each trait; and	X'	and	X5,	Z'	and	Z5,	U'	and	U5,	and	M'	and	
M5	are	the incidence matrices for the fixed, animal, pen and litter effects, respectively, 
for each trait. For the repeated measurement model, model [3] was applied to the 
vectors of repeated measurements of ADG and VL at each stage of infection. 
Additionally, BW at each stage of infection was fitted as a fixed covariate, and 
permanent environmental effects were also included as an additional random effect (as 
in model [2]). 
 
3.2.7 Association of the WUR resistance genotype with tolerance 
Association of the WUR genotype with tolerance was estimated by including genotype 
and genotype-by-VL as fixed covariates in models [2] and [3], providing estimates of 
least-square means for the genotype effect on growth and tolerance slope, respectively. 
Significance of the associations of the genotype with traits were assessed using an f-




3.3.1 Single measures model for different stages of infection 
3.3.1.1 Evidence for genetic variation in tolerance at different stages of infection 
The null model including VL as a fixed covariate identified a statistically significant 
linear association between growth and VL at only mid stage VL (p=0.02, p<.0001 for 
ADGmid and ADGlate, respectively), and at late stage VL p<.0001 for ADGlate. Growth 
at any stage of infection was not associated with early stage VL. Only models 
including mid and late stage VL are therefore considered from hereon. Population 
average tolerance slope estimates were negative but generally very flat: for ADGmid 
and ADGlate on VLmid growth rate only decreased on average by -1.42E-03 (4.65E-04) 
and -2.43E-03 (4.85E-04) kg/day per unit of VL increase, respectively, and for ADGlate 
on VLlate the decrease in growth rate was -1.91E-03 (4.39E-04) kg/day per unit VL 
increase. The log-likelihood of the model was significantly improved when genetic 
effects (random sire effects) were included in the model (level model) at all stages of 
infection (p<.0001), indicating significant genetic variance in growth of pigs infected 
with PRRSV. Models with sire effects on both level and tolerance slope, as well as a 
genetic covariance between them, yielded a significantly better fit than the null model 
at all stages of infection (p<.0001). However, a statistically significant improvement 
of the model fit of the level-slope model over the level model was only observed when 
ADG at late stage of infection was regressed on VL at mid stage of infection (p<0.05) 
(Table 2, bold). All other models constrained covariance between level and slope at 
zero, similar to what was seen in the level slope models investigated in chapter 2.  
Genetic variances of level were relatively stable across all stages of infection for both 
level-only model and level-slope model (Table 2). Genetic variance estimates for 
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tolerance slope varied greatly depending on stage of infection, by up to four orders of 
magnitude (Table 2). As would be expected, genetic variance for slope was largest 
when ADGlate was regressed on VLmid (1.77E-05 (1.83E-05)). Similarly, covariances 
between level and slope varied greatly in magnitude depending on stage of infection, 
but all covariances were negative. The genetic covariance estimate for the ADGlate - 
VLmid model was noticeably stronger than for the other models (Table 2). 
 
Table 2. Genetic variance components for ADG (kg/d) at mid and late stage of 
infection regressed on VL at mid and late stage of infection, respectively. The last 
column denotes the p-value of the LRT used to test whether the level-slope model 
significantly improves the model fit over the level model.  For definition of stages of 
infection, see text.  
  
 Level-only model Level-Slope model Model fit  
VL ADG Level Level Covariance Slope P-value 
Mid 
Mid 3.47E-03 (1.56E-03) 3.39E-03 (1.56E-03) -1.02E-11 (5.73E-13) 3.40E-06 (6.24E-06) 0.743 
Late 2.33E-03 (1.24E-03) 2.52E-03 (1.30E-03) -6.90E-05 (9.61E-05) 1.64E-05 (1.02E-05) 0.024 
Late Late 1.96E-03 (1.15E-03) 1.97E-03 (1.15E-03) -8.47E-13 (4.77E-14) 1.13E-09 (6.35E-11) 1.000 
 
 
3.3.1.2 Relationship between level, slope and resistance at different stages of 
infection 
For ADGlate regressed on VLmid, genetic correlation between level and tolerance slope 
was -0.38 (0.45); between level and VL, the genetic correlation was -0.40 (0.37); and 
between VL and slope, the genetic correlation was 0.31 (0.50). Due to high standard 
errors, these genetic correlations were not significantly different from zero. Phenotypic 
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correlation was generally lower than genetic correlation: between level and VL was 
0.27 (0.05), indicating that individuals that had higher VL were likely to grow faster 
growth under infection (i.e. less resistant individuals grew faster); and between slope 
and VL was 0.23 (0.06), indicating that individuals with higher VL tended to be more 
tolerant (i.e. that more resistant individuals were less tolerant and vice versa). 
Phenotypic correlations between level and slope could not be calculated as there was 
no covariance between level and slope for residual or additional random effects. 
 
3.2.1.3 Association of WUR genotype with tolerance across individual stages of 
infection 
The WUR genotype did not have an association with tolerance slope at any stage of 
infection (p>0.05 for each stage). 
 
3.3.2 Repeated measures model:  
3.3.2.1 Genetic variation in tolerance across all stages of infection  
A very weak, but statistically significant association between growth and VL was 
detected by the repeated measurement model (p=0.01), with an average slope of 8.17E-
04 (4.10E-04) kg/day per unit VL increase. Similarly, a weak but significant 
association between BW at each stage of infection with growth under infection was 
found (p<.0001) with a positive regression coefficient of 2.74E-02 (1.08E-03). In other 
words, pigs that are 1kg heavier at a specific stage of infection tended to grow on 
average by 20g/d faster.  
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Table 3. Variance components (with standard errors) for ADG (kg/d), obtained 
by the repeated measures model including ADG and VL measures for all three defined 
stages of infection (early, mid and late), together with the LogLikelihood value 
associated with the different models. Variance components estimated from random 
regression models: null model, containing no genetic effect; level-only model, 
containing only the overall sire effect on growth under infection; and level-slope 
model, containing sire effects on level and slope, respectively. All other fixed 
effects/covariates and random effects were identical between models. Variance 
component estimates for the other random effects (e.g. pen, litter, common 
environmental, residuals) were identical between the models and not shown.  
 





Level . 1.33E-03 (5.76E-04) 1.80E-03 (7.39E-04) 
covarianc
e . . 8.10E-05 (5.05E-05) 
Slope . . 1.61E-05 (4.36E-06) 
LogLikeli
hood 4717.39 4725.31 4767.28 
 
The log-likelihood of the repeated measures model improved significantly when 
genetic effects (i.e. random sire effects) were included in the model (level model) 
(p<.0001) (Table 3). Furthermore, a statistically significant increase in the log-
likelihood of the level-model was observed when genetic effects for level, slope and 
covariance between the latter were included (p<.0001), indicating statistically 
significant genetic variation in tolerance. Similar to the single measures model, 
variance estimates were relatively robust across the different models.  
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3.3.2.2 Relationship between level, tolerance slope and resistance across all stages 
of infection  
Genetic correlation between level and tolerance slope was 0.51 (0.23), indicating that 
individuals that genetically had faster growth rate under infection were likely to be 
genetically more tolerant. Between level and VL, the genetic correlation was -0.92 
(0.27), indicating that individuals with higher genetic resistance tended to grow faster 
under infection. Between VL and tolerance slope, the genetic correlation was -0.79 
(0.31), indicating a favourable genetic relationship between resistance and tolerance.  
Phenotypic correlation was generally lower than genetic correlation: between level and 
VL it was -0.13 (0.03), and between VL and tolerance slope it was -0.08 (0.02).  
 
3.3.2.3 Association of WUR genotype with tolerance across all stages of infection 
The WUR genotype was suggestively associated with tolerance over all stages of 
infection, (p=0.045). As with resistance, the B allele also conferred higher tolerance, 
where individuals with the AB genotype had a tolerance slope 1.6% ± 0.88% higher 
than individuals with the AA genotype. As there were only 36 individuals with the BB 
genotype, these results are not reported. 
 
3.4 Discussion 
3.4.1 Summary of findings 
In contrast to the inconclusive evidence for genetic variation in tolerance of pigs to 
PRRS obtained in the precious chapter, this study found strong evidence for significant 
genetic variation in tolerance of pigs to PRRS. This was achieved by partitioning the 
entire infection period into three different stages of infection based on individual 
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viremia profile characteristics (early, mid and late), and by either assessing tolerance 
genetics at each particular stage, or by utilizing the information from longitudinal data 
in a repeated measurement model.  
According to the single stage models, significant genetic variance in tolerance could 
only be detected when late stage ADG regressed against mid stage VL. This would 
indicate that genetic variation in tolerance is sensitive to the timing of measurements, 
and that a unit reduction in VL at the rapid phase of post-peak viremia decline is 
associated with genetic differences in pigs’ growth responses at the late stage of 
infection: whereas some pigs may be genetically predisposed to experience 
compensatory growth, other pigs are genetically predisposed to suffer a prolonged 
growth depression. At all other stages of infection, lack of evidence for genetic 
variance in tolerance was accompanied by similar statistical constraints as observed in 
chapter 2 (e.g. confounding between level and slope, convergence issues). 
The statistical constraints associated with the single measures models for tolerance 
could be overcome by adopting a repeated measurement model that included viremia 
and growth measures at the different stages of infection. This model provided strong 
evidence for significant genetic variation in tolerance, as indicated by the considerably 
better model fit of the level-slope model over level-only model. Furthermore, it 
provided plausible non-zero estimates with low standard errors for the “overall” 
genetic variance in tolerance across all stages of infection, as well as for the genetic 





3.4.2 Association of the WUR genotype with tolerance 
The WUR genotype was not statistically associated with tolerance slope at any stage 
of infection (p>0.05). This was in line with Rashidi et al. who, using a random 
regression model regressing ADG from 0 to 28 dpi on VL from 0 to 14 dpi, using a 
slope-only model (see chapter 2) with the same PHGC dataset, found that WUR was 
not associated with tolerance slope. Instead, only a suggestive association with a 
genomic region on chromosome 1 [87]. However, the WUR genotype was 
suggestively associated with overall tolerance slope through all stages of infection. It 
is likely that WUR, which has been shown to be significantly associated with 
resistance, is associated with tolerance when genetic correlation between resistance 
and tolerance is strong and positive, as was the case with the repeated measurement 
level-slope model. This indicates that resistance and tolerance may be pleiotropic, with 
the WUR SNP affecting both traits. The association of WUR with resistance and 
growth at different stages of infection is further discussed in chapter 4. 
 
3.4.3 The importance of stages of infection to identify genetic variation in tolerance 
Partitioning the 42-day observation period into different stages of infection helped to 
resolve the previously encountered statistical constraints for detecting genetic 
variation in tolerance of pigs to PRRS in two ways: firstly, it provided repeated 
measurements of virus load and growth to boost the statistical power of the models, 
and secondly it helped to focus the analysis to a stage of infection where genetic 
differences in tolerance are most pronounced. 
In this study, the individual stages of infection were defined with help of the 
mathematical Woods function, which had been previously shown to provide a close fit 
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to the viremia data of the majority of pigs in the PHGC trials that had not experienced 
a viremia rebound.  Adopting this function allowed the definition of infection phases 
based on viremia profile properties, such as the phase associated with viremia increase 
towards peak viremia, the phase of rapid post-peak decline, and the later phase 
corresponding to more gradual viremia decline. The question arises how sensitive the 
results are to the definition of infection stages. For this purpose, the analyses of this 
chapter were repeated for an alternative definition of stages of infection, in which the 
stages were simply defined according to the following three fixed time periods: from 
0-7 dpi (early), from 7-21 dpi (mid) and from 21-42dpi (late). As shown in the 
appendix to this chapter, the results were similar: The repeated measurement model 
provided strong evidence for significant genetic variation in tolerance to infection and 
the single measures models applied to VL and ADG at different stages of infection 
provided evidence for genetic variance in tolerance only for the late stage of infection 
(although in this case when ADGlate was regressed on VLlate, rather than on VLmid as 
was the case when stages of infection were defined based on viremia characteristics). 
The results thus imply that the results are robust to different definitions of infection 
stages. Nevertheless, it should be mentioned that the statistical models with fixed time-
period infection stages were more prone to numerical constraints during the fitting 
process than infection stages based on viremia characteristics. For example, estimates 
for genetic correlations between resistance and tolerance could not be obtained from 
the repeated measures model with infection stages defined by fixed time intervals. 
Conventionally, host resistance and tolerance are considered as two alternative host 
defence mechanisms to fight infections. Based on this, one may expect a negative 
genetic correlation between both traits. However, in this study, the single measurement 
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model applied to individual infection stages and the repeated measurement model 
provided ambiguous results with regards to the genetic correlation between resistance 
and tolerance: whereas the single stage analysis was suggestive for an antagonistic 
genetic correlation between resistance and tolerance (estimated genetic correlation 
between VL and tolerance slope at mid stage of infection was 0.31 (0.5)), the multi-
stage analysis indicated a strong favourable genetic relationship between both traits 
(estimated genetic correlation between VL and tolerance slope was -0.79 (0.31). The 
results would thus suggest that the relationship between resistance and tolerance is 
time dependent. More effective reduction in pathogen load at a particular stage of 
infection may temporarily decrease host tolerance, but the compromise between the 
traits may disappear when traits are considered over a longer period of infection.  
 
3.4.4 Implications for breeding programmes and conclusions 
The results of this study suggest that, in principle, genetic selection for greater 
tolerance of pigs to PRRS is possible. However, in practical terms, tolerance may still 
be difficult to target for genetic selection, given that multiple repeated measures are 
required for each individual, and information of performance and within-host pathogen 
load are required for multiple offspring of each sire. The strong favourable genetic 
relationship between resistance and tolerance, and the fact that the WUR resistance 
allele also seems to infer greater tolerance observed in this study would imply that both 
mechanisms likely work together to improve host resilience and that selection for 
greater resistance will simultaneously improve tolerance. Thus, genetic selection for 




3.1 Stage of infection defined by duration 
In the main text, we defined stages of infection by individual viremia profile 
characteristics to identify genetic variation in tolerance at each stage of infection, and 
across all stages of infection using a repeated measures model. In this appendix, we 
used fixed time intervals as a proxy for different stages of infection. Stages of infection 
were defined from 0 to 7 dpi (early), 7 to 21 dpi (mid) and 21 to 42 dpi (35 dpi for 
trials 7 and 8) (late), as these durations similar to the average viremia peak, and 
maximal rate of viremia clearance used to define stages of infection in the main text. 
It should be noted, that although 14 dpi was closer to maximal rate of viremia 
clearance, previous research had used up to 21 dpi to define acute stage of infection, 
so 21 dpi onwards was used to define stages here. These duration-defined stages of 
infection were implemented using model [2] to identify genetic variation at each stage 
of infection and in repeated measures model [3] to identify genetic variation in 
tolerance across all stages (see main text). 
 
3.2 Genetic variation in tolerance at different stages of infection 
The null model including VL as a fixed covariate identified a statistically significant 
linear association between growth and VL (p<.0001). The log-likelihood of the model 
was significantly improved when genetic effects (random sire effects) were included 
in the model (level model) at all stages of infection (p<.0001), indicating significant 
genetic variance in growth of pigs infected with PRRSV. However, as indicated in 
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Table A1, significant improvement of the level-slope model fit over the level-only 
model only occurred at “late” stage of infection i.e. in the 21-42 dpi infection period. 
 
Table A1. Genetic variance components for ADG (kg/d) at each stage of infection 
defined by fixed time periods from 0 to 7, 7 to 21 and 21 to 42 dpi. The last column 
denotes the p-value of the LRT used to test whether the level-slope model significantly 












































3.3 Genetic variation in tolerance across all stages of infection 
When the repeated measurement model was applied, the level-slope model was a 
significantly better fit than the level-only model (p<.0001) (Table A2), indicating 
genetic variation in tolerance across all stages of infection could also be detected when 
stages of infection were defined by fixed time periods rather than by time periods 
defined by viremia curve characteristics.  
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Table A2. Variance components for ADG (kg/d) over all duration-defined stages of 








Level . 2.70E-03 (1.03E-03) 2.81E-03 (1.09E-03) 
covariance . . -2.20E-05 (4.91E-05) 
Slope . . 9.80E-06 (2.86E-06) 
Residual 1 3.06E-02 (1.15E-03) 3.06E-02 (1.15E-03) 2.96E-02 (1.11E-03) 
Residual 2 1.62E-02 (6.44E-04) 1.62E-02 (6.39E-04) 1.52E-02 (6.03E-04) 
LogLikelih
ood 
4059.50 4071.44 4106.00 
 
3.4 Relationship between level, slope and resistance from 21-42 dpi 
Correlations between level, tolerance slope and resistance were estimated for the 
infection duration 21-42 dpi. Genetic correlation between level and slope was 0.25 
(0.43). Between level and VL, the genetic correlation was -0.61 (0.37), indicating that, 
overall, individuals who were more resistant had faster growth; and between VL and 
slope, the genetic correlation was 0.13 (0.38). Phenotypic correlation was generally 
lower than genetic correlation: between level and VL was 0.37 (0.08), indicating that 
those that less resistant individuals grew faster under infection. Between VL and slope, 
the phenotypic correlation was 0.16 (0.05), indicating that more resistant individuals 
tended to be less tolerant and vice versa, however correlations were low, so this 
association was not strong. Phenotypic correlations between level and slope could not 
be calculated as there was no covariance between level and slope for residual or 
additional random effects. 
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3.5 Association of WUR genotype with tolerance slope 
The WUR was not associated with tolerance slope at any stage of infection or across 
all stages of infection (p>0.05). 
 
3.6 Relationship between level, slope and resistance across all 
duration stages of infection 




Genome-wide association studies for resistance and 
growth at different stages of infection 
 
4.1 Introduction 
Genome-wide association studies (GWAS) have played an important part in genetic 
analyses of host response to Porcine Reproductive and Respiratory Syndrome (PRRS) 
virus infections. To date, various host genomic regions have been identified which 
were associated with growth and resistance of pigs to PRRSV infection  [55,57,58]. In 
particular, using the same PHGC data as used in this thesis, a single nucleotide 
polymorphism (SNP) was identified that explains a considerable amount of the total 
genetic variance in resistance and weight gain of weaned piglets following 
experimental infection. This WUR10000125 (WUR) SNP covers a ~1MB region at 
Sus Scrofa chromosome (SSC) 4, where the favourable B allele corresponded to higher 
resistance (indicated by lower within-host viral load (VL)) and faster growth rate. 
Furthermore, genetic correlations between growth and resistance were shown to be 
positive and strong (ranging from 0.57 to 0.75 for different virus strains [22,55,57]). 
As such, selection for improved resistance would be expected to simultaneously 
improve growth under infection and vice versa.  
In existing publications, the relationship between resistance and growth has, thus far, 
been exclusively assessed based on cumulative response over 0 to 21 or 0 to 42 days 
post-infection (dpi). However, as indicated in chapter 3, partitioning the infection 
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period into separate stages of infection, e.g. based on individual viremia curve 
characteristics, may provide novel insights about how the relationship between 
resistance and growth over time and the effect of the WUR genotype on it. This study 
aimed to define and assess the genetic basis of, and relationship between, growth and 
resistance across different stages of infection, defined by viremia curve characteristics. 
Secondly, this study investigated the association of the WUR genotype with these 
traits, and whether the strength of this association changed through stages of infection. 
Finally, by conducting a genome-wide association study (GWAS), this study aimed to 
identify genomic regions associated with each trait, and how this association differed 
across stages of infection. Note that it was not possible to carry at a GWAS for 
tolerance, as this was part of an alternative PhD project, and thus, due to legal reasons, 




The same PHGC data as used in chapter 3 were used in this chapter. In this study, data 
from 1183 pigs were used [3]. Using the Illumina A/B genotype reference system (see 
chapter 3), the number of animals in each WUR genotype category were where n=689, 
286 and 36 for AA, AB and BB genotypes, respectively. The genotypes were 






4.2.2 Statistical models 
4.2.2.1 Defining stages of infection 
The stages of infection were defined as outlined in chapter 3. Briefly, based on 
individual viremia profile characteristics, stages were defined as early (from start of 
experimental infection to time of peak viremia); mid (from time of peak viremia to 
time of maximal viremia clearance rate); and late (from time of maximal viremia 
clearance rate to the end infection). Using these stages of infection, resistance was 
defined for each individual as the area under the viremia curve at early, mid and late 
stages of infection (VLearly, VLmid, and VLlate, respectively); and growth was defined 
as average daily gain for the respective stages of infection (ADGearly, ADGmid and 
ADGlate). 
 
4.2.2.2 Genetic models 
To determine the underlying genetic basis of ADG and VL at each stage of infection, 
heritabilities, phenotypic and genetic correlations of, and between, traits were 



























where 9: and 9; are ADG and VL for different stages of infection (early, mid or late), 
respectively; 	?: and ?; are a vectors of fixed effects/covariates for ADG or VL, 
containing the interaction of experimental trial and parity of the dam, when offspring 
were born (trial-by-parity), sex of the offspring, and BW0 (for ADG only) and age, 
which were fitted as fixed covariates; A: and A; are the additive genetic effects for 
ADG and VL, respectively, assumed to follow a multi-variate normal distribution with 
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mean zero and Var
A:
A;




; , where XA:
;  and XA;
;  are 
the variance of A:, and A;, respectively, XA:A; is the covariance between animal effects 
for each trait, and A is the numerator relationship matrix among animals;  C: and C; 
are vectors of pen effects nested within a trial for each trait, with Var
C:
C;
= L⊗ M, 
where L is the identity matrix and M is the corresponding variance-covariance matrix 
of pen effects for the different traits; E: and E; are the vectors of litter effects for each 
trait, with Var E:
E;
= L ⊗ N, with corresponding variance-covariance matrix N; F:, and 
F; are the vectors of error terms for each trait, with Var
F:
F;
= L ⊗ O, where O is the 
variance-covariance matrix for the residual effects for each trait; and =', =5, @', @5, 
B', B5, D', and D5 are the incidence matrices for the fixed, animal, pen and litter 
effects, respectively. A bivariate model was used to provide more robust estimates 
than a multivariate model. 
 
4.2.2.3 Association of WUR genotype with stages of infection 
To ensure highest accuracy, associations of the WUR genotype for ADG and VL at 
early, mid and late stages of infection were estimated for each trait using the 
corresponding univariate animal models to model [2] (i.e. same fixed and random 
effects), but also including the WUR genotype as a fixed effect, providing estimates 
of least-square means for the genotype effect on ADG and VL. Statistical associations 




4.2.2.4 Genome Wide Association Study 
Associations of SNP genotypes with individual traits were analysed fitting all SNP 
simultaneously in the genome-wide association study implemented using GenSel 
software [92]. In this approach, all SNPs were fitted simultaneously as random effects 
in an iterative manner. GenSel incorporates Bayesian methods, which generate 
posterior distributions for the parameter of interest (here effect size) based on 
information from both the phenotypic data and the prior information to identify 
relevant SNPs [47,49,50]. A burn-in period was specified, where 1000 initial iterations 
are removed from analysis [49,50]. Iterations then sample from the posterior 
distribution of previous iterations. If a SNP was fitted in the model (£S=1) and 
explained a larger proportion of the genetic variance than other fitted SNPs, then that 
particular marker was more likely to be included in the model in subsequent iterations. 
For this, a parameter p was specified, where p is the proportion of markers expected 
to have no significant effect on the trait. Bayesian variable selection assumes that a 
SNP has a zero effect on the trait of consideration, with probability equal to p, or has 
an effect sampled from a normal distribution with probability equal to 1-p. The 
parameter p can be calculated as (1 – number of animals genotyped/ number of SNPs), 
which in this study gave p=0.974. By specifying this value, the model was informed 
that 0.926% of markers will be associated with the phenotype. In this study, where 
50,000 SNPs were included in the analysis, the model thus contained 463 markers 
fitted in each iteration of Bayesian variable selection. 
As nearby genetic markers are in high LD, they will be in high LD with a causative 
mutation. Therefore, association of all SNPs within a genomic region were considered 
using a window-based approach, where effects of all SNPs were summed within each 
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window. Each non-overlapping window was defined by 1 Megabase (Mb) segments 
on the chromosome [93]. The GenSel software allowed only fixed effects and 
covariates to be included in the model. Thus previously fitted random effects (e.g. pen 
or litter) were included as fixed effects so that the only random effects were the SNP 
effects, leading to model [2] below: 
9 = =? + §S
•
S¶:
α®δ® + F	[;] 
where 9 is ADG or VL for each stage of infection (early, mid or late), respectively; = 
is the incidence matrix relating ADG or VL to fixed effects; ? is a vectors of fixed 
effects/covariates for ADG or VL, containing the interaction of experimental trial and 
parity of the dam when offspring were born (trial-by-parity), sex of the offspring, pen, 
and BW0 (for ADG only) and age, which were fitted as fixed covariates (due to 
limitations of software in including additional random effects); §S is a vector of the 
genotype covariates for SNP i for each trait, α® is the allele substitution effect for SNP 
i for each trait, and δi is an indicator for whether SNP i was included (δi = 1) or 
excluded (δi = 0) in the model for a given iteration of the Monte Carlo Markov Chain. 
The prior probability of δi = 0 was set equal to π = 0.974, and implemented using 
Bayes-B [94]; and F was a vector containing residual errors.  
 All SNPs were fitted simultaneously as random effects in an iterative manner, over 
50,000 iterations. 
The posterior distribution of the proportion of genetic variance explained by each of 
these windows was derived as such: The total genomic estimated breeding value 
(GEBV) for each individual was computed by summing the product of the genotype 
covariate and the estimate of SNP effects across all evaluated SNPs for each 
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individual. For each window, the posterior means of the relevant SNP effects were 
multiplied by their corresponding genotype covariates and summed to calculate the 
window GEBV of each individual. The variance of these window GEBV across 
individuals, expressed as a proportion of the variance of the total GEBV across 
individuals, was used to identify genomic regions that were most strongly associated 
with the phenotype. To control for false positives, a threshold to define significant 
windows was set using a posterior probability of inclusion over 0.80 [49]. 
 
4.3 Results 
4.3.1 Genetic basis and relationship between ADG and VL across stages of infection 
ADG across all stages of infection ranged from -0.11 to 0.80kg/day (table 1). Mean 
ADG increased with stage of infection from 0.25 to 0.43kg/day at early and late stages 
of infection, respectively, indicating that individuals were, generally, able to grow 
faster at later stages of infection. Mean VL increased from 37.07 to 67.58 from early 
to late stage of infection, respectively. The VL increase is mainly attributed to the 
longer time period associated with the late stage of infection (on average 14.3 days 
compared to 6.9 and 9.2 days associated with the early and mid stage of infection, 
respectively). Whereas the phenotypic variance for growth is stable across the different 






Table 1. Descriptive statistics of growth (ADG (kg/day) and viral load (VL 
(log10RT-PCR) at early, mid and late stages of infection.  
Trait Mean Standard deviation Minimum Maximum 
ADGearly 0.25 0.13 -0.11 0.64 
ADGmid 0.29 0.13 -0.09 0.68 
ADGlate 0.43 0.14 0.00 0.80 
VLearly 37.07 6.49 16.36 57.21 
VLmid 58.37 9.21 35.64 87.11 
VLlate 67.58 10.39 39.05 99.31 
 
Both ADG and VL were found to be moderately heritable across all stages of infection 
(table 2). VL had lowest heritability at early stage of infection (from 0 dpi to peak 
viremia (0.17)) and reached highest heritability at the mid stage (between peak viremia 
and max viremia clearance (0.31)). Conversely, ADG was most heritable at earliest 
stage of infection (0.28) and least heritable by late (0.18).  
 
Table 2. Heritabilites, of growth (ADG) and viral load (VL) at early, mid and late 
stages of infection, and genetic and phenotypic correlations between the traits 
(lower and upper diagonal, respectively). Standard errors are in brackets. 
Trait ADGearly ADGmid ADGlate VLearly VLmid VLlate 
ADGearl
y 
0.28 (0.07) 0.35 (0.03) 0.24 (0.03) 0.03 (0.03) -0.06 (0.03) 
-0.12 
(0.03) 

















(0.28) 0.45 (0.28) 
-0.38 







(0.27) 0.01 (0.37) 0.82 (0.12) 0.20 (0.10) 
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Genetic correlations between all stages of infection were generally high and positive 
for ADG (in the range of 0.74-0.84). Phenotypic correlations were also positive, but 
weaker. Genetic correlations between stages for VL were strong between consecutive 
stages of infection (0.73 to 0.82), but very weak between early and late stage (-0.01), 
indicating that individuals with lower VL early in infection did not necessarily imply 
lower VL at late stage. Phenotypic correlations were moderate to strong between 
consecutive stages, but weak and negative between early and late stages. Estimates for 
genetic correlations between ADG and VL varied depending on stage of infection, and 
had high standard errors. At the early and mid stage of infection, genetic correlations 
between ADG and VL were weak to moderate (0.22 and 0.45 for early and mid stages, 
respectively), indicating that individuals with may have had greater genetic resistance 
at these stages of infection tended to grow faster during these stages. However, by late 
stage of infection, genetic correlation between ADG and VL was strong and negative 
(-0.61). The strongest genetic relationship between VL and ADG (0.83 (0.26)) was 
observed between ADG at mid stage of infection and VL at early stage of infection, 
implying that individuals with lower genetic resistance at early stage of infection 
tended to grow faster at the mid stage, and vice versa (see discussion). However, 
standard errors were high for genetic correlations between ADG and VL, with 
exception of ADGmid with VLearly and ADGlate with VLlate. Phenotypic correlations 





4.3.2 Association of WUR genotype with ADG and VL across different stages of 
infection 
The WUR genotype was associated with VL across at stages of infection (p<.0001), 
but only significantly associated with ADG at mid and late stages of infection 
(p<.0001). Although standard errors were high individuals with the favourable B allele 
generally had higher ADG than those with genotype AA (Figure 1a). Similarly, 
individuals with heterozygous AB genotype had lower VL across all stages of 
infection than those with the AA genotype (Figure 1b). As there were few individuals 
with BB genotype, only differences between AA and AB are considered from here-
on. The largest difference in ADG between genotypes was at the late stage of infection, 
where individuals with AB genotype grew, on average, 55g/day faster than those with 
AA. However, largest difference in VL occurred at the mid stage of infection, where 




Figure 1. Effect of WUR genotype of a) ADG and b) Viral load (VL) across early, 
mid and late stages of infection, where B allele is the favourable allele. The red, blue 
and green lines correspond to AA, AB and BB genotypes, respectively. Lease-square 
means of ADG (kg/day) with standard errors and VL (area under viremia curve) are 




4.3.3 Genome Wide Association Study 
This study did not find any genomic regions explaining a significant percentage of the 
genetic variance of ADG at early stage of infection (Figure 2), although a small 
percentage of the total genetic variation was explained by two regions on chromosome 
5 (1.56% and 0.88% by each window). Additionally, there were no significant 
genomic regions for VL at late stage of infection identified by the GWAS. 
The only genomic region which explained a significant percentage of the total genetic 
variance (i.e. had a posterior greater than 0.8) was on chromosome 4 containing 40 
SNP (window 793). This genomic region explained 7.29% of the total genetic variance 
for ADG at both mid and late stage of infection, and 8.13% and 7.48% of total genetic 
variance for VL at early and mid-stage of infection, respectively. This window 
contains the previously identified WUR genotype, in which SNP have been shown to 
be in strong LD [23]. As such, no further investigation was carried out on the SNP 




Figure 2. Manhattan plots of the genome-wide association study of ADG (upper row) 
and VL (lower row) at early, mid and late stage of infection showing percentage of 
total genetic variance explained by non-overlapping 1Mb genomic regions, arranged 




4.4.1 Summary of findings 
Partitioning infection into stages of infection informed by viremia profile 
characteristics provided new insight into how the genetic regulation of pigs’ response 
to experimental PRRSV infection changed over the time-course of infection. ADG and 
VL were heritable across all stages of infection, which implies that genetic selection 
for resistance to PRRS is expected to affect growth and viremia patterns at all stages 
of infection. Heritability for resistance was greatest for VL during the highly immune-
active time-period between peak viremia and maximal rate of viremia clearance. This 
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would suggest that the phase associated with the most rapid viremia decline would be 
easiest to manipulate by genetic selection. For ADG, heritability was greatest at the 
early stage of infection. It is not clear whether this reflects heritable genetic differences 
in growth per se, or captures already different growth responses to infection. Indeed, 
genetic correlation between VL and ADG were strongest between pre-peak VL and 
post-peak ADG, indicating that growth response lags behind viremia response.  
Genomic regions containing the WUR SNP explained a significant percentage of total 
genetic variance at early-mid stage of VL and mid-late stage ADG, with the AB 
genotype conferring both higher resistance and higher growth under infection. This is 
consistent with previous studies, which found similar heritabilities and associations of 
the WUR genotype with these traits at 21 and 42 dpi [57,55]. No previously 
unidentified genomic regions associated only with a particular phase of infection were 
found.  
 
4.4.2 Why define stages of infection? 
Defining stages of infection based on underlying pathogen load could provide deeper 
and novel insights into the genetics underlying the mechanisms influencing an 
individual’s infection profile. Cumulative viral load for a prolonged period of time 
(e.g. 21 or 42 days) provides a summary of how an individual copes with infection, 
but does not capture the dynamic changes of the individual’s viremia curve resulting 
from different sets of immune functions at different stages of infection. For example, 
two individuals may have equal VL over the 21-day infection period, but one of the 
individuals may experience higher viremia over a short time, while the other may have 
low viremia over a prolonged time. This may reflect different immune response 
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patterns, but the genetic signal is blurred by using cumulative VL as phenotype. By 
defining stages of infection based on underlying viremia curve characteristics, the 
corresponding VL measures are more likely to reflect different sets of immune 
response parameters to PRRSV, and thus possibly different sets of genomic regions 
associated with these. For example, the time of fastest rate of viremia clearance, which 
defined the boundary between mid and late phase in this study, coincides with the time 
at which neutralizing antibodies are produced at highest rates [95]. Thus, the late stage 
of infection is likely determined by the ability of the individual to mount an effective 
adaptive immune response [96]. There has been evidence of genetic variation in 
antibody response to PRRS. Indeed, Hess et al. estimated heritability of 0.13 for serum 
levels of IgG during PRRS infection [95], and Serão et al identified genomic regions 
associated with IgG in serum of PRRS infected animals at 46 dpi [97]. 
This study found indeed that heritabilities for resistance and growth, and their genetic 
correlation changed considerably over the time-course of infection. Furthermore, the 
WUR SNP that had been previously identified to explain a significant part of genetic 
variation in VL and growth over the 21 and 42-day infection period, was found to be 
only associated with particular phases of infection in this study. However, no novel 
QTL associated with only a particular stage of infection, was detected.  
 
4.4.3 Relationship between resistance and growth 
The WUR genotype was associated with growth only at mid to late stages of infection, 
but associated with VL at early to mid stages of infection. In line with this, genetic 
correlation was strongly positive between ADG at mid stage of infection and VL at 
early stage of infection (0.83 (0.26)), implying that genetically resistant individuals 
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with lower VL earlier in infection would subsequently have slower growth rate at later 
stage of infection. This is likely due to individuals with higher genetic resistance 
needing to divert more resources away from growth to combat infection, where greater 
investment in early immune response to infection would result in a less severe 
infection, but a temporary reduction in growth. These results are consistent with 
resource allocation theory, where a trade-off between fighting infection and growth 
would occur due to limited energy resources available for both biological processes 
[13]. 
At the late stage of infection, the genetic correlation between ADG and VL shifts from 
strongly positive to negative (e.g. genetic correlation between VLlate and ADGlate is -
0.61 (0.27)). This is likely due to return to homeostasis or even compensatory growth, 
where those animals that mange to clear the virus faster can allocate resources to 
growth [98]. In summary, these results combined imply that selection for lower VL at 
the post-peak viremia phase may lead to reduction in growth, but faster growth at the 
later stages of the infection period and overall.  It is only by examining the dynamic 
interplay between growth and resistance across different stages of infection, that this 
relationship becomes clear and gives biological meaning. 
It should be noted that in chapter 3, genetic variation in tolerance was only identified 
when late ADG was regressed on mid VL. This is surprising, given the strong genetic 
correlation between ADG and VL at these stages of infection.  
 
4.4.4 Association of WUR with growth and resistance to PRRS 
By analysing the host response to infection based on underlying biological properties, 
we were able to identify with which stages of infection the WUR genotype was 
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associated. The GWAS showed that the only window which explained a significant 
percentage of the total genetic variance was window 793, which contains the 
previously identified WUR SNP [23,57,58]. Window 793 was significant only at 
early-mid stage for VL, and mid-late stage for ADG. The effect of the WUR SNP was 
significant at these stages also. This SNP has been shown to be in high linkage 
disequilibrium (LD) with other SNPs in this window [23,57]. Thus, it is likely that this 
window was significant due to the effect of the WUR SNP. Furthermore, WUR has 
previously been shown to be in high LD with a causative mutation in the guanylate 
binding protein 5 (GBP5 gene), which plays a role in the inflammatory immune 
response [99,100]. In line with Boddicker et al and Hess et al, this study found a 
beneficial effect of the WUR genotype for both ADG and VL, where individuals with 
the favourable AB genotype demonstrated higher ADG and lower VL [55,57]. 
Additionally, Hess et al found that the genotype at the WUR SNP was associated with 
all viremia curve characteristics, where individuals with the AB genotype generally 
had lower Vpeak, Tpeak was reached 0.2 days earlier, Vmax was 3.8% faster and Tpeak was 
reached 0.68 days earlier. In this study, the genotype had strongest association with 
VL at early stage of infection, explaining 8.13% of the total genetic variance. 
Thus, selection to increase the frequency of the B allele of the WUR genotype would 
be expected have the greatest influence on early viremia patterns. However, the 
selection to response is likely to be limited, as only a small percentage of the total 
genetic variance is explained by genomic region containing the WUR SNP. Resistance 
is a highly polygenic trait, with multiple pathways involved in mounting an effecting 
immune response to PRRS. As there are no windows that explain a significant 
percentage of total genetic variance of VL at late stage of infection, it is likely that 
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there is no single genomic region that has a large effect at this stage of infection, given 
that it was moderately heritable. Indeed, the AB genotype may increase resistance at 
early-mid stages of infection, with a consequent positive effect on growth at the 
subsequent stages. In chapter 3, we found that the WUR genotype had no association 
with tolerance at any stage of infection. This, together with the results of this chapter, 
would thus imply that the association between WUR and ADG at mid to late stage of 
infection is a direct consequence of the effect of the genotype on resistance. 
 
4.4.5 Conclusions 
Using stages of infection defined by viremia curve characteristics is suitable for 
analysing the genetic change and interplay between growth and resistance over the 
time-course of infection. This study found that the genetic relationship between 
resistance and growth change considerably over different stages of infection. The 
results of this study support the resource allocation theory, suggesting a trade-off 
between resistance and growth i.e. that early investment in resistance has a short-term 
effect on growth, but leads to faster growth at late stage of infection. This study 
established that the WUR SNP would confer resistance at early stage-mid stage of 
infection, which would have a beneficial impact on growth at later stages of infection. 






Chapter 5  
Health trajectories reveal the dynamic contributions of host 
genetic resistance and tolerance to infection outcome 
Graham Lough, Ilias Kyriazakis, Silke Bergmann, Andreas Lengeling, and Andrea B. 
Doeschl-Wilson 
Authors’ contributions	
Design and conduct of infection experiment: AL, SB; Development of statistical 




In chapters 2 and 3, we found limitations with adopting random regression models to 
identify genetic variation in tolerance in outbred populations. Through utilising 
repeated measures, we were able to identify a positive relationship between resistance 
and tolerance over all stages of infection. However, in chapter 4, we found that the 
relationship between growth and resistance changed over the time-course of infection. 
In this chapter, we propose a novel methodology that enables interpretation of the 
dynamics between resistance and tolerance over the time-course of infection. 
Resistance and tolerance are two alternative strategies hosts can adopt to survive 
infections. Both strategies may be genetically controlled. To date, the relative 
contribution of resistance and tolerance to infection outcome is poorly understood. 
Here, we use a bioluminescent Listeria monocytogenes (Lm) infection challenge model 
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to study the genetic determination and dynamic contributions of host resistance and 
tolerance to listeriosis in four genetically diverse mouse strains. Using conventional 
statistical analyses, we detect significant genetic variation in both resistance and 
tolerance, but cannot capture the time-dependent relative importance of either host 
strategy. We overcome these limitations through the development of novel statistical 
tools to analyse individual infection trajectories portraying simultaneous changes in 
infection severity and health. Based on these tools, early expression of resistance, 
followed by expression of tolerance, emerge as important hallmarks for surviving Lm 
infections. Our trajectory analysis further reveals that survivors and non-survivors 
follow distinct infection paths, which are also genetically determined, and provides 
new survival thresholds as objective endpoints in infection experiments. Future studies 
may use trajectories as novel traits for mapping and identifying genes that control 
infection dynamics and outcome. 
 
5.2 Introduction 
Two alternative host response strategies to pathogen challenge contribute to survival: 
resistance, defined as the ability of a host to limit or inhibit pathogen replication, thus 
reducing infection severity [19]; and tolerance, defined as the ability of an infected 
host to limit the impact of infection on fitness or health. Tolerance mechanisms reduce 
or prevent damage associated with pathogen challenge, but have no direct impact on 
the pathogen itself [5,6,19,101]. In addition, tolerance is also an important mechanism 
for the co-evolution of symbiotic interactions between beneficial commensal microbes 
and the host, which has been long recognised in both plants and animals [102,103]. As 
host strategies, both resistance and tolerance may be genetically determined [5,30,34]. 
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Assessment of their relative contribution to survival requires quantitative estimates of 
resistance and tolerance based on empirical evidence. Resistance may be defined as 
the inverse of infection severity, conventionally quantified by measures of within-host 
pathogen burden. Obtaining quantitative estimates of tolerance has proven difficult in 
practice, owing to its statistical definition as reaction norm of health with respect to 
changes in pathogen burden [5,9,35] and the high frequency of measurements 
associated with constructing and analysing reaction-norms [4,7,35,37]. Although 
conceptually defined at the individual level, quantitative tolerance estimates can 
usually only be obtained at the level of groups of (related) individuals, which 
constitutes a major limitation to unravelling the host genetic regulation of tolerance 
[4,35,37]. 
These static definitions of resistance and tolerance, and the limitation of estimating 
tolerance at the group level, cannot further our understanding of the relative 
contribution of resistance and tolerance to individual survival, which is likely to 
change over the time course of infection [41]. Recently, individual health trajectories 
have been introduced as potentially powerful tools to capture the dynamic nature of 
infection and its impact on health in individual hosts [38,41]. Trajectories are 
constructed by plotting individual measurements of infection severity (e.g. pathogen 
burden) against health in 2-dimensional space at different stages of the infection. 
Following this pair-wise progression over time produces a trajectory that illustrates the 
dynamic interplay of resistance and tolerance mechanisms by describing how changes 
in within-host pathogen burden are associated with changes in health throughout the 
infection period, not currently captured by static definitions of resistance and tolerance 
(Figure 1A). We suggest that using trajectories as an alternative to conventional 
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statistical analysis of resistance and tolerance will help describe individuals’ infection 
paths towards a specific outcome (e.g. death or survival), and reveal critical stages of 
the infection associated with the greatest impact on health or fitness. It has been 
postulated that infection trajectories can be classified into distinct trajectory types 
[38,41] that may be linked to genetic background of the host [41]. It may thus be 
possible to map host genotypes to specific trajectory types, and target these for genetic 
improvement of host response to infections [38].  
 
Figure 1. An infection severity - health trajectory for an individual mouse.  
Graph 1A. Illustration of trajectory phases from start of infection to death. A 
trajectory for an individual mouse was produced by plotting longitudinal pairwise 
measurements of body weight (BW) and infection severity (bacterial load measured 
by log-transformed light intensity plus one [LLI]), in a 2-dimensional space, and 
following their progression over time. The graph also shows the four characteristic 
phases of infection associated with distinct changes in infection severity and health 
(indicated by arrows), as described in the text. 
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Graph 1B.  Illustration of trajectory vectors and resulting sequences. The 
trajectory vector V_0 with components VH (change in %BW) and Vs (change in 
infection severity), represents simultaneous change in infection severity (decrease, S-
) and health (increase, H+) between 0-1 dpi.  The bottom right panel shows the 4 
quadrants (S+H-, S-H-, S-H+, S+H+) in the Severity-Health (SH) plane specifying the 
direction of a trajectory vector, together with the associated sequence numbers (1-4). 
Each trajectory is mapped to a sequence comprising 14 numbers, representing the 
directions of the trajectory vectors at 14 consecutive daily intervals, and with the 
sequence number 0 indicating death. The trajectory of the individual depicted in this 
figure corresponds to the sequence {32211200000000}, i.e. it died after dpi 6. 
 
 
Although proven powerful on conceptual grounds, the use of trajectories to study host 
response to infection has not previously been supported by experimental data [38,41]. 
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Their wider application in infectious disease research has been hampered by the lack 
of statistical methods for quantitative trajectory analyses [37]. Trajectories often 
display loops (Figure 1A), which implies that they cannot be represented by 
mathematical functions, and are thus not amenable to conventional statistical models.  
In this study, we develop a novel statistical framework for quantitative trajectory 
analysis, making use of non-invasive bioluminescent imaging tools to analyse the time 
course of listeria infection in four inbred mouse strains. Listeria monocytogenes (Lm) 
is a Gram-positive, facultative intracellular bacterium that causes food-borne 
infections in animals and humans. Lm is responsible for the life-threatening disease 
listeriosis in elderly and immunocompromised individuals [104,105]. In healthy 
individuals, Lm infections are usually self-limited but can cause acute, febrile 
gastroenteritis [106]. Inbred mouse strains differ substantially in their apparent 
susceptibility to listeriosis, through contributions of multiple genetic loci [107–109], 
but genetic variation in tolerance to Lm, and the relative contributions of resistance 
and tolerance to survival are currently unknown. We use this model system to (i) 
determine whether there is genetic variation in tolerance to Lm, and whether mouse 
strains rank similarly in terms of resistance and tolerance, (ii) study the kinetic 
infection severity-health relationships using trajectory analysis, and their association 
with survival and (iii) assess whether different host genotypes map on to distinct 








The data were obtained from Lm infection challenge experiments of 108 mice from 
four genetically diverse inbred mouse strains as outlined in Bergmann et al [110]. 
Briefly, female mice aged between 9-10 weeks from the strains A/J, BALB/cJ (BALB) 
and C57BL/6J (B6J), and C3HeB/FeJ (C3H) were orally infected with bioluminescent 
Lm as described below. The inbred mouse strains were selected due to known 
differences in resistance to listeriosis development, similar mature body weights, and 
for their suitability for in vivo bioluminescence imaging (BLI). All mice were 
subjected to BLI or analysed for bacterial organ loads. On 1, 3, 5 and 7 days post 
infection (dpi), 18 to 30 mice from each strain (27, 18, 30 and 30 mice for A/J, C3H, 
BL6 and BALB, respectively) were sacrificed to measure colony forming units (CFU) 
of Lm from organ homogenates [110]. This enabled assessment of the spread of Lm to 
different internal organs, and to calibrate the infection severity measures obtained by 
the BLI analysis (see below). Ten mice per strain were maintained after inoculation 
until 14 dpi, or until they had to be euthanized due to reaching humane endpoints of 
infection severity. This was the case for all mice from strain C3H, 80% of A/J mice 
and 40% of BALB mice, which were all euthanized between 5-7 dpi due to onset of 
clinical signs of advanced listeriosis, according to established protocols and approved 
animal welfare regulations [110]. All mice were housed under specific-pathogen-free 
conditions. At the start of the experiment, all mice had reached mature body weights. 
Thus, any changes in body weight post infection were assumed to be a direct 
consequence of the infection challenge. 
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5.3.2 Infection protocol 
Prior to challenge with Lm, the mice were acclimatised for 1 to 2 weeks in the facility. 
On the day prior to infection, the mice were starved overnight, with drinking water 
replaced with carbonate buffered water. The next day, mice were intragastrically 
challenged with 5x109 CFU Lm EGDe-InlA-mur-lux, an internalin A (inlA) modified 
strain of Lm as previously described [110,111]. After infection challenge mice had ad 
libitum access to both food and water.  
 
5.3.3 Measurement of infection severity and health  
In line with the literature, resistance was quantified as an inverse measure of infection 
severity [5], defined here in terms of log-transformed measures of light-intensity (LLI) 
obtained daily from bioluminescent in vivo imaging (See Appendix 5.1). Higher LLI 
values correspond to higher Lm loads, which is indicative of higher infection severity 
[19].   
As Lm infection in adult mice causes a significant drop in body weight (BW), BW was 
used as an indicator of impact of the infection on health. BW was recorded for each 
individual mouse immediately prior to infection, and daily post infection over the 14-
day duration of the experiment. The impact of infection on health at a particular dpi 
was then represented as percentage loss of BW at that day from the initial BW at 0 dpi, 






5.3.4 Conventional statistical analysis of resistance and tolerance 
The statistical analysis used data only from the 40 mice that had not been analysed 
prior to 14 dpi for CFU counts, as only these provided information about the 
association of resistance and tolerance to survival. Data were analysed with the SAS 
statistical package (2010, version 9.3) using procedure proc MIXED. 
 
5.3.4.1 Estimating resistance and tolerance based on peak infection severity and 
minimum health 
In accordance with Raberg et al [5], we defined resistance in terms of maximum 
infection severity, here represented by peak LLI levels over the 2 week observation 
period. Tolerance estimates were obtained accordingly based on maximum infection 
severity (peak LLI) and minimum health (maximum %BW loss) achieved during the 
observation period.  
To assess genetic variation in resistance, a linear mixed model was used with peak LLI 
as the dependent variable, and mouse strain, binary survival outcome (succumbed to 
infection within 14 dpi (surviving)/did not succumb to infection (non-surviving)), and 
their interactions as fixed effects.   
In line with existing studies of tolerance genetics [5,7], an analysis of covariance 
(ANCOVA) was used to assess genetic variation in tolerance. The ANCOVA was 
performed using maximum %BW loss as dependent variable and peak LLI as 
independent variable, and mouse strain, survival outcome and the corresponding 
interactions as fixed effects. The intercept was fixed at zero, corresponding to zero 
percent BW loss in the absence of infection. The ANCOVA slope coefficients 
resulting from regressing individual health measures against infection severity provide 
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group estimates of tolerance, where steeper negative slopes correspond to less tolerant 
groups. Differences between these slope estimates based on the F-test statistics for 
strain-by-infection severity interaction thus provide evidence for genetic variation in 
tolerance.  
 
5.3.4.2 Assessing the sensitivity of resistance and tolerance estimates to time of 
measurement 
To determine the sensitivity of resistance and tolerance estimates to the timing of 
measurement, we replaced the extreme measures of peak LLI and maximum %BW 
loss with daily measures of LLI and %BW loss to obtain daily least square means 
(LSM) for infection severity (inverse of resistance) and tolerance slope for every 
mouse strain by survival outcome using the repeated measurement models as outlined 
in the Appendix 5.2. 
  
5.3.5 Infection severity - health trajectories  
Infection severity-health (SH) trajectories were generated by plotting the 14 daily 
health measurements (represented by %BW maintained) against the corresponding 
infection severity measures (LLI) recorded until 14 dpi for each individual, or until 
time of death if infection-dependent euthanasia occurred prior to 14 dpi. Successive 
scatter points were connected using the spline curve and, for illustrative purposes, 
smoothed using the SM30 smoothing procedure in SAS. Figure 1A shows an example 




5.3.5.1 Trajectory comparison and numerical representation 
Trajectories were first visually inspected to determine common features and 
differences related to levels and timing of simultaneous changes in infection severity 
and health. “Bad neighbourhoods”, associated with subsequent death due to infection, 
were identified in the 2D phase plane by simply overlaying trajectories of surviving 
mice and those that succumbed to infection. 
For statistical comparison of trajectories associated with different individuals, 
trajectories were mapped to numerical sequences, which were constructed as follows: 
first, for each individual trajectory, daily 2D vectors ´_≠ = (\ cÆ , \ ØÆ ) were 
produced as shown in Figure 1B, where \ cÆ  represents the change in infection 
severity (in LLI units) from day k-1 to day k, and \ØÆ  represents the corresponding 




describes the rate of change in the 2D host state between days k-1 and k (Figure 1B). 
The direction of ´_≠ (determined by the signs of both vector components) indicates 
whether an increase or decrease in infection severity (S+ / S-) between days k-1 and k 
is associated with a simultaneous improvement or deterioration in health (H+ / H-). 
Four possible sign combinations give rise to four SH categories (1=S+H-, 2=S-H-, 3 = 
S-H+ and 4 = S+H+) according to which quadrant in the SH plane the trajectory vector 
faces (Figure 1B).  To reduce the impact of measurement noise in the statistical 
analysis, S+ or H- were only assigned if infection intensity had increased by more than 
0.1 LLI units, and BW had dropped by more than 2% compared to the last 
measurements, respectively. Otherwise, changes in either direction were assigned to 
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S- and H+, respectively. Finally, stringing the 14 daily consecutive SH combinations 
together generated an SH - time series for each individual represented by a sequence 
of numbers between 0 and 4, where 0 indicates death of the host and 1-4 refer to the 
different combinations of simultaneous changes in infection severity and health as 
specified above (Figure 1B).  
 
5.3.5.2 Statistical analysis of trajectory sequences  
Representing trajectories by numerical sequences allowed quantitative comparison of 
trajectories associated with different individuals. For this purpose, Hamming distances 
between all pairs of individual trajectory sequences, describing the proportions of non-
zero sequence elements that differed between two sequences, were calculated. To 
prevent sequences associated with individuals who succumbed to infection within the 
14 days observation period being assigned shorter distances, sequences were truncated 
to the last time point where both individuals of the pair in consideration were still alive.    
In order to determine whether the 40 trajectories could be classified into few distinct 
types depending on their patterns as had been proposed previously [38,41], cluster 
analysis was carried out using an agglomerative clustering method, ‘clusterdata’ 
function in Matlab (version R2013b), with the truncated Hamming distances as 
measure of similarity, and the weighted average distance as distance metric between 
clusters. The number of maximum clusters specified was 2, 4 and 6. Resulting clusters 
were visualized using BioLayout Express 3D [112]. 
Furthermore, a permutation test (in which trajectory sequences were randomised) was 
applied to test statistically significant differences between (truncated) trajectory 
sequences belonging to different clusters, mouse strains or survival groups.  The 
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permutation test assessed whether truncated Hamming distances between any two 




Infection established in all mice, as indicated by high levels of LLI, and all mice 
experienced a drop in BW at a certain stage of infection, although at varying levels 
and duration. None of the mice were able to clear the infection within the 14-day 
experimental infection period. All B6J mice survived the infection period, whereas all 
C3H mice succumbed to infection within 6 dpi. There was within-strain variation in 
survival outcome for A/J and BALB mice: two A/J mice and six BALB mice survived 
until the end of the experimental observation period. This led to the following six 
mouse strains by survival outcome groups: C3H, B6J, A/J non-survivors, A/J 
survivors, BALB non-survivors and BALB survivors.  
 
5.4.1 Estimates of resistance and tolerance 
5.4.1.1 Estimates of resistance and tolerance based on peak infection severity and 
minimum health 
Analysis of resistance revealed statistically significant strain and survival effects, as 
well as strain-by-survival interactions (p<0.05) (Figure 2A). There was no statistically 
significant difference in resistance amongst the non-survivors, but all non-survivors 
(non-surviving BALB or A/J mice and C3H) ranked significantly lower in terms of 
resistance than any survivor (Figure 2A). The mouse strains also differed significantly 
in tolerance to Lm infection, and tolerance varied between survival groups within the 
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mouse strains (Figure 2B). However, the ranking of the strains differed for the two 
traits (Figure 2). In particular, non-survivors did not rank consistently lower in 
tolerance than survivors. C3H and B6J strains characterised by 0% and 100% survival, 
respectively, were at the opposite ends of the resistance spectrum, but had similar 




Figure 2. Least square mean (LSM) estimates for resistance and tolerance based 
on measures of maximum infection severity and minimum health.  (A) LSM 
Resistance, (quantified as the inverse of peak infection severity (LLI)) (B) LSM 
Tolerance (defined as regression slope based on regressing maximum %BW loss 
against peak infection severity (LLI)).  
 
Different mouse inbred strains are indicated by different colours and mouse strains or 
defined subgroups that succumbed to infection are indicated by dotted lines. LSM 
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estimates (standard errors, SE) for peak infection severity (LLI) ordered from least to 
most resistant were: BALB non-survivors: 7.06(0.16); C3H: 7.04(0.10); A/J non-
survivors: 6.95(0.11); BALB survivors: 6.36(0.13); A/J survivors: 6.14(0.23); B6J: 
5.93(0.10).  LSM tolerance estimates (SE) ordered from least to most tolerant were: 
BALB non-survivors: -4.03(0.23); A/J survivors: -4.02(0.37); A/J non-survivors: -
3.51(0.17); C3H: -3.45(0.15); B6J: -3.18(0.17); BALB survivors: -2.93(0.21). Stars 
indicate statistically significant differences from pair-wise comparison (*** p<0.001; 
** p<0.01, * p<0.05). 
 
5.4.1.2 Dynamic trends in resistance and tolerance estimates 
Although the actual resistance and tolerance estimates were sensitive to the timing of 
measurements, genetic variation in both resistance and tolerance could be detected 
throughout the entire 14-day infection period (Appendix 5.2 Figure and Appendix 5.2). 
Ranking in both traits was relatively time stable, except for a reverse in ranking of A/J 
mice, which started the experiment as the most tolerant strain, and emerged as the least 
tolerant out of the three remaining mouse strains. B6J emerged as the most resistant 
mouse strain already after 2 dpi, and eventually also as the most tolerant strain. In 
accordance with the results above, non-survivors differed significantly from survivors 
in resistance only, indicating that resistance may be more important than tolerance for 






5.4.2 Trajectory Analysis  
5.4.2.1 Trajectory characteristics and determinants of survival 
Visual inspection of individual trajectories (Figure 3 and Appendix 5.3) revealed 
common patterns in individual’s routes of infection and distinct survival 
characteristics. Four distinct phases over the course of infection were identified with 
characteristic changes in infection severity and health, as represented by different 




Figure 3. Representative trajectories for each mouse-strain by survival outcome, 
together with the corresponding numerical sequence representing daily changes in 
infection severity and health (SH). We refer to Fig. 1 and the main text for explanation 
of the latter. The numbers in the trajectories denote the day at which the measurements 




Phase 1 described the establishment of infection during 0-1 dpi, and is related to the 
initial reduction in infection severity due to partial clearance of the inoculated 
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pathogen accompanied by partial recovery in body weight (i.e. S-H+). This phase was 
seen in all mice except C3H mice, most of which experienced weight loss (i.e. S-H-). 
Phase 2 corresponded to a period during which infection severity was stable but BW 
continued to drop (S-H-). Phase 3 was associated with resurgence in pathogen load and 
continued weight loss (i.e. S+H-). The final phase 4 differed between survivors and 
non-survivors. All survivors regained weight and controlled infection severity. Non-
survivors, in contrast, continued to lose body weight, although some were able to limit 
pathogen load. Mice in this phase generally fluctuated between expression of S-H+ and 
S+H+. With the exception of phase 1, which lasted one day for all mice, the duration 
of the individual phases varied between mice. Only mice that survived the infection 
experienced an improvement in health (H+) at some stage after 4 dpi.  
By overlaying trajectories, an infection severity threshold of approximately 6.5 LLI 
units for pathogen resurgence could be identified that discriminated between survival 
and death (Figure 4). All mice that had crossed this threshold after 1 dpi succumbed 
to infection, regardless of their genotype, the exact day when the threshold was crossed 
(which occurred between 4 and 5 dpi), or whether infection severity temporarily 
decreased thereafter. All mice that suppressed pathogen replication below this 
threshold survived. Interestingly, there was no such discriminating threshold for BW 
loss within the limits of animal welfare regulations (Figure 4). The results suggest that 
trajectories can provide more predictive thresholds for the definition of ethical 




Figure 4. Spaghetti plots of individual trajectories of each mouse strain.  The 
purple line shows the infection severity threshold that discriminates between survivors 
and non-survivors, independent of mouse inbred strain. All non-survivors, except for 
one A/J mouse had crossed this threshold after 1 dpi, whereas none of the survivors 
had crossed this threshold after 1dpi. 
 
 
5.4.2.2 Statistical analysis and genetic footprint of infection severity-health 
trajectories 
Cluster analysis, combined with a permutation test, applied to the corresponding 
(truncated) trajectory sequences indicated that individual trajectories group into 
distinct trajectory types (Appendix 5.4). When the stipulated maximum number of 
clusters was two, the resulting clusters comprised of either non-survivors or survivors. 
The permutation test confirmed a highly significant difference in the truncated SH 
sequences associated with both survival groups (p<0.0001). Hence, infection paths of 
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mice that succumbed to infection were significantly different to those of surviving 
mice at the early stage of infection.   
When the stipulated maximum number of clusters was gradually increased, four 
distinct trajectory clusters (p<0.02 for all cluster pairs) emerged, with the greatest 
sequence differences found between clusters comprising exclusively C3H and B6J 
mice, respectively (Fig 5). The different clusters correspond to different survival 
outcomes and SH patterns within survivors / non-survivors, respectively, rather than 
to the four different inbred mouse strains (Figure 5). However, each trajectory cluster 
is dominated by a specific mouse strain, suggesting that trajectories are partly 
genetically determined (Figure 5).  
 
Figure 5. Graphical representation of similarities between truncated trajectory 
sequences associated with different mouse inbred strains and survival groups 
within the mouse strains.  
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Each node (ball) represents an individual mouse, and each edge (connecting line) 
represents the degree of similarity between trajectory sequences of two mice, 
represented by 1-H, where H is the pairwise Hamming distance. Only similarities 1-
H > 0.8 are depicted in the graph. Colours represent different mouse strains and 
survival groups, respectively. The graph was produced with the BioLayout Express 3D 
software [112], which spatially distributes the nodes according to the similarity 
measure 1-H, so that individuals with similar trajectory sequences (i.e. 1-H close to 
1) are placed in close proximity to each other, whereas individuals with different 
trajectory sequences (i.e. 1-H close to 0) are placed far apart. The graph illustrates 
that differences between trajectory sequences were on average smallest within each 
mouse strains and greatest between C3H mice (light blue; all succumbing to infection) 
and B6J mice (red; all surviving infection).  Within the A/J (black) and BALB (green) 
mice, sequences associated with survivors and non-survivors survival (survivors: 
light, non-survivors: dark) did not fall into different visual clusters. The graphical 
results were confirmed by statistical cluster analysis (see text). 
 
The permutation test applied to different mouse strains confirmed a statistically 
significant difference (p<0.05) between trajectory sequences associated with different 
mouse strains, except for A/J and BALB mice (Table 1). Interestingly, the trajectory 
sequences of surviving and non-surviving BALB or A/J mice were statistically 
indistinguishable (p=0.53 and p=0.06, respectively), implying that within a mouse 




Table 1. P-Values of permutation test used to assess whether mouse strains differ 
significantly in their SH trajectory sequences. 
Between-strain A/J: C3H B6J BALB 
A/J: . <10-6 0.0003 0.31 
C3H  . <10-6 0.0002 
B6J   . 0.0002 
BALB    . 
 
5.5 Discussion 
Host genetic variation in both resistance and tolerance can account for a substantial 
part of the observed variation in host response to infection [5,30,35,113]. Many studies 
have provided conclusive evidence for genetic variation in host resistance to Listeria 
monocytogenes [5,114–117]. We have demonstrated that mice from genetically 
distinct inbred strains, previously found to differ significantly in resistance to the 
bacteria, also differ in tolerance. Resistance and tolerance are often considered as static 
traits that constitute alternative host defence strategies against invading pathogens 
[5,6]. The data show clearly that expression of resistance (reduction in pathogen load) 
and tolerance (damage prevention and repair) and their relative contribution to survival 
varies over the time course of infection. We therefore propose a paradigm shift in 
considering resistance and tolerance as dynamic, rather than static traits. In practice, 
this can only be achieved through time series measurements in individual infected 
hosts, which in turn depend upon non-invasive technologies, such as imaging. 
Recently, there have been rapid advances in the development of such imaging 
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technologies [118–120], and this has led to increasing demands for advanced statistical 
tools to analyse infection dynamics, such as the trajectory methods proposed here.  
The novelty of this research lies in the development of simple and versatile 
mathematical tools for capturing the dynamic development of resistance and tolerance 
in each individual, and their relative importance on the outcome of infection. The 
conventional reaction-norm approach to tolerance has severe limitations that have 
hampered progress in tolerance studies [4]. Firstly, it usually restricts tolerance 
estimates to group level, which is not helpful for improving tolerance of individuals or 
identifying tolerance genes. Secondly, the high data demand associated with 
estimating tolerance parameters from this approach limits reaction norms to linear 
models, thus ignoring all biological understanding of the highly nonlinear and time-
dependent relationship between pathogen burden and health [7]. In contrast, individual 
trajectories, which can be easily constructed if longitudinal measurements are 
available, illustrate how changes in infection severity are related to health change 
within each individual throughout infection. Although not synonymous with resistance 
and tolerance, the 2D trajectory vectors crudely reflect how resistance and tolerance 
are co-expressed at different stages of infection. For example, simultaneous decrease 
in infection severity and health (S-H-) reflects expression of resistance at the cost of 
deterioration in health, indicating incomplete tolerance. As demonstrated in this study, 
trajectories can reveal distinct phases of infection associated with different patterns of 
co-expression of resistance and tolerance, and illustrate for each individual the 2D path 
towards death or survival.  Previous studies of trajectories have defined ‘bad 
neighbourhoods’ in the infection-severity health plane that appear predictive for fatal 
infection outcome [5,37,38]. In the mouse data we identified an infection severity 
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threshold that discriminated between death and survival (Figure 4). All mice that 
succumbed to the infection experienced a drastic increase in infection severity between 
3-7 dpi, whereas all survivors managed to restrict pathogen resurgence below this 
threshold during this critical phase. The critical infection severity threshold was 
independent of host genotypes and timing. Any mouse that crossed this threshold 
eventually succumbed to infection, even if thereafter it managed to reduce infection 
severity below the threshold. Interestingly, there was no apparent health threshold that 
discriminated between death and survival. All mice experienced body weight loss as a 
consequence of infection, but all of the survivors and none of the non-survivors 
managed to recover some of the lost weight, in some cases despite continued increase 
in pathogen load. Our results thus indicate that both early expression of resistance and 
tolerance at the later stages of infection are important determinants of survival to Lm 
infections. Discriminatory thresholds, such as those identified here, can provide more 
informative criteria than body weight for defining humane endpoints for termination 
of animal infection.  
Individual trajectories have been used previously to classify and predict host responses 
to infection but their assessment was limited to qualitative analysis [38,41]. By 
transforming visual trajectories into numerical sequences that preserve the key 
topological trajectory features, we were able to subject trajectories to rigorous 
statistical analysis. Our statistical analysis confirmed that individual trajectories 
cluster into a limited number of genetically regulated distinct trajectory types [38,41]. 
Trajectories thus open new avenues for genetic studies of host response to infections. 
Future studies may focus on genetic dissection of different trajectory types to identify 
novel genetic variants that control infection dynamics at a molecular level. 
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Despite a clear genetic footprint in trajectory patterns, trajectory sequences could not 
capture within-strain differences in survival outcome. This could be due to several 
reasons: firstly, body weight may only be a crude indicator of health [5]. Alternatively, 
since mice were euthanized due to welfare considerations based upon weight loss, 
some of the mice classified as non-survivors may actually have survived the infection. 
Furthermore, survival outcome may be partly determined by individual differences in 
the gastro-intestinal flora, which have been found to show substantial inter-strain 
variation even in similarly highly controlled environments as used in our study [121]. 
Higher-dimensional trajectories comprising other types of measurements (e.g. related 
to the immune response or microbiota) in addition to measures of health and pathogen 
load may shed light on relevant host response mechanisms controlling an individual’s 
infection path and its outcome. Note that, although more difficult to visualize, multi-
dimensional trajectories can still be represented as a series of vectors defined by their 
direction and length and are thus amenable to similar statistical analyses as those 
presented here.  
Previous studies have estimated an antagonistic relationship between resistance and 
tolerance at the phenotypic and genetic level [30,122]. These results led to the notion 
of a trade-off between resistance and tolerance mechanisms and their consideration as 
alternative host defence strategies to fight infections, and shaped predictions of 
evolutionary consequences for both hosts and pathogens [32,79,123,124]. These 
studies do not take account of the dynamic relationships that emerge from our study. 
For example, expression of resistance at the early stages of infection is likely to affect 
the expression of tolerance at the later stages as fast pathogen clearance may prevent 
tissue damage and obviate any requirement for damage prevention or repair 
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mechanisms associated with tolerance. Conventional statistical models that do not 
account for this kind of interdependence between traits may produce a spurious 
antagonistic relationship between traits, both on the phenotypic, as well as on the 
genetic level [125], even if resistance and tolerance are controlled by different sets of 
genes or genetic pathways as suggested by immunological evidence [19,101]. 
Trajectories enable us to bypass the complex relationship between resistance and 
tolerance, and may give rise to novel phenotypes for future genetic analyses that may 
lead to the discovery of genes that control an individual’s infection path.  
All of the infected mice experienced a substantial body weight loss after the initial 
reduction in pathogen burden, but of itself, body weight loss did not influence survival. 
From a resource allocation perspective, this would suggest that resistance mechanisms 
are costly [13,126]. By reducing resources allocated to other functions, such as 
searching for and digesting food, the host may be able to direct resources to the 
immune response, resulting in temporary body weight loss. This has been put forward 
as the evolutionary basis of pathogen-induced anorexia and ‘sickness’ behaviours 
[12,126–128]. Our previous applications of the resource allocation theory to assess the 
effect of genetic resistance on the long-term effects of infection, showed that hosts 
with greater genetic resistance may suffer greater performance loss (e.g. growth or 
body weight loss) in the short-term, but are able to revert to original levels of 
performance faster than non-resistant genotypes [129]. This is consistent with our 
study, where the B6J mice emerged as most resistant genotype after 3 dpi and were 
the only mouse strain that managed to fully restore the original body weight within 14 
dpi.  
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To study the dynamic co-expression patterns of resistance and tolerance to Listeria 
monocytogenes in different mouse inbred strains we have taken advantage of a 
bioluminescent Lm infection model in which the listerial strain EGDe-InlA-mur-lux 
recognises the host receptor E-cadherin and intestinal expressed N-cadherin 
[110,111,130,131] Other Lm infection models have been shown to elicit different host 
responses [131,132]. It would be interesting to apply our novel methods to data from 
these models to determine whether the dynamic contributions of resistance and 
tolerance to survival are preserved across different pathogen and host strains. 
However, this would require the introgression of humanised alleles of CDH1 
(encoding E-cadherin) into the different mouse genetic backgrounds followed by 
repeated backcrossing to make mice permissive to oral Lm challenge [110,114].  
In conclusion, our study complements existing evidence for genetic variation in both 
host resistance and tolerance, and for the importance of both host strategies in fighting 
infections [5,6,9,19,30,34,101–103,109,129]. However, our study also highlights the 
potential benefits that may arise from considering the dynamic patterns of co-
expression of genetic resistance and tolerance over the time course of infection. 
Trajectories capture the dynamic signature and genetic footprint of both mechanisms 




Quantifying infection severity by bioluminescence 
 
In this study resistance was quantified as an inverse measure of infection severity, 
which was derived from bioluminescence as follows: For detection of 
bioluminescence, mice were anesthetized with isoflurane and monitored using the 
IVIS 200 imaging system (CaliperLS), as outlined in Bergman et al. [22]. Increased 
light intensity (LI) (measured in photons p/sec/cm2/sr (RAD) units) corresponded to 
increased Lm loads, which was indicative of higher infection severity [22]. Light 
intensity was high for all mice at 0 dpi, indicating a successful administration of the 
Lm inoculum, and subsequently varied over time between the different mouse strains. 
A Pearson correlation of r=0.81 between log transformed colony forming units (CFU) 
tissue counts and log-transformed light-intensity plus one (LLI) measures indicated a 
high correlation between the two measures of infection severity. Therefore, LLI was 




Sensitivity of resistance and tolerance estimates to the timing 
of measurement 
5.2.1 Statistical models 
To assess genetic variation in resistance based on longitudinal measures of infection 
severity, a linear mixed model was used with log-transformed light intensity (LLI) as 
the dependent variable, and mouse strain, binary survival outcome (succumbed to 
infection within 14 dpi / did not succumb to infection within 14 dpi), day of measure 
(dpi), and all statistically significant interactions as fixed effects, and individual mouse 
as random effect.  To account for potential auto-correlations between repeated 
measurements a heterogeneous first-order autoregressive covariance structure 
(ARH(1)) was fitted. This covariance structure assumes that variances in the resistance 
measures can differ between time points and covariances between measures at 
different time points decrease exponentially over time. This structure was selected 
amongst the range of available correlation structure based on the lowest Akaike’s 
Information Criterion (AIC) used as model fit statistics. Statistical comparison 
between individual strain/survival differences and different time points were 
conducted using the CONTRAST statement in SAS (SAS Institute Inc. 2011. 
SAS/STAT® 9.3 User’s Guide. Cary, NC: SAS Institute Inc.).  The analysis thus 
provided least square means (LSM) and standard errors for infection severity for every 
mouse strain by survival outcome at each day post infection.  
Similarly, the linear mixed model for carrying out the repeated measures ANCOVA 
for tolerance used daily %BW loss as dependent variable, daily LLI as covariate, and 
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mouse strain, binary survival outcome, day of measure (dpi), and all statistically 
significant interactions as fixed effects, and individual mouse as random effect. The 
intercept was fixed at zero, corresponding to zero percent BW loss in the absence of 
infection.  The analysis provided least square means (LSM) tolerance slope estimates 
with standard errors for every mouse strain by survival outcome at each day post 
infection. Significant differences between these slope estimates based on the F-test 
statistics for mouse strain-by-infection severity-by-dpi interaction provided evidence 
for genetic variation in estimated tolerance trends over time. The analyses provided 
least square means (LSM) and standard errors for infection severity (inverse of 
resistance) and tolerance slope estimates for every mouse strain by survival outcome 
at each dpi. 
 
5.2.2 Results 
Appendix 5.2 Figure shows the daily Least square mean (LSM) estimates (and 
standard errors) for resistance and tolerance. Initial reduction in infection severity 
occurred in all strains between 0 and 1 dpi, reflecting partial clearance of the inoculated 
bacteria (Appendix 5.2 Figure).   
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Appendix 5.2 Figure. Least square mean (LSM) estimates (and standard errors) 
for resistance and tolerance estimates over the time-course of infection based on 
daily measures of infection severity and health.  (A) LSM Resistance, (B) LSM 
Tolerance. Different mouse inbred strains are indicated by different colours and mouse 
strains or defined subgroups that succumbed to infection are indicated by dotted lines. 
Caution is advised when interpreting the results for the surviving A/J mice, as there 




Bacterial replication was then moderately controlled in all surviving mouse strains 
after 1 dpi, whereas all mice that succumbed to infection experienced resurgence in 
infection severity from 3 dpi onwards (Appendix 5.2 Figure A). The statistical analysis 
for resistance revealed statistically significant strain, survival and day effects, as well 
as strain by survival by day interactions (p<0.05). Differences in resistance between 
mouse strains were greatest at 5 dpi, with the most striking difference between 
survivors and non-survivors (Appendix 5.2 Figure A).  For the surviving mice, the 
ranking between strains was relatively stable over time, with B6J maintaining highest 
resistance estimates for the majority of time points.  
Similar to resistance, each of the fixed effects and all interactions fitted in the statistical 
models for tolerance proved statistically significant (p<0.05), indicating that the trends 
in daily tolerance estimates vary substantially between the mouse strains and survival 
groups. In contrast to resistance, survivors do not necessarily rank above non-survivors 
in tolerance estimates at any day post infection (Appendix 5.2 Figure B). Appendix 
5.2 Figure B also reveals a common time trend in tolerance estimates: With the 
exception of C3H, all mouse strains experienced initial increased levels of estimated 
tolerance between 0 and 1 dpi. After 1 dpi, tolerance estimates decrease to negative 
values for all mouse strains and remain negative throughout the two weeks observation 
period. Depending on the mouse strain and survival group, minimum levels of 
tolerance were reached between 4 to 7 dpi, after which tolerance estimates gradually 
increase for all surviving mouse strains. B6J is the only mouse strain to fully recover 
its body weight as illustrated by a LSM tolerance estimate close to zero at 14 dpi.   
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Appendix 5.3 














Numerical trajectory sequences  
Denoting simultaneous changes in infection severity (S) and health (H) over time for 
40 mice from four different inbred strains, and corresponding trajectory types resulting 
from the cluster analysis with 4 clusters.  Sequence numbers 1,2,3,4 and 0 refer to S+H-
, S-H-, S-H+, S+H+, and death, respectively. Day i (top row) corresponds to the time 





Alternative approaches to tolerance: infection trajectories of 





Using random regression models applied to single cumulative measures of pathogen 
load and growth for paternal half-sibs we did not find conclusive evidence for genetic 
variation in tolerance of pigs to PRRS (chapter 2). Only when the 21 or 42 day 
observation period was broken down into individual stages of infection, or when 
longitudinal information was harnessed with a repeated measures model, could genetic 
variation in tolerance of pigs to PRRS be identified (see chapter 3). However, the 
random regression models were sire models, implying that estimated breeding values 
could only be obtained per sire rather than for each individual.  As such, tolerance 
maybe of limited use for genetic selection for improvement of host response to 
infection. 
Studies, including our own study presented in chapter 5, have shown that within an 
individual, both expression of resistance and tolerance change over the time-course of 
infection [31,37,39,85]. In chapter 5 we have shown that infection trajectories that 
follow the pairwise progression of host performance and within-host pathogen load of 
each individual over time offer a way to capture these dynamics on the individual level. 
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We have also demonstrated that trajectories are partly determined by underlying host 
genetics (chapter 5, [85]). However, the mouse study was limited to four genetically 
distinct highly inbred mouse strains. The PRRS Host Genetics Consortium (PHGC) 
dataset, which provides repeated measures of viremia and growth and was used to 
examine genetic variation in tolerance of pigs to PRRS in chapters 2 to 4, offers a 
unique dataset to construct and examine infection trajectories of outbred animal 
populations.  
 In chapter 5, genetic differences between the inbred mouse strains could be captured 
by applying permutation tests to numerical trajectory sequences of each individual 
from the four distinct strains.  This methodology does not lend itself to study genetic 
variation in infection trajectories of outbred populations. For this reason, a different 
approach was adopted to statistically analyse infection trajectories of PRRSV infected 
pigs. Rather than performing quantitative genetic analysis directly on the trajectories, 
the approach in this chapter was to derive novel phenotypes based on trajectory 
characteristics, and then to apply standard quantitative genetic mixed models to these 
phenotypes.  This study thus aimed to a) construct infection trajectories of pigs 
infected with PRRSV in order to derive novel phenotypes from trajectories for 
subsequent quantitative genetic analysis; b) identify genetic variation in these 
trajectory-derived phenotypes; c) assess whether the previously identified WUR 







6.2.1 Infection experiment and data 
The PRRS Host Genetics Consortium (PHGC) data from the 9 PRRSV challenge trials 
described in chapter 1 were used (see chapter 1 for details). As the novel phenotypes 
derived from trajectories required unidirectional movement, i.e. no loops in the 
trajectories, only measurements from 14 dpi onwards were used in this study, as 
according to previous analyses, all individuals had reached peak viremia by 10.6 dpi 
and started to gradually reduce viremia  [62]. Similarly, only individuals that did not 
have a rebound in viremia were used, as rebounders also generate trajectory loops.  
The data analysed in this study thus comprised of 1183 pigs from 104 sires. 
 
6.2.2 Construction of PRRSV infection trajectories and definition of trajectory 
phenotypes 
Trajectories were constructed using weekly repeated measures of growth (Average 
Daily Gain (ADG)) for each individual. ADG was calculated as growth rate between 
day k-1 and k. For example, ADG between 21 and 28 dpi (ADG28) was the difference 
in BW between these two days divided by 7. Weekly changes in viremia were also 
used to construct trajectories using predictions from the Woods function (see chapter 
3). For example, viremia28 was predicted using Woods viremia predictions at 28 dpi. 
In this way, these weekly ADG and viremia measures were used to construct 
trajectories for each individual. 
To derive trajectory components, weekly two-dimensional vectors were calculated for 
each trajectory: 
´≠ = (\(∞±Æ), \(^_`Æ)) 
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where \(∞±Æ) represents change in pathogen load (PL = viremia) from week ≤-1 to ≤, 
and \(^_`Æ) represents corresponding change in performance (ADG) for the same 






where ≥¥ is the angle between the trajectory vector ´≠ and the viremia-axis. Thus	≥¥  
assumes values between -90º and 90º, where the sign of the angle corresponds to 
negative or positive changes in \(^_`Æ). Thus, high positive values of  ≥¥ represent a 
fast increase in weekly growth rate as viremia decreases from week ≤-1 to ≤. 
The second trajectory derived component was the magnitude of the weekly trajectory 
vector ||V_Ñ||, and was given by: 
||V_Ñ|| = (\∞±Æ)
5 + (\̂ _`Æ)
5) 
which describes the magnitude of the combined weekly change in growth rate and 




Figure 1. Trajectories from two individuals (A and B), where each vector connects 
weekly pairwise measures of viremia and ADG (starting at 7 dpi, through weekly to 
42 dpi). Each trajectory thus depicts dynamic changes in ADG with respect to changes 
in viremia. Individual A increases in ADG while steadily reducing viremia from 7 dpi 
to the end of the experiment, whereas the growth rate of individual B decreases overall. 
Also illustrated in Figure 1A is the trajectory vector between 21 and 28 dpi: V_28, with 
components VADG (change in ADG) and VPL (change in pathogen load (viremia)), 





Figure 2. Illustration of two novel phenotypes derived from trajectory vector 
components for 3 individuals (A, B and C, coloured green, blue and red, 
respectively), where each line represents a trajectory vector from week ≤-1 to ≤. ≥_¥ 
represents the angle from origin of each vector with the viremia axis, where higher 
value of ±≥_¥ corresponds to higher gain/loss in ADG with respect to a unit change in 
viremia. ||V_Ñ|| represents the magnitude of each vector from week ≤-1 to ≤, where the 
higher the value of ||V_Ñ||, the greater the rate of combined change in viremia and 
growth. Individual A has the highest ≥_¥, but the lowest ||V_Ñ||; in contrast to 
individuals A and B, individual C has negative ≥_¥, so experiences a reduced ADG 
with decreasing viremia. Individual B experiences the fastest rate of change (||V_Ñ||), 







6.2.3 Statistical analyses 
All statistical analyses were carried out using ASReml 3.0 (Gilmour et al., 2009). To 
identify genetic variation in trajectory components, the following univariate animal 
model was adopted: 
9 = =? + 	@A + BC +DE + F,	 [1]	
where 9 is a vector comprising individual records for ≥_¥ or ||V_Ñ|| from week ≤-1 to 
≤; ? is a vector of fixed effects, including for the interaction of experimental trial and 
parity of the dam when offspring were born (trial-by-parity), sex of the offspring, and 
age, which was fitted as a fixed covariate; A is a vector of additive genetic effects, with 
Var(A) = I⨂K is the genetic variance-covariance matrix where I is a vector of 
genetic variances and A the pedigree relationship matrix; C is a vector of pen effects 
nested within trial, with Var(C) = L⨂M, where is the identity matrix, and M is the 
corresponding vector of variances for pen effects; E is a vector of litter effects, where 
Var(E) = L⨂N, where N is the corresponding vector of pen effect variances; and F is a 
vector of residuals, with Var(F) = L⨂O where O is the variance-covariance matrix for 
the residual effects for each trait; and =, @, B and D are incidence matrices for fixed, 
animal, pen and litter effects, respectively. Traits and model residuals were normally 
distributed, as indicated by a Shapiro-Wilk test (p<.0001). 
 
6.4 Results 
Mean ≥_¥ was lowest from 21-28 dpi (-4.11) and highest by end of infection (2.08), 
indicating that recovery in growth with respect to unit changes in viremia was higher 
towards the end of infection (Table 1). There was a huge variation in ≥_¥ associated 
with each weekly trajectory vector, in particular, at the later infection stages. 
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Magnitude of vectors (||V_Ñ||) decreased throughout infection from 21 dpi onwards, 
with highest at 14-21 dpi (1.79) and lowest at 35-42 dpi (0.73), indicating that weekly 
changes in ADG and viremia reduced in magnitude after 3 weeks post infection. 
Standard deviation also decreased with infection time. 
  
Table 1. Summary statistics of weekly ||Q_•||  and π_≠, where ||V_Ñ||  is rate of 
change between two weekly measurements (indicated by days post infection (dpi)), 
where high ||V_Ñ||  means higher magnitude of vector between two measurements; and 
≥_¥ (between − 90°	and	90°) is the degree change in ADG with respect to change in 
viremia between consecutive weeks, respectively, where higher positive or negative 
angle means higher gain/loss of performance with respect to change in pathogen load. 
  dpi mean sd min max 
π_≠ (°) 
14-21 -2.55 7.94 -55.83 49.93 
21-28 -4.11 12 -61.41 56.2 
28-35 -2.13 22.4 -76.8 69.28 
35-42 2.08 31.04 -73.55 83.25 
 
||Q_•|| 
14-21 1.79 0.48 0.34 3.37 
21-28 1.42 0.26 0.27 2.94 
28-35 1.02 0.23 0.44 2.49 
35-42 0.73 0.24 0.1 1.99 
 
Heritability of ≥_¥ was not significantly different from zero across all time-points of 
infection, indicating that there was no identifiable genetic variation (Table 2). Rate of 
change (||V_Ñ||) was of low to moderate heritability at earlier time of infection (0.20 
and 0.12 for 14-21 and 21-28 dpi, respectively), but was not significantly different 
from zero later in infection. Furthermore, inclusion of WUR in the model was not 
statistically significant at any time of infection for either ≥_¥ or ||V_Ñ||, indicating that 
WUR was not associated with either of the traits. 
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Table 2. Heritability (h2), standard error (in brackets) of increase in growth, with 
respect to change in viremia (π_≠) and rate of change in growth and viremia 
(||Q_•||). Standard errors are in brackets. p-values for inclusion of WUR in the model 
are also given. 
Trait  dpi h2 WUR (p-value) 
π_≠ (°) 
14-21 0.00 0.110 
21-28 0.00 0.600 
28-35 0.02 (0.04) 0.890 
35-42 0.00 (0.04) 0.300 
||Q_•|| 
14-21 0.20 (0.09) 0.129 
21-28 0.12 (0.08) 0.278 
28-35 0.00 0.159 
35-42 0.00 0.161 
 
Given the low heritabilities of each trait at all time points of infection, genetic 
correlations between traits were not estimated. Phenotypic correlations between the 
traits, without adjusting for additional fixed and random effects, were not significantly 
different from zero.  
 
6.5 Discussion 
6.5.1 Summary of findings 
This study aimed to derive novel phenotypes from trajectories which explain 
simultaneous changes in host performance with changes in pathogen load under PRRS 
infection. Two phenotypes were derived which explained gain/loss in weekly ADG in 
relation to change in viremia (≥_¥); and the magnitude of combined change in ADG 
and viremia between two consecutive weeks (||V_Ñ||). However, with exception of 
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||V_Ñ|| from 14-21 dpi, the traits were not found to have a significant genetic 
component. Given this, the WUR genotype was not associated with either trait. 
 
6.5.2 Alternative approaches to analyse trajectories of outbred populations 
Previous studies have highlighted the potential usefulness of individual trajectories for 
classifying and predicting host responses to infection [38,40,41]. However, no study 
to date has attempted to estimate genetic variance of trajectories of infected farm 
animals.  Indeed, it is not obvious how to estimate genetic variance and breeding values 
for entire infection trajectories. 
In chapter 5, we quantified differences in individual trajectories based on sequence 
construction followed by a permutation test [85]. However, a permutation test can only 
be applied to identify statistical differences between a limited number of groups (such 
as the 4 inbred mouse strains used to identify genetic variation in trajectories between 
strains in chapter 4), and was thus an inappropriate methodology to quantify genetic 
variation in infection dynamics of an outbred population. Defining novel phenotypes 
derived from trajectory characteristics, as performed in this chapter, constituted a 
straight-forward approach to carry out quantitative genetic analyses on trajectories.  
An alternative quantitative genetics approach to estimate genetic variation of 
unidirectional (i.e. no loops) trajectories would be by adopting random regression 
models with spline functions fitted through the data trajectories [66,133]. These could 
also be exploited to estimate covariance functions affecting trajectory shape. This 
random regression approach was indeed attempted, but genetic variation could not be 
identified due to convergence issues. This is somewhat not surprising, since the linear 
random regression models were already difficult to fit to the PHGC data (see chapters 
	 153	
3 and 4).  As such, this approach was not pursued further and the derivation of 
trajectory phenotypes was done instead. 
 
6.5.3 Potential use of trajectory phenotypes for genetic improvement of host 
response to infection 
In chapters 3 and 4, we identified a changing relationship between growth and 
resistance over the time-course of infection. Trajectories complement these analyses 
as they describe how growth rate changes with respect to changes in within-host VL 
over the time course of infection.  Although don’t lend themselves easily to 
quantitative genetic analysis, trajectory-derived phenotypes may provide valuable 
phenotypes which could be used for genetic selection of response trajectories. For 
example, a trajectory where rapid increase in viremia is not accompanied by drastic 
reductions in growth may be desirable. This could be achieved by increasing the 
trajectory angle ≥_¥ at the time when viremia increase is fastest. ≥_¥ could be loosely 
interpreted as a proxy for tolerance (higher growth at higher within-host viral load) 
measured at the individual level. If a pathogen is prevalent in a population and 
tolerance is the preferred trait to mitigate the impact of infection on the host, these 
trajectory-derived phenotypes could allow genetic selection for “tolerance” without 
the statistical requirements and complications of random regression methodology 
identified in chapters 2 and 3. Furthermore, genetic correlations between trajectory 
angles would provide useful insights whether genotypes experiencing low reduction 
in growth at an earlier stage of infection would be expected to also grow faster at the 
later stages of infection. These measures would thus provide useful insight about 
which trajectories are feasible to achieve through genetic selection.  
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The requirement for repeated measurements is a major bottleneck for implementing 
trajectories into breeding programmes. In a farm setting, it may not be possible to 
record repeated measures for each animal. As such, it may be possible to construct 
crude trajectory vectors and phenotypes ≥_¥ and ||V_Ñ|| between two consecutive 
measurements to interpret overall change in growth with relation to long-term 
reduction in VL. Clearly, further studies are needed before infection trajectories can 
be implemented in breeding programmes.  
 
6.5.4 Future research 
The primary interest in adopting trajectory analysis is to identify the interaction 
between tolerance and resistance and how they change over the time-course of 
infection. Trajectory-derived phenotypes allow analysis of simultaneous changes in 
growth and VL that can be applied to an outbred population. Given that this study did 
not detect genetic variation in trajectory-derived phenotypes, alternative phenotypes 
or approaches which capture host infection dynamics and allow for genetic selection 
on the individual level may need to be explored. However, these phenotypes may be 






7.1 Aims of study 
This research aimed to: 1) Identify genetic variation in tolerance of pigs to PRRS using 
conventional random regression methodology; 2) Examine the relationship between 
resilience, resistance and tolerance over different stages of infection; 3) Assess 
genomic regions associated with growth and resistance at different stages of infection 
4) Identify genetic variation in tolerance and resistance to listeria infection in mice 
using conventional linear mixed model methodology; 5) Develop a novel trajectory 
analysis methodology to analyse changes in resistance and tolerance over time, and 
determine genetic variation in trajectories; 6) Apply trajectory analysis to PRRS by 
deriving novel phenotypes from trajectories. 
In chapter 2, we could not conclusively identify genetic variation in tolerance of pigs 
to PRRS based on random regression methods using the same time periods as previous 
studies [23,57,58]. However, this highlighted the potential limitations of adopting a 
reaction norm approach to identify genetic variation in tolerance in outbred 
populations (described on page 104). To overcome these limitations, performance in 
absence of infection (vigour) was simulated for half-sibs of individuals in the 
experiment. Genetic variation in tolerance to PRRS was thus demonstrated under the 
assumptions made in simulations, but only when genetic correlation between vigour 
and growth under infection was low to moderate. In chapter 3, stages of infection 
(early, mid and late) were defined based on underlying viremia profile characteristics 
for each individual. Using these stages of infection, we identified genetic variation in 
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tolerance at mid to late stage of infection. Additionally, by adopting a more robust 
repeated measurement model, we identified genetic variation in tolerance over the 21 
and 42 days infection period, and a positive genetic correlation between resistance and 
tolerance, indicating that individuals who are more genetically resistant were also 
likely to be more genetically tolerant to PRRS. Furthermore, we identified that the 
WUR genotype previously associated with resistance was also suggestively associated 
with tolerance slope, highlighting that, over all stages of infection, resistance and 
tolerance may be pleiotropic. However, the WUR genotype was not associated with 
tolerance slope at any stage of infection; and resistance and tolerance were possibly 
negatively correlated. This indicated that care must be taken as to when genetic 
selection is used to improve host response to PRRS. Indeed, in chapter 4, the 
relationship between growth under infection (resilience) and resistance changed at 
each stage of infection. Individuals who had high resistance were likely to lose weight 
at early stage, but clear the virus by late stage, thus recovering in growth. However, at 
mid-stage of infection, less resistant individuals had higher growth, demonstrating that 
genetic selection for improved growth during this stage of infection could have 
undesirable consequences. Finally, this study showed that the WUR genotype, 
previously associated with resistance and growth at 21 and 42 dpi, respectively, was 
significant only at early-mid stages for resistance, but mid-late stages for growth, 
indicating a lag effect of VL on growth. No other genomic regions were associated 
with growth or resistance at any stage of infection.  
In chapter 5, a diversion from virus infected pigs to bacterial infected mice was 
performed, as the mice data provided a suitable dataset for developing and validating 
a novel trajectory analysis without the inherent noise affecting disease phenotypes of 
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outbred populations.  By adopting novel trajectory analysis, this study demonstrated 
that genetic variation in resistance and tolerance to listeria in mice existed. 
Furthermore, we found that early expression of resistance determined survival of 
infection. Survivors and non-survivors followed different paths of infection, which 
were partially determined by genetics. The results were encouraging for applying 
trajectory analysis also on the outbred pig population of this thesis. In chapter 6, we 
derived novel phenotypes from PRRS trajectories of pigs that explained changes in 
growth in relation to change in pathogen load as a proxy for tolerance, and applied 
them to the PRRS data. However, there was limited evidence to suggest genetic 
variation in these phenotypes. 
This chapter will discuss 1) whether tolerance is a feasible trait for genetic 
improvement of livestock response to infectious disease; 2) whether genetic selection 
for resilience is a suitable infectious disease control strategy; 3) the adoption of novel 
methodology to analyse changes in resistance and tolerance over time, and the 
potential for genetic selection for host response at different stages of infection, and 
finally 4) implications of this research in a wider context. 
	
7.2 Is tolerance a feasible trait for genetic improvement of livestock 
response to infectious disease? 
Robust phenotypes are required for identification of genetic variation in traits, and to 
permit genetic selection for improvement of host response to infection. Conceptually, 
tolerance is a powerful and useful descriptive phenotype that has attractive qualities 
and outcomes which should appeal to animal breeders. However, to date, there is still 
a large gap in knowledge of whether animals in outbred populations vary genetically 
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in tolerance. It is likely that this has been partly due to difficulty in meeting the 
statistical requirements to accurately estimate genetic variance in tolerance to 
infection. 
Tolerance is a phenotype which describes change in host performance with respect to 
pathogen load; a trait which could provide excellent benefits in both maximising 
growth under difficult conditions, and that has potential evolutionary benefits if 
implemented into a breeding program, as highlighted in the general introduction. 
However, conventional methodology to estimate tolerance may be difficult to 
implement in practice, where a reaction norm approach is adopted to regress health or 
performance on within-host pathogen load [8].  
In chapters 2 and 4, we identified genetic variation in tolerance of pigs to PRRS, and 
in mice to listeria using a reaction norm approach where maximum body weight (BW) 
loss was regressed on maximum pathogen load [85]. As such, this approach was 
adequate to identify genetic variation in tolerance. However, the reaction-norm 
approach has been relatively simple to implement in estimating genetic variation in 
tolerance where groups are few. Raberg et al used 5 inbred mouse strains [5], Blanchet 
et al. used 8 sites of measurement [29], and, in chapter 5, four highly inbred mouse 
strains were used [85]. This allows adoption of a regression approach in which group-
by-pathogen load interaction is included as a fixed covariate. By adopting this 
approach, genetic variation in tolerance could be identified by a statistically significant 
interaction between family (e.g. genotype or strain) and pathogen load in an ANCOVA 
[5]. 
If a reaction-norm approach is required for a more complex population structure, 
random regression models (RRMs) must be adopted to estimate genetic variance in 
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tolerance [4,35,37]. 
While RRMs have previously been shown to be powerful tools that require few 
parameters to estimate genotype-by-environment interaction [134], there are 
complications and potential confounding when applied to tolerance weakens their 
application to identify genetic variation in tolerance. Firstly, RRMs are highly 
senstitive to the underlying data structure and may generate biased estimates, 
particularly if sample size is limited or relatedness is poor. [35,36,70]. Bias in slope 
can be caused if family size is small [35]. As such multiple measures per group and a 
large amount of statistical power is required. In chapter 3, we found difficulty in 
implementing RRMs to identify genetic variation in tolerance of pigs to PRRS for 
these reasons. Genetic variation could only be identified under certain assumptions 
made in simulations. However, the requirement to double the size of the dataset was 
likely helpful in increasing statistical power required to identify genetic variation in 
tolerance, by reducing confounding between level and slope, and increasing the 
distribution of data around centred VL. Indeed, in chapter 4, we used repeated 
measures for each individual to triple the size of the dataset, which provided adequate 
statistical power to estimate genetic variance in tolerance slope. This requirement for 
large amount of data to overcome limits the potential of random regression when 
applied to animal breeding. Furthermore, tolerance is conceptually defined at the 
individual level, where change in host performance with regards to change in within-
host pathogen load. However, tolerance can only be defined at the group level using a 
reaction norm approach, which limit their application in animal breeding [4,5].  
Reaction-norms estimate tolerance as a static trait, which, as found in chapters 2 and 
3, is unlikely to be the case, given the changing relationship between resistance and 
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tolerance and resistance and growth. Again, repeated measures for each individual 
required to correctly estimate potential changes in tolerance further limits the 
application of a reaction norm for improvement of host response to infection. 
Accurate estimation of tolerance on performance in absence of infection (vigour) 
provides an additional challenge. Assuming a linear relationship between pathogen 
load and performance, heterogeneity in vigour will affect the slope (see figure 1 in 
general introduction). In this research, estimates of vigour were not available for the 
PHGC data. The weak evidence for significant genetic variation in tolerance to PRRS 
from the univariate random regression models in this study may simply reflect a lack 
in statistical power for disentangling sire effects on regression slope and level. Genetic 
variation in tolerance was only evident where low genetic correlations with vigour 
were simulated (chapter 2). This may be partly overcome by setting vigour to 0, or 
100% for all individuals, as we did in chapter 5, and modelling subsequent losses in 
performance. However, estimation of tolerance is still dependent on vigour, which is 
an additional complication of application of RRMs to animal breeding. 
It is important to note that genetic variation in resistance to PRRS could cause potential 
caveats for estimating tolerance, as it implies that VL values are not homogeneously 
distributed amongst sires, with more resistant sires having predominantly low VL 
measures, and less resistant sires predominantly high VL values. This dependence of 
tolerance on resistance is another limitation to their application. A further complication 
is that dependence of tolerance on resistance may be also depend on the type of 
immune response mechanism at time of measurement, i.e. tolerance may be a due to 
direct (damage caused by pathogen) or indirect (damage caused by immune response) 
tolerance mechanisms, and this may change throughout infection. Indeed, this 
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highlights another possible problem with tolerance as a phenotype. Firstly, at what 
time and how to measure within-host pathogen load is a decision that will greatly affect 
tolerance. It is likely that the most robust measure is the area under the curve of 
pathogen load [4]. However, this requires repeated measures, and may be difficult to 
implement (see chapters 1 to 3). If repeated measures are available however, a possible 
proxy for tolerance may be found with trajectories and their derived phenotypes which 
address the various potential problems with tolerance applied to outbred populations 
outlined above. 
 
7.3 Would selecting for resilience be sufficient? 
Resilience is commonly defined as the ability of the host to maintain performance 
when exposed to infection, i.e. the genetic effect on performance during an outbreak 
of disease [25,134]. Resilience differs from tolerance in that the underlying pathogen 
load of the host is not considered. In chapters 1 and 2 we discussed the statistical 
constraints of estimating genetic variance in tolerance. Resilience is unlikely to have 
these statistical constraints. As such, resilience may be a more practical and attractive 
trait to implement into an animal breeding program. However, resistance and tolerance 
together contribute to overall resilience of an individual [4]. A careful balance between 
resistance and tolerance that would maximise resilience of the individual to infection 
is the ideal genetic selection program for control of infectious disease. It should be 
noted that where within-host pathogen load is low, both tolerant and non-tolerant 
individuals may be resilient to infection, given that an increase in pathogen load could 
lead to loss of tolerance. However, where pathogen load is high, it is only tolerant 
individuals that exhibit resilience. Thus, care must be taken to account for within-host 
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pathogen load when selecting for resilience. In chapter 3, we identified an overall 
positive strong relationship between resistance and tolerance i.e. that individuals who 
were more resistant were also more tolerant. Furthermore, we identified that the WUR 
genotype that was known to be associated with growth under infection and resistance 
to PRRS [23,57,58], was also suggestively associated with tolerance. This indicates 
that resistance and tolerance may be pleiotropic, indicating that selection of one trait 
may potentially have a positive effect on the other. If this is indeed the case, then 
selection for resilience would likely improve both resistance and tolerance to PRRS.  
It could be concluded, then, that from a pure production point of view at least, genetic 
selection for resilience may indeed be the answer to improving pigs response to 
PRRSV infection. However, it should be noted that this may not be the case for other 
infectious diseases. As stated in the introduction, there are theoretical different 
epidemiological and evolutionary outcomes for selecting for resistance or tolerance, 
or indeed, a balance of both. Briefly, resistance could put selection pressure on the 
pathogen and drive pathogen co-evolution, where tolerance would not affect the 
pathogen, per se, and therefore would not drive pathogen co-evolution. Furthermore, 
only resistance could potentially eradicate a pathogen from a population, where 
tolerance would only mitigate the impact of infection on the host [32,79,124]. As such, 
selection for tolerance would be preferred where a pathogen is highly prevalent and 
difficult to eradicate from a population, such is the case with PRRS. Our finding that 
resistance and tolerance are positively correlated indicates that the epidemiological 
and evolutionary theory may be more convoluted, in that there may not be the trade-
off between resistance and tolerance highlighted in the literature [30], at least when 
applied to PRRS.  
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Still, great care must be taken as to the timing of genetic selection. Having identified 
genetic variation in tolerance at mid-late stage of infection, we also analysed the 
relationship between resistance and tolerance at this stage. Although standard errors 
were high, there was a negative genetic correlation between resistance and tolerance 
at this stage, suggesting that there is a trade-off between resistance and tolerance at 
certain stages of infection. In which case, selecting for resilience may have undesired 
consequences on either tolerance or resistance at a certain stage of infection. Indeed, 
in chapter 4 we analysed the relationship between resistance and resilience at different 
stages of infection (growth under infection). Early in infection, resistant individuals 
had slower growth, in accordance with resource allocation theory, which would imply 
that energy resources were diverted from growth to combat infection [13]. Indeed, a 
strong positive correlation between VL and growth at mid stage infection suggested 
that those who were less resistant had consequently higher growth under infection. If 
this is the case, again, there would those selected for resilience at this stage would have 
higher VL, and would thus be more likely to spread the virus. This research also found 
a beneficial effect of the WUR genotype for growth, tolerance and resistance, where 
individuals with the favourable B allele demonstrated higher growth, less steep 
tolerance slope, and lower VL. It is likely then, that in this case, selecting for resilience 
would also improve resistance and tolerance to PRRS, and vice versa. Further research 
must be carried out into the underlying relationship between resistance and tolerance 





7.4 The application of trajectories in animal breeding 
A linear relationship between pathogen load and performance under infection cannot 
be assumed, as demonstrated in chapter 5, where trajectories revealed distinct phases 
of infection associated with different patterns of co-expression of resistance and 
tolerance. Trajectories are a conceptual tool which allow identification of ‘bad 
neighbourhoods’ in the infection-severity health plane, and illustration the 2D path 
towards death or survival for each individual [85]. Clinical evidence and mathematical 
dynamical systems theory stipulate that infection severity-health trajectories can be 
classified into few distinct types which may be useful for disentangling resistance and 
tolerance, which would be of great use for animal breeding [38,41]. Assuming 
resistance and tolerance are genetically regulated, implies that trajectories should also 
be under host genetic control, as was found in chapter 5, and may thus may be 
amenable to genetic selection. Immunological studies suggest that the outcome of 
infection may not necessarily depend on either resistance or tolerance alone, but is 
more likely to depend on genetically regulated dynamic interactions between the two 
mechanisms. Thus both mechanisms need to be evoked at the right time to ensure 
survival [5]. Considering resistance and tolerance as static traits that represent 
alternative host defense strategies may limit the power of genetic studies, not only 
because tolerance cannot be measured on the individual level, but also because 
resistance or tolerance may be expressed at different levels throughout the infection 
and depend on each other. Ignoring the dynamic co-expression of resistance and 
tolerance within a host may however lead to biased estimates of phenotypic and 
genetic correlations between both traits. For example, expression of resistance at the 
early stages of infection is likely to affect the expression of tolerance at the later stages 
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as fast pathogen clearance may prevent tissue damage and thus the onset of repair 
mechanisms associated with tolerance. Conventional statistical models that don’t 
account for this kind of interdependence between traits would result in a spurious 
antagonistic relationship between the traits, both on the phenotypic as well as on the 
genetic level [125], even if resistance and tolerance were controlled by different sets 
of genes or genetic pathways as suggested by immunological evidence [5,101]. 
Trajectories capture the dynamic signature and genetic footprint of both mechanisms 
on the level of individuals, together with their impact on survival. They may thus 
constitute useful phenotypes to identify novel genes that control infection dynamics 
and outcome. 
However, there are several drawbacks to trajectories that may limit their application 
to animal breeding. Firstly, they require longitudinal measures for each individual, 
which may be difficult to obtain in the field. Secondly, individuals may be at different 
stages of infection (see chapters 2 and 3), and thus measures taken in the field to define 
trajectories may be misleading. Thirdly, trajectories are a visual tool, and thus lend 
themselves more easily to qualitative rather than quantitative assessment. This allows 
identification of properties and that are shared and different between genetic 
background, for example expression of resistance and associated change in 
performance. However, this is not practical for genetic selection. Instead, trajectories 
need to be quantified.  
In chapter 6, we tried to identify genetic variation in trajectories by fitting a spline 
through the PHGC data using RRMs. Unfortunately, we could not determine if 
individuals varied genetically in trajectories due to model convergence issues. Instead, 
we derived novel phenotypes, which could serve as a proxy for tolerance by analyzing 
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change in host performance with respect to change in pathogen load. These may serve 
as novel phenotypes that can be applied to animal breeding. However, we did could 
not identify genetic variation in the phenotypes with this data. This may have been due 
to complications of individuals being at different stages of infection and highlights a 
potential constraint of trajectory analysis applied to animal breeding. However, it may 
be possible that there is genetic variation identifiable using other data, and this should 
be fully explored in future research.  
By utilising repeated measures for each individual, stages of infection were defined, 
in chapters 2 and 3, to explore the relationship between resistance, tolerance and 
growth under infection. Genetic variation was evident in both resistance and growth 
under infection, and this relationship was found to change throughout infection, with 
early resistance being associated with loss in growth, and less resistant individuals 
having faster growth under infection, implying potential tolerance. Indeed, if 
resistance and tolerance are overall under pleiotropic control, as suggested by results 
of chapter 3, it may be that genes conferring early resistance also confers later 
tolerance to infection. That the two are related means that it may be timing that is most 
important to select for an ideal balance between resistance tolerance. It may be 
possible, then, that defining stages of infection is another solution to exploring 
resistance-tolerance dynamics in outbred populations. Indeed, although the genetic 
signal was not as clear, it was possible to use duration to define stages of infection, 
making the definition of stages of infection easier to implement in animal breeding. 
Again, further research is required into different infection models to explore the 
possibilities of trajectory analysis and stages of infection. 
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7.5 Implications of research 
This study identified genetic variation in tolerance of pigs to PRRS in an outbred 
population using repeated measures. Tolerance may thus be a viable trait which can 
be explored in different infection models and under different scenarios. We have 
already made aware the potential pitfalls and limitations of tolerance and a phenotype. 
Here we discuss the potential implications of our findings, and the possibilities of 
using tolerance to explore new research. 
In chapters 2 and 3 we found that the WUR genotype was associated with resilience 
and resistance at different stages of infection, and with tolerance over all stages of 
infection. Genetic selection for individuals with the AB WUR genotype will likely 
simultaneously increase resilience, resistance and tolerance to PRRS, but this may 
affect other genomic regions associated with each trait. Whilst we did not identify 
other genomic regions statistically associated with these traits, that may not necessarily 
be the case for other infections. Furthermore, we found that WUR may be associated 
with growth at later stage of infection as a consequence of its association with 
resistance at early stage of infection. So, it may be that the WUR genotype was 
suggestively associated with tolerance over all stages of infection due to the positive 
relationship between resistance and tolerance. Further genomic analysis is required to 
analyse the relationship of genomic regions associated with these traits and between 
traits.  
The effect of resistance on tolerance cannot be ignored in future research. All the 
evidence provided from our research suggests that the two are related. Selection for 
one is likely to have consequences on other traits not targeted directly in the selection 
criterion. Further work must be carried out using longitudinal methods in different 
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infection models as to the different dynamics between resistance and tolerance, their 
contribution to overall host resilience, and the impact of their association on the 
epidemiology and evolution of the pathogen of interest. As large amounts of data are 
required for such infection experiments, simulations may be of interest to predict the 
effect of this different relationship on breeding values. For example, in chapter 2, we 
simulated performance in absence of infection (vigour) for relatives of individuals 
under infection, and tested the strength of association between vigour and tolerance 
slope, and the consequent impact of this relationship of the significance on tolerance 
slope. Although these findings are under a given set of assumptions, they constitute a 
valuable starting point at which to disentangle resistance and tolerance, and their 
contribution to resilience. By using breeding values for resilience and resistance it may 
be possible to infer their effect on tolerance by simulating a changing genetic 
correlation between resistance and resilience. Consequent predictions of genetic 
selection could then be tested, and if they are of interest, epidemiological models could 
be adopted to assess the impact of selection on spread of the pathogen of interest. 
In order to assess the impact of genetic selection for resistance, tolerance or trajectory 
characteristics on PRRS epidemiology and virus evolution, a genetic-epidemiological 
prediction model could be developed based on the results of this thesis. Such models 
already exist for other diseases, e.g. bacterial and parasite infections in small ruminants 
[135–137]. For PRRS, the genetic epidemiological model of MacKenzie et al. [138] 
or various epidemiological models for PRRS developed [139–142] may be a useful 
starting points. The results of this thesis would help to make these models more useful 
for breeding purposes. The theory of resistance driving pathogen co-evolution is also 
called into question if resistance and tolerance to PRRS are co-expressed at different 
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stages of infection. Pathogen co-evolution may be forced by individuals at early stage 
of infection, where those individuals express resistance. However, given the strong 
genetic relationship between resistance and tolerance, theoretically, those individuals 
may also be able to tolerate different strains of the pathogen, if mechanisms of 
tolerance reduce the damage caused by the pathogen or host immune response. That 
is, individuals will resilient to different strains of the pathogen, but may also drive 
pathogen co-evolution. This must be taken into account for heterogeneous populations, 
and any further evolutionary models should consider this if predicting mutations in 
PRRSV with relation to genetic selection programs.  
 
7.6 Conclusions 
With the PHGC dataset, it could be concluded that resilience may be a sufficient target 
for a genetic selection program to improve the response of pigs to PRRSV infection. 
Improving resilience in this case will likely both improve host resistance and tolerance 
to PRRS. However, there is potential unknown epidemiological and evolutionary 
implications of co-expression of resistance and tolerance at different stages of 
infection that must be accounted for before undertaking such a breeding program. 
Indeed, with the alternative Listeria dataset for inbred mouse populations studies 
within this thesis, we highlighted potential uses of trajectory analysis for subsequent 
genetic studies. Successful integration of trajectories in genetic evaluations of outbred 
animal populations would account for the relationship between resistance and 
tolerance, and may increase overall resilience. Finally, should we aim for genetic 
improvement of host resistance or tolerance to infectious disease? For PRRS, the 
answer is likely both.  
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